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Editorial on the Research Topic
Spotlight on the Background Actors - Physiology and Pathophysiology of Supporting, 
Accessory and Less Common Cell Types in the Gastrointestinal Tract
The gastrointestinal (GI) tract is an entire system of different organs and tissues, which not only 
forms a continuous passageway between the mouth and the anus, but also includes the organs 
that aid food intake and digestion such as the pancreas, liver, gallbladder, or tongue. The primary 
role of the GI tract is ingestion of food, followed by breakdown and absorption of nutrients as 
well as removal of the remaining waste. Additionally, the GI tract serves as part of the immune 
system and maintains the microbial homeostasis by hosting gut microflora and preventing the 
expansion of potentially harmful bacteria. Given the magnitude and complexity of its roles, it 
is not surprising that the GI tract comprises vast spectrum of cell types of distinct morphology 
and specialized functions. However, not all of those cells receive the same amount of scientific 
attention. Owing to their prevalence or obvious physiological functions, cells such as hepatocytes, 
enterocytes, or pancreatic acinar cells have been subjects of a large number of studies in the past 
decades. Many other cell types of lower abundance or less clear physiological roles have not been 
perceived as equally attractive research targets and as a result have not been extensively investigated 
or characterized.
As the name of this Research Topic suggests we intended to put in the spotlight somewhat 
overlooked “background actors” of the GI tract. Although nine articles in this collection might 
at first seem very diverse in terms of the subjects they touch on, they share a focus on accessory, 
supporting or less common cell types found in the intestine, stomach, or pancreas. These articles 
explore physiological roles pertaining to these cells, describe new methodology or provide a concise 
review of the current knowledge.
An interesting example of an intestinal cell type are Paneth cells. These cells are known for their 
role in the innate immunity as they secrete antimicrobial peptides. Singh et al. review the literature 
on metaplastic Paneth cells in order to understand their etiology and the role they play in intestinal 
metaplasia. The authors conclude that the presence of metaplastic Paneth cells at extra-intestinal 
mucosal sites could be linked to a protective response induced by the altered microbiome. A study
by Burgueno et al. also touches on the subject of gut microbiota. 
The authors not only describe methodology for measuring 
epithelial production of H2O2 but also demonstrate very 
interesting evidence that intestinal epithelial cells (IECs) generate 
and release H2O2 in response to chronic inflammation or as a 
result ofmicrobial imbalance. This underlies the pivotal role IECs 
play in the innate defense mechanisms and in maintaining the 
intestinal homeostasis.
Moving onto the stomach, populations of cells in the gastric 
epithelium that express a bitter taste receptor Tas2r126 have been 
identified by Widmayer et al.. Although their role is not yet 
entirely clear, the authors speculate that these cells may be part 
of a “surveillance system” that could detect certain constituents 
of the luminal content and, by conveying this information to the 
gastric effectors, control appropriate responses of the stomach 
to the chemical composition of the luminal content. Further, 
Baratta et al. provide a review of research methodology used in 
studies on the parietal cells, an epithelial cell type in the stomach 
whose main function is secretion of hydrochloric acid. The article 
describes parietal cell isolation and culture as well as discusses the 
(patho)physiology of these elusive cells and highlights the major 
research milestones.
Pancreatic cell types have received relatively a lot coverage 
in this Themed Issue. Gal et al. describe a method of 
acute isolation of the pancreas that is particularly useful 
in studying pancreatic ducts and ductal cells. The method 
is based on injection of low-melting-point agarose into the 
pancreas via the common bile duct and it allows not only 
for morphological characterization of these cells but also for 
functional investigation. A very interesting study comes from 
DelGiorno et al., who show that chronic pancreatitis (CP) and 
acinar-to-ductal metaplasia trigger formation of tuft cells in the 
mouse pancreas and that this process appears to be affected by 
the mouse genetical background.
Finally, the physiology of pancreatic stellate cells (PSCs), 
whose activation is a hallmark of pancreatic disorders, has 
been highlighted by articles from three different groups. Kuntze 
et al. have investigated the function of mechanosensitive ion 
channel Piezo1 in these cells and draw conclusions about its 
role in the pathogenesis of pancreatic ductal adenocarcinoma 
(PDAC). Stimulation of this channel induces Ca2+ influx and
is associated with alterations in the cytoskeletal architecture. 
According to the repot, Piezo1 is sensitive to extra- and 
intracellular acidification, which may downregulate its excessive 
activation in response to the mechanical stress exerted by the 
PDAC stroma and thus protect PSCs against Ca2+ overload and 
cell death. Hu et al. present the role of Yes-associated protein 
1 (YAP) in the regulation of PSC activation, proliferation, and 
fibroinflammatory responses during CP and PDAC progression. 
The authors also highlight the crosstalk between the YAP, 
TGF-ß , and PDGF signaling pathways, all of which regulate PSC 
activation and growth. We can learn even more about signaling 
pathways in PSCs from the article by Kusiak et al., who set the 
focus of their brief review on the Hippo, W nt pathways, Ca2+ 
signaling as well as mechanosensing, highlighting the role of all 
the above in (patho)physiology of the pancreas.
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Introduction: The tissue slice technique offers several benefits compared to isolated 
cells and cell clusters that help us understand the (patho)physiology of several organs 
in situ. The most prominent features are preserved architecture and function, with 
intact homotypic and heterotypic interactions between cells in slices. In the pancreas, 
this technique has been utilized successfully to study acinar and endocrine islet cells. 
However, it has never been used to investigate ductal function. Since pancreatic ductal 
epithelial cells (PDECs) play an essential role in the physiology of the pancreas, our aim 
was to use this technique to study PDEC structure and function in situ.
Materials and methods: Eight- to sixteen weeks old C57BL/6 mice were used for 
preparation of pancreas tissue slices. Low melting point agarose was injected into the 
common bile duct and the whole organ was extracted. For morphological studies, 
pieces of tissue were embedded in agarose and cryosectioned to obtain 15 ^m  thick 
slices. In order to visualize pancreatic ducts, (i) the Giemsa dye was added to the 
agarose and visualized using light microscopy or (ii) immunostaining for the cystic 
fibrosis transmembrane conductance regulator (CFTR) was performed. For functional 
characterization, agarose-embedded tissue was immediately cut to 140 ^m  thick tissue 
slices that were loaded with the cell permeant form of the Oregon Green 488 BAPTA-1 
dye and used for confocal calcium imaging.
Results: Giemsa staining has shown that the injected agarose reaches the head and 
body of the pancreas to a greater extent than the tail, without disrupting the tissue 
architecture. Strong CFTR expression was detected at the apical membranes of PDECs 
and acinar cells, whereas islet cells were completely negative for CFTR. Stimulation 
with chenodeoxycholic acid (CDCA, 1 mM) resulted in a robust transient increase in 
intracellular calcium concentration that was readily visible in >40 ductal cells per slice.
Conclusion: Our results confirm that the acutely-isolated pancreas tissue slice
technique is suitable for structural and functional investigation of PDECs and their 
relationship with other cell types, such as acini and endocrine cells in situ. In combination 
with different genetic, pharmacological or dietary approaches it could become a method 
of choice in the foreseeable future.
K eyw ords: pancreas, s lice , duct, ca lc ium , CFTR, G iem sa, ch en o d eo xych o lic  acid
INTRODUCTION
The tissue slice technique is a suitable in situ experimental system 
for investigating structure and function of different tissues, 
such as the brain, liver, adrenal gland, and retina (Skrede and 
Westgaard, 1971; Moser and Neher, 1997; Enoki et al., 2006; 
Graaf et al., 2007). Speier et al. applied and optimized this 
technique to study pancreatic beta cell function (Speier and 
Rupnik, 2003). Since then, it was successfully used to study 
the functional organization and calcium dynamics of beta cells 
within islets (Dolensek et al., 2013; Stozer et al., 2013a,b). 
The technique has also been applied to characterize acinar cell 
morphology and secretory function (Marciniak et al., 2013, 2014; 
Liang et al., 2017). Although there are several in vitro approaches 
for the isolation of both islets and acini from the pancreas, 
importantly, the greatest advantages of tissue slice preparation 
technique is that it does not require enzymatic digestion and 
the architecture and viability of the cells are retained in an 
intact, nearly physiological environment. It is also important to 
emphasize that this technique is suitable for both morphological 
and functional imaging, as well as for electrophysiological 
studies and investigating interactions between neighboring cells 
or between the exocrine and endocrine part of the pancreas 
(Marciniak et al., 2013; Klemen et al., 2014).
Basically, there are two major cell types in the exocrine 
pancreas, the acinar cells and the pancreatic ductal epithelial 
cells (PDECs). Although PDECs comprise only a very small 
fraction of the entire organ, they play an essential role in 
maintaining the integrity of the pancreas. PDECs secrete an 
H C O --rich, alkaline solution that neutralizes the acidic pH 
of gastric juice, curtails premature trypsinogen activation, and 
delivers digestive enzymes from the pancreas to the small 
intestine (Argent Be, 1994; Argent, 2006; Dolensek et al., 2017). 
Insufficient or decreased HCO--secretion can lead to cystic 
fibrosis or trigger acute or chronic pancreatitis (Scheele et al., 
1996; Venglovecz et al., 2008, 2011; Hegyi and Rakonczay, 
2010). Therefore, intensive research has been conducted to 
characterize the ductal function both under physiological and 
pathophysiological conditions (Hegyi et al., 2011; Judak et al., 
2014; Katona et al., 2016; Venglovecz et al., 2018). In the 80’s, 
Barry Argent and his colleagues worked out a novel technique 
that allows the isolation of intact intra-interlobular pancreatic 
ducts from the pancreas of rodents (Argent et al., 1986). This 
methodological development was a very important milestone in 
the physiology of the pancreas, since it pointed out that ductal 
cells not only provide a framework for acini, but also secrete 
HCO- . However, this technique has many limitations. Ducts are 
isolated from the pancreas after an enzymatic digestion that may 
result in functional changes. The isolation procedure is long and 
the ducts should be incubated overnight in order to facilitate 
their regeneration, similarly to isolation and cultivation of islets 
of Langerhans, which can importantly affect their function 
(Gilon et al., 1994). In addition, the biggest disadvantage of this
Abbreviations: CDCA, chenodeoxycholic acid; CFTR, cystic fibrosis
transmembrane conductance regulator; ECS, extracellular solution; OG B-1, 
Oregon Green 488 BAPTA-1; PDECs, pancreatic ductal epithelial cells.
technique is that the ductal cells are isolated from their normal 
environment and, therefore not influenced by other cell types, 
which can fundamentally support and influence their function. 
We strongly believe that the pancreas slice preparation is much 
closer to the physiological conditions than the duct isolation 
technique and therefore provides a better experimental model 
to study the function of PDECs both under physiological and 
pathophysiological conditions.
Our aim in this study was to use the acutely-isolated 
pancreas tissue slice technique for the morphological and 
functional investigation of PDECs. We have shown that the 
ductal cells preserve their viability after the preparation and 
that the technique is suitable for functional multicellular 
calcium imaging.
MATERIALS AND METHODS 
Ethical Approval
Animal experiments were conducted in compliance with 
the Guide fo r  the Care and Use o f  Laboratory Animals 
(United States, Department of Health and Human Services, 
NIH publication No 85-23, revised 1985) and the experimental 
protocol was approved by the local Ethical Board of the 
University of Szeged, the National Scientific Ethical Committee 
on Animal Experimentation (Budapest, Hungary), and the 
Veterinary administration of the Republic of Slovenia (permit 
number: U34401-12/2015/3).
Chemicals and Solutions
Cystic fibrosis transmembrane conductance regulator (CFTR) 
human, polyclonal antibody was ordered from Alomone Labs 
(Jerusalem, Israel). Alexa Fluor Goat Anti-Rabbit IgG secondary 
antibody was obtained from Abcam (Cambridge, UK). Cell 
permeant acetoxymethyl ester of Oregon Green 488 BAPTA- 
1 (OGB-1) was from Invitrogen (Eugene, OR, USA). All other 
laboratory chemicals were ordered from Sigma-Aldrich Kft. 
(Budapest, Hungary). Extracellular solution (ECS) contained (in 
mM): 125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 6 glucose, 
6 lactic acid, 3 myo-inositol, 0.5 ascorbic acid, 2 Na-pyruvate, 
1 MgCl2, and 2 CaCl2. ECS was gassed with 95% O2/5% CO2 
to set pH to 7.4. For calcium dye loading, we used a HEPES- 
buffered solution containing (in mM): 150 NaCl, 10 HEPES, 6 
glucose, 5 KCl, 2 CaCl2, 1 MgCl2; titrated to pH =  7.4 using 
1 M NaOH. For stimulation of PDECs during confocal imaging, 
we used 1 mM chenodeoxycholic acid (CDCA) dissolved 
in ECS.
Preparation of Pancreas Tissue Slices
Eight- to Sixteen weeks old C57BL/6 mice of either sex were used. 
Preparation of acutely-isolated pancreas tissue slices has been 
described in detail previously (Speier and Rupnik, 2003; Stozer 
et al., 2013a; Marciniak et al., 2014). Briefly, after sacrificing 
the animal, the abdomen was accessed via median laparatomy, 
the papilla of Vater clamped distally and 1.5-2.5m l of low- 
melting-point agarose (1.5—1.8%, with or without Giemsa dye, 
according to protocol) was injected into the common bile duct 
using 30 G needles. The injected pancreas was then cooled with
FIGURE 2 | Giemsa staining of the pancreas. Representative cryosections were cut from the head (A), body (B), and tail (C) of the pancreas. Giemsa stain causes 
dark coloring of the nuclei of inter-intralobular ducts in the head and body of the pancreas and slightly in the tail. (D) Magnified picture of (A). Arrows indicate dark 
coloring of the nuclei. (E) Representative cryosection from the head of the pancreas shows that Giemsa stained the duct (d) but not the blood vessels (bv).
ice-cold ECS and transferred into a sterile Petri dish containing 
ice-cold ECS (Figure 1A). Higher magnification image of the 
gland shows the presence of an interlobular duct (Figure 1B) . 
In the next step, the pancreas was cleaned from fat and 
connective tissue, and cut into small pieces (0.25-1.0 cm3 in 
size) using surgical scissors. Individual pieces of agarose-injected 
pancreas were embedded in agarose (1.5-1.8%) (Figure 1C) and 
further sectioned either for immunohistochemistry (IHC) or
for calcium imaging. For IHC, the isolated tissue was further 
embedded in cryomatrix and cut into 15 ^m  sections using a 
CM1800 cryostat (Leica Biosystems, Wetzlar, Germany). For 
calcium imaging, 140 ^m  thick sections were cut using a VT1000 
vibratome (Leica Biosystems, Wetzlar, Germany) while the tissue 
was continuously buffered with ice-cold gassed ECS. Thirty to 
forty slices were prepared per animal and used immediately 
for staining.
FIGURE 1 | Preparation of pancreas slices. (A) Mouse pancreas after injection with agarose. (B) Higher magnification (40X) of the isolated pancreas with an 
intralobular duct (black arrow head). (C) Pancreas tissue pieces embedded in agarose cubes.
Immunohistochemistry
The cryosections were fixed in 4% (v/v) paraformaldehyde for 
20 min at room temperature (RT) and washed in PBS 2 -3  times. 
Slices were permeabilized with 0.05% TritonX-100 at RT for 
30 min and blocked with the mixture of 1% (v/v) bovine serum 
albumin/Tris-buffered saline (BSA/TBS) and 10% (v/v) goat 
serum for 30 min. After the blocking step, slices were incubated 
with the CFTR rabbit polyclonal antibody (1:100 dilutions) at 
40C, overnight. After the incubation, slices were washed 2-3 
times with PBS and incubated with Alexa fluor 488-conjugated 
goat anti-rabbit IgG secondary antibody (1:400 dilutions) for 
3h  at RT. Nuclei were stained with DAPI (1:500 dilutions in 
BSA/TBS) for 15 min, followed by washing three times in PBS. 
Slices were mounted using Fluoromount and analyzed using 
a LSM 880 confocal laser scanning microscope (Carl Zeiss 
Technika Kft., Budaörs, Hungary). Pancreas slices were excited 
at 405 (Dapi) and 488 (Alexa fluor 488) nm and emissions were 
collected at 453 and 516 nm, respectively.
Giemsa Staining
Giemsa was diluted in low-melting-point agarose (1.5%) at a 
ratio of 1:10, then injected into the common bile duct of the 
mice as described in the Preparation of Pancreas Tissue Slices 
section. After the injection, the pancreas was removed cleaned 
and cut into three pieces (head, body, and tail). Each pieces 
of the pancreas were then embedded into cryomatrix and cut 
into 15 ^m  sections using a CM1800 cryostat (Leica Biosystems, 
Wetzlar, Germany) and Giemsa staining was analyzed using
an Axio Scope.A1 light microscope (Carl Zeiss Technika Kft., 
Budaörs, Hungary).
Calcium Imaging
Ten to fifteen slices were incubated in dye-loading solution 
containing 6 ^M  of OGB-1, 0.03% Pluronic F-127 (w/v) and
0.12% dimethylsulphoxide (DMSO, v/v, dissolved in HEPES- 
buffered solution) for 50 min at RT on an orbital shaker (50 
turns min- 1 ). Imaging was made within 12 h after staining. 
Following staining, slices were kept protected from light in a dye- 
free HEPES-buffered solution, which was exchanged every 2 h. 
Individual slices were transferred into the recording chamber of 
either a Leica TCS SP5 II inverted confocal system [Leica HCX PL 
APO CS 20x immersion objective (NA =  0.7)] or an upright Leica 
TCS SP5 II confocal system [Leica HCX APO L water immersion 
objective (20x, NA =  1.0)]. Slices were continuously perfused 
with gassed ECS at 370C. OGB-1 was excited by an argon 488 nm 
laser and fluorescence detected by Leica HyD hybrid detector in 
the range of 500-650 nm. Eight-bit 512 x  512 pixels images at 1 
frame per second were acquired. CDCA stimulation was achieved 
by manually exchanging delivery tubes of the perifusion system.
RESULTS 
Visualization of Pancreatic Ducts in Freshly 
Prepared Slices
In order to investigate how deep, the agarose penetrates into 
the ductal tree, Giemsa dye was added to the low melting 
point agarose (1.5%) in 1:10 dilutions and injected into the
FIGURE 3 | Representative immunofluorescence staining of CFTR in agarose-injected mice pancreas. Pictures were taken at 20X magnification.
FIGURE 4 | [Ca2+ ] i response in ductal cells after stimulation with 1 mM CDCA. (A) Confocal fluorescence image of a ductal structure and surrounding acinar tissue 
with selected regions of interest (ROI) denoting nuclei of individual PDECs. (B) Chenodeoxycholic acid (CDCA) induced [Ca2+ ]  responses of individual cells 
corresponding to numbered ROIs in (B) (1-6). (C) Concurrent transmitted light image. (D) Dashed vertical line indicates the start of exposure to 1 mM CDCA. (E,F) 
Bee swarm plots with interquartile ranges and medians for delays of responses after stimulation with 1 mM CDCA (n =  65 cells from 4 slices) (E) and durations of 
transient [Ca2+ ]  events (n =  38 cells from 4 slices) (F).
main pancreatic duct, as described in section Materials and 
Methods. Freshly prepared pancreas slices of 15 ^m  thickness 
from the head, body, and the tail were examined under a 
stereomicroscope. Figure 2 shows representative tissue slices 
with intact pancreas morphology and visible structures of 
exocrine and endocrine cells. Strong nuclei staining was detected 
in the intra- and inter-lobular ducts of the head (Figures 2A,B) 
and the body of the pancreas (Figure 2C ), whereas only weak 
staining was found in the tail part (Figure 2D ). Blood vessels were 
completely negative (Figure 2E ), indicating that the injection 
affects only the ductal tree. Using CFTR immunostaining, we 
were able to identify more specifically the ductal cells in the tissue 
slices. Under normal conditions, CFTR channel is expressed at 
the apical membrane of the ductal cells. As shown on Figure 3 , 
strong CFTR staining was detected at the apical membrane of 
PDECs and acini, whereas islet cells and blood vessels were 
completely negative for CFTR.
CDCA Stimulation Induced a Transient 
Change in Intracellular Calcium 
Concentration
To functionally characterize ductal-like structures, we resorted 
to confocal calcium imaging. Under non-stimulatory conditions, 
PDECs were brightly stained with OGB-1. Moreover, the 
dye accumulated in the nuclei producing a typical visual 
pattern of a mono-layered epithelium (Figures 4A -C  and 
Supplemental Video 1). The tissue slice technique also 
enables simultaneous visualization of exocrine acinar cells 
and islets of Langerhans (Supplemental Figure 1 and 
Supplemental Video 1). Moreover, calcium activity could 
be recorded from acinar cells in parallel with PDEC activity, 
whereas the islets of Langerhans did not respond to the stimulus 
used in this study (Supplemental Figure 2 ). We stimulated 
the PDECs using a square pulse-like protocol in which the 
tissue slices were initially perifused with ECS only, followed by
FIGURE 5 | Spatial displacement of ductal cells after stimulation with 1 mM 
CDCA. An intralobular duct is shown before (A) and during (B,C) the 
stimulation with chenodeoxycholic acid (CDCA). Constructs depicting early (B) 
and late (C) [Ca2+ ]i response to CDCA display a background of cellular 
morphology in gray, and an overlay of calcium response in green (see Results 
section for detailed description). In some PDECs no spatial movement was 
detected (insets *), whereas in some cells noticeable spatial displacements 
were observed (insets ^). Please note that in the PDECs that were displaced 
during CDCA response, change in [Ca2+ ]i preceded the spatial displacement, 
therefore not interfering with the calcium response detection.
ECS containing 1 mM CDCA for 10 min. CDCA stimulation 
evoked a response that was detected in many cells within a 
single visual field (Figure 4B ). Individual PDECs responded 
with a transient increase in [Ca2 + ] i , followed by a decrease 
in [Ca2 + ] i  to a sustained plateau (Figure4D ) . The median 
response delay to CDCA stimulation was 14.0 s (Q1 =  11.0s 
and Q3 =  24.8 s, Figure 4E ) and the median duration of 
the transient change in [Ca2 + ]  was 27.5s (Q1 =  17.0s and 
Q3 =  38.0 s, Figure 4F ).
Coupled with the calcium response, a spatial displacement of 
PDECs was observed upon stimulation with CDCA (Figure 5 ) . 
In order to exclude the possibility that the detected [Ca2+ ]j 
signal in response to CDCA stimulation was an artifact of cell 
displacement, we meticulously characterized the movement and 
compared it with the [Ca2 + ]  signal. The calcium response was 
calculated as Fresp (t) =  F(t) — F 0 , where Fresp (t) presents 
the calculated calcium response at time t, F0 the average of the 
first 100 frames under non-stimulatory conditions and F (t) the 
calcium signal at time t. A construct was created in which 
the Fo  frame was displayed in grayscale and Fresp (t) was 
overlaid in green (Figure 5 and Supplemental Video 2 ). Figure 5 
shows this construct before CDCA stimulation (Figure 5A), 
as well as the immediate (Figure 5B ) and late response to 
CDCA (Figure 5C). The initial increase in [Ca2 + ]  was coupled 
with either no (Figure 5B , inset *) or minimal (Figure 5B , 
inset f ) spatial movement. In contrast, later during the calcium 
response, some cells failed to display the spatial displacement 
(Figure 5C , inset *), whereas others profoundly changed their 
location (Figure 5C , inset f ). The facts that (i) the [Ca2 + ]  
increase preceded the spatial displacement, and that (ii) [Ca2+ ] j 
transients, similar to the ones in PDECs that did not displace, 
were recorded from all PDECs that underwent displacement, 
strongly substantiate that the observed [Ca2 + ] i  signals are not a 
motion artifact.
DISCUSSION
We successfully applied the tissue slice preparation technique to 
study PDECs. The main hallmark of the tissue slice approach, 
especially in contrast to the majority of studies that were done 
by isolating ducts using enzymes, is that the homotypic as 
well as heterotypic interactions are preserved. Histological and 
functional evaluations of the slices have shown that the slicing 
procedure did not damage the structure or the function of the 
tissue indicating that this technique represent an excellent in 
situ model in which the function and the cell-cell interactions of 
PDECs can be investigated.
For the study of pancreatic acini and islets, the thickness 
of the tissue slices is critical. The ideal thickness is 100­
200 ^m , depending on the use of the slice (Marciniak et al., 
2014). For the functional cell imaging of PDECs, we found 
that a practically useful thickness of the slices is 140 ^m , 
enabling the calcium dye to penetrate the cells and allowing 
for preservation of morphological tissue structure at the same 
time. Moreover, this thickness allowed for diffusion of gases
and nutrients into the tissue. Tissue slices could be maintained 
for > 8 h  in HEPES-buffered solution at RT, however, for even 
longer studies optimization of the culturing media and use of 
culture incubators might be needed. One of the critical steps 
in the preparation of the slices was the injection of agarose. 
Since pancreas is a “soft” type tissue, injection of agarose 
serves as a scaffold that stabilized the tissue during cutting. 
The scaffold effect was achieved by injecting low-melting point 
agarose at 37° C into the common bile duct, filling the ductal 
tree retrogradely. Our results have shown that agarose reaches 
the head and the body of the pancreas and to a smaller 
extent the tail. We found that the injection procedure did 
not affect the function or the structure of the ductal cells 
as confirmed by the histological and functional investigations. 
Preservation of the intact epithelium has also been confirmed 
by the fact that the presence of the epithelial-specific ion 
channel, CFTR, could be detected on the apical membrane of the 
ductal cells.
Normal calcium signaling plays a central role in the 
physiological regulation of HCO— secretion by PDECs which 
is important for neutralization of protons secreted by acinar 
cells, as well as for keeping trypsinogen in an inactive form and 
washing it away. Pathologically changed calcium signals, through 
calcium overload of PEDCs, decreased ATP production due to 
mitochondrial damage, and impaired HCO3— secretion seem to 
importantly contribute to pathogenesis of acute and chronic 
pancreatitis (Lee and Muallem, 2008). The toxic calcium signals 
may be an interesting therapeutic target and thus models that 
enable studies of PDECs function in normal and pathological 
conditions are of great practical relevance (Hegyi and Petersen, 
2013; Maleth and Hegyi, 2014). To the best of our knowledge, 
there is only one previous study that analyzed calcium signals in 
response to bile acids in PDECs. In guinea pig intra-interlobular 
ducts, low concentration of CDCA, i.e., 0.1 mM, elicited 
regenerative calcium oscillations that lasted 2 -5  min and at 
this concentration, HCO3— secretion was significantly stimulated 
(Venglovecz et al., 2008). This concentration corresponds with 
concentrations of taurolithocholic acid sulfate (TLC-S) that 
elicited calcium responses in the majority of mouse acinar 
cells. Interestingly, the calcium response in acinar cells was 
qualitatively very similar to the one in guinea pig PDECs 
(Voronina et al., 2002). In contrast, 1 mM CDCA produced 
a transient increase in [Ca2 + ] i  lasting approximately 5 min, 
followed by a sustained plateau that returned to the baseline 
upon termination of stimulation. At this concentration, HCO3— 
secretion was strongly inhibited (Venglovecz et al., 2008). High 
concentration of TLC-S (0.5 mM) caused a qualitatively very 
similar response in [Ca2 + ] i in mouse acinar cells (Voronina 
et al., 2002). An important difference in the calcium response 
between the primary tissue and the slice preparation is that 
the transient was approximately an order of magnitude shorter 
(i.e., lasting about 30 s) in the case of slices. Also, in contrast 
to the behavior in acinar cells, the calcium signals did not 
seem to be synchronized between different PDECs (Petersen 
and Findlay, 1987). It needs to be pointed out however, that 
during supraphysiologically high [Ca2 + ] i also acinar cells may 
be uncoupled (Hegyi and Petersen, 2013). In future studies,
the dose dependence of calcium responses in PDECs needs 
to be studied into more detail and the slice preparation 
offers the possibility to simultaneously study the responses of 
acinar cells. In addition, the specific composition of mouse 
bile should be taken into account and different bile acids 
tested for their potential to produce regenerative or sustained 
calcium responses (Sayin et al., 2013). This shall enable 
us to assess whether the observed quantitative differences 
are due to different methodological approaches or due to 
inter-species differences in responses to bile acids, depending 
on the relevance of a given bile acid in a given species. 
Most importantly, a more detailed description of normal and 
pathological calcium signals in mouse PDECs can help us better 
understand the etiopathogenesis of pancreatitis and find new 
therapeutic targets.
An especially interesting observation in this study was that 
following the CDCA stimulation, we recorded movement of 
PDECs, a property of PDECs not shown before (Figure 5 ) . 
This active PDEC movement was not uniformly detected in all 
the cells, moreover it was preceded by the [Ca2 + ] i  increase, 
confirming that the recorded [Ca2 + ] i  signal was not an artifact 
of this movement. It is not clear what is the mechanism 
causing the movement of PDECs following CDCA stimulation. 
A change in osmolality of the local milieu due to the stimulated 
HCO3— secretion may result in an osmotically driven movement. 
However, we believe this not to be the case since (i) 1 mM 
CDCA more likely inhibits than stimulates HCO3— secretion 
(Venglovecz et al., 2008), and (ii) the shape of the PDECs as 
well as of the surrounding acinar cells remained unaffected. 
More likely, myoepithelial cells in the ducts could provide a 
mechanistic substrate for active contraction (Puchtler et al., 
1975). Therefore, further experiments will be needed to resolve 
this issue.
In conclusion, we have successfully applied the tissue slice 
preparation in which the structure and function of PDECs are 
preserved. This model represents an in situ microenvironment 
that enables studying PDECs under both physiological and 
pathophysiological conditions and their interaction with the 
acinar or endocrine cells. This model also opens up the 
possibilities to investigate human pancreatic function in an 
intact, in vivo-like environment.
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S upp lem en ta l V ideo  1 | XYZ-stack of OGB-1 loaded acute tissue slice. 
Morphology of the intralobular duct can be followed, and surrounding acinar and 
islet cells can be observed. Please note that the structure of acinar cells, as well 
as an islet of Langerhans, can also be observed in the XYZ-stack.
S upp lem en ta l V ideo  2 | Video demonstrates construct of confocal time series 
images (see Results section for detailed description). CDCA stimulation from 
3.07 s onwards. Background displays cellular morphology in gray, and an overlay 
of calcium response is depicted in green. See Results section for interpretation.
S upp lem en ta l F igure 1 | OGB-1 loaded acute tissue slice demonstrating that 
different cells types can be visualized simultaneously. The yellow stars depict 
exocrine acinar cells, the yellow dashed line depicts the border of a pancreatic 
duct, and the yellow dashed-dotted line depicts the border of an islet of 
Langerhans.
S upp lem en ta l F igure 2 | (A) OGB-1 loaded tissue slice. (B) On the same slice, 
PDECs responding to  1 mM CDCA (red) and spontaneously active acinar cells 
(blue) are depicted. Numbers correspond with calcium traces in (C). (C) Calcium 
activity o f PDECs during stimulation with 1 mM CDCA (red) and spontaneous 
activity o f acinar cells within the slice shown in (B). Numbers correspond with the 
labels in (B).
REFERENCES
Argent Be, C. R. (1994). “Pancreatic ducts. Cellular mechanism and control of 
bicarbonate secretion” in Physiology o fth e  G astrointestinal Tract, ed L .John son  
(New York, NY: Raven Press), 1473-1497.
Argent, B. (2006). “Cell physiology of pancreatic ducts,” in Physiology  
o f  the G astrointestinal Tract, 4th Edn, ed L. Johnson (San
Diego, CA: Elsevier), 1376-1396. doi: 10.1016/B978-012088394-3/
50057-X
Argent, B. E., Arkle, S., Cullen, M. J., and Green, R. (1986). Morphological, 
biochemical and secretory studies on rat pancreatic ducts maintained in 
tissue culture. Q. J. Exp. Physiol. 71, 633-648 . doi: 10.1113/expphysiol.1986.sp
003023
Dolensek, J., Poherec, V ., Rupnik, M. S., and Stozer, A. (2017). “Pancreas 
Physiology,” in Challenges in P ancreatic Pathology , ed A. Seicean (Romania: 
IntechOpen), 19-52. doi: 10.5772/65895 
Dolensek, J., Stozer, A., Skelin Klemen, M ., Miller, E. W ., and Slak Rupnik, M.
(2013). The relationship between membrane potential and calcium dynamics 
in glucose-stimulated beta cell syncytium in acute mouse pancreas tissue slices. 
PLoS ON E  8:e82374. doi: 10.1371/journal.pone.0082374 
Enoki, R., Jakobs, T. C., and Koizumi, A. (2006). Horizontal slice preparation of 
the retina. J. Vis. Exp. e108. doi: 10.3791/108 
Gilon, P., Jonas, J. C., and Henquin, J. C. (1994). Culture duration and 
conditions affect the oscillations of cytoplasmic calcium concentration 
induced by glucose in mouse pancreatic islets. D iabetolog ia  37, 1007-1014. 
doi: 10.1007/BF00400464 
Graaf, I. A., Groothuis, G. M ., and Olinga, P. (2007). Precision-cut tissue slices as 
a tool to predict metabolism of novel drugs. E xpert Opin. D rugM etab. Toxicol. 
3, 879-898 . doi: 10.1517/17425255.3.6.879 
Hegyi, P., Pandol, S., Venglovecz, V ., and Rakonczay, Z. Jr. (2011). The acinar- 
ductal tango in the pathogenesis of acute pancreatitis. Gut 60, 544-552. 
doi: 10.1136/gut.2010.218461 
Hegyi, P., and Petersen, O. H. (2013). The exocrine pancreas: the acinar-ductal 
tango in physiology and pathophysiology. Rev. Physiol. B iochem . P harm acol. 
165, 1-30. doi: 10.1007/112_2013_14
Hegyi, P., and Rakonczay, Z. (2010). Insufficiency of electrolyte and fluid secretion 
by pancreatic ductal cells leads to increased patient risk for pancreatitis. Am . J. 
G astroenterol. 105, 2119-2120 . doi: 10.1038/ajg.2010.191 
Judak, L., Hegyi, P., Rakonczay, Z. Jr., Maleth, J., Gray, M. A., and Venglovecz, 
V. (2014). Ethanol and its non-oxidative metabolites profoundly inhibit 
C FTR  function in pancreatic epithelial cells which is prevented by ATP 
supplementation. PflugersA rch. 466, 549-562 . doi: 10.1007/s00424-013-1333-x 
Katona, M ., Hegyi, P., Kui, B., Balla, Z., Rakonczay, Z. Jr., Razga, Z., et al.
(2016). A novel, protective role ofursodeoxycholate in bile-induced pancreatic 
ductal injury. A m . J. Physiol. Gastrointest. L iver Physiol. 310, G 193-G 204. 
doi: 10.1152/ajpgi.00317.2015
Klemen, M. S., Dolensek, J., Stozer, A., and Rupnik, M. S. (2014). 
“Measuring exocytosis in endocrine tissue slices,” in Exocytosis M ethods. 
N eu rom ethods , ed P. Thorn (Totowa, NJ: Humana Press), 127-146. 
doi: 10.1007/978-1-62703-676-4_7 
Lee, M. G., and Muallem, S. (2008). Pancreatitis: the neglected duct. Gut 57, 
1037-1039. doi: 10.1136/gut.2008.150961 
Liang, T., Dolai, S., Xie, L., Winter, E., Orabi, A. I., Karimian, N., et al.
(2017). Ex vivo human pancreatic slice preparations offer a valuable model 
for studying pancreatic exocrine biology. J. Biol. C hem . 292, 5957-5969. 
doi: 10.1074/jbc.M 117.777433
Maleth, J., and Hegyi, P. (2014). Calcium  signaling in pancreatic ductal 
epithelial cells: an old friend and a nasty enemy. C ell C alciu m  55, 337-345. 
doi: 10.1016/j.ceca.2014.02.004 
Marciniak, A., Cohrs, C. M., Tsata, V ., Chouinard, J. A., Selck, C., Stertmann, J., 
et al. (2014). Using pancreas tissue slices for in situ studies of islet of Langerhans 
and acinar cell biology. Nat. Protoc. 9, 2809-2822 . doi: 10.1038/nprot.2014.195 
Marciniak, A., Selck, C., Friedrich, B., and Speier, S. (2013). Mouse pancreas 
tissue slice culture facilitates long-term  studies of exocrine and endocrine cell 
physiology in situ. PLoS ONE 8:e78706. doi: 10.1371/journal.pone.0078706 
Moser, T ., and Neher, E. (1997). Rapid exocytosis in single chromaffin 
cells recorded from mouse adrenal slices. J. Neurosci. 17, 2314-2323. 
doi: 10.1523/JN EU RO SCI.17-07-02314.1997 
Petersen, O. H., and Findlay, I. (1987). Electrophysiology of the pancreas. Physiol. 
Rev. 67, 1054-1116. doi: 10.1152/physrev.1987.67.3.1054
Puchtler, H., Waldrop, F. S., Meloan, S. N., and Branch, B. W. (1975). Myoid fibrils 
in epithelial cells: studies of intestine, biliary and pancreatic pathways, trachea, 
bronchi, and testis. H istochem istry  44, 105-118. doi: 10.1007/BF00494071 
Sayin, S. I., W ahlstrom , A., Felin, J., Jantti, S., Marschall, H. U., Bamberg, K., et al.
(2013). Gut microbiota regulates bile acid metabolism  by reducing the levels of 
tauro-beta-m uricholic acid, a naturally occurring FX R  antagonist. C ell M etab. 
17, 225-235 . doi: 10.1016/j.cm et.2013.01.003 
Scheele, G. A., Fukuoka, S. I., Kern, H. F., and Freedman, S. D. (1996). Pancreatic 
dysfunction in cystic fibrosis occurs as a result of impairments in luminal 
pH, apical trafficking of zymogen granule membranes, and solubilization of 
secretory enzymes. Pancreas  12, 1-9 . doi: 10.1097/00006676-199601000-00001 
Skrede, K. K., and Westgaard, R. H. (1971). The transverse hippocampal slice: 
a well-defined cortical structure maintained in vitro . Brain  Res. 35, 589-593. 
doi: 10.1016/0006-8993(71)90508-7 
Speier, S., and Rupnik, M. (2003). A novel approach to in situ 
characterization of pancreatic beta-cells. Pflugers Arch. 446, 553-558. 
doi: 10.1007/s00424-003-1097-9 
Stozer, A., Dolensek, J., and Rupnik, M. S. (2013a). Glucose-stimulated calcium 
dynamics in islets of langerhans in acute mouse pancreas tissue slices. PLoS  
ONE 8:e54638. doi: 10.1371/journal.pone.0054638 
Stozer, A., Gosak, M ., Dolensek, J., Perc, M ., Marhl, M ., Rupnik, M. S., et al. 
(2013b). Functional connectivity in islets of Langerhans from mouse pancreas 
tissue slices. PLoS Com put. Biol. 9:e1002923. doi: 10.1371/journal.pcbi.1002923 
Venglovecz, V ., Hegyi, P., Rakonczay, Z. Jr., Tiszlavicz, L., Nardi, A., Grunnet, 
M ., et al. (2011). Pathophysiological relevance of apical large-conductance
C a2+-activated potassium channels in pancreatic duct epithelial cells. Gut 60, 
361-369 . doi: 10.1136/gut.2010.214213 
Venglovecz, V ., Pallagi, P., Kemeny, L. V ., Balazs, A., Balla, Z., Becskehazi, E., 
et al. (2018). The importance of aquaporin 1 in pancreatitis and its relation 
to the C FTR  C l— channel. Front. Physiol. 9:854. doi: 10.3389/fphys.2018. 
00854
Venglovecz, V ., Rakonczay, Z. Jr., Ozsvari, B., Takacs, T ., Lonovics, J., Varro, A., 
et al. (2008). Effects of bile acids on pancreatic ductal bicarbonate secretion in 
guinea pig. Gut 57, 1102-1112. doi: 10.1136/gut.2007.134361 
Voronina, S., Longbottom, R., Sutton, R., Petersen, O. H., and Tepikin, A.
(2002). Bile acids induce calcium signals in mouse pancreatic acinar cells: 
implications for bile-induced pancreatic pathology. J. Physiol. (Lond). 540,
49 -55 . doi: 10.1113/jphysiol.2002.017525
Conflict o f Interest Statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2019 Gal, D olensek, Stoźer, P ohorec, E bert an d  Venglovecz. This is an 
open-access article distributed u nder the term s o f th e  Creative C om m on sA ttribu tion  
License (CC BY). The use, distribution  or reprodu ction  in oth er foru m s isperm itted , 
p rov id ed  the original author(s) an d  the copyright ow ner(s) are cred ited  an d  that the 
orig inal pu blication  in this jo u rn a l is cited, in accordan ce with accepted  academ ic  
practice. N o use, distribution  or reprodu ction  is p erm itted  w hich does n ot com ply  
with these terms.
ORIGINAL RESEARCH
published: 03 December 2019 
doi: 10.3389/fphys.2019.01467
Yes-Associated Protein 1 Plays Major 
Roles in Pancreatic Stellate Cell 
Activation and Fibroinflammatory 
Responses
Cheng H u 1,2, Jiayue Yang23, Hsin-Yuan Su2, R ichard T. Waldron24, M engm eng Z h i2,3,
Ling Li3, Qing X ia1, Stephen J. Pandol2,4 and  Aurelia Lugea2,4*
1Department and Laboratory o f Integrated Traditional Chinese and Western Medicine, Sichuan Provincial Pancreatitis Centre 
and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China, 
2Departments o f Medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States, 
3Department o f Endocrinology, Zhongda Hospital Southeast University, Nanjing, China, 4Department o f Medicine, David 















This article was subm itted to 
Gastrointestinal Sciences, 
a section o f the journal 
Frontiers in Physiology
Received: 31 August 2019 
Accepted: 14 November 2019 
Published: 03 December 2019
Citation:
Hu C, Yang J, Su H-Y, Waldron RT, 
Zhi M, L i L, Xia Q, Pandol SJ and 
Lugea A  (2019) Yes-Associated 
Protein 1 Plays M ajor Roles in 
Pancreatic Stellate Cell Activation 
and Fibroinflammatory Responses.
Front. Physiol. 10:1467. 
doi: 10.3389/fphys.2019.01467
Background: Yes-associated protein 1 (YAP), a transcriptional co-activator and major 
effector of the Hippo pathway, regulates cell differentiation and morphology in many cell 
types and supports aberrant tumor growth. Recent studies showed that YAP is expressed 
in pancreas tissues in pancreatic ductal adenocarcinoma (PDAC) patients and experimental 
models of PDAC, with YAP largely found in cancer cells and pancreatic stellate cells 
(PaSC) in the stroma.
Methods and Results: We studied here the role of YAP in the activated phenotype of 
PaSC. We found that YAP is expressed at low levels in normal mouse pancreas, but 
protein levels significantly increased after pancreas inflammatory damage induced by 
repeated cerulein administration in wild-type mice or upon initiation of neoplastic 
transformation of the pancreas parenchyma in Ptf1-Cre;LSL-KrasG12D/+ (KC) mice. In these 
animal models, YAP upregulation occurred in parallel with activation and proliferation of 
PaSC. Consistent with these findings, we found robust YAP expression in culture-activated 
mouse and human PaSC but not in quiescent, freshly isolated cells. Fully activated PaSC 
isolated from KC mice or PDAC patient tissues exhibited robust nuclear YAP suggesting 
YAP transcriptional activity. Agents that induce quiescence such as the Bromodomain 
and Extra-Terminal (BET) inhibitor iBET151 and the p38 MAPK inhibitor SB203580 reduced 
YAP levels in PaSC. Stimulation of PaSC with the potent mitogen PDGF elicited marked 
YAP Ser127 phosphorylation. However, unexpectedly, this effect did not diminish YAP 
nuclear localization, suggesting that YAP phosphorylation at this site does not govern 
YAP cellular localization in PaSC. siRNA-mediated knockdown of YAP reduced PDGF- 
induced PaSC expansion in culture and blunted the persistent activation of Akt and ERK 
elicited by PDGF stimulation, supporting a role for YAP in PDGF-induced cell growth. YAP 
knockdown also blunted fibroinflammatory gene expression responses both in unstimulated 
and transforming growth factor beta 1 (TGFß1)-stimulated PaSC.
Conclusion: Our data suggest a central role for YAP in sustaining the activated phenotype 
and fibroinflammatory responses in PaSC. Moreover, our findings indicate that a complex 
crosstalk between YAP, TGFß1, and PDGF pathways regulates PaSC activity and growth.
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INTRODUCTION
Acute (AP), recurrent acute (RAP), and chronic pancreatitis 
CP are inflammatory disorders of the exocrine pancreas associated 
with significant morbidity, a high rate of hospitalizations and 
mortality (Peery et al., 2012; Lew et al., 2017). Further, CP 
of diverse etiologies significantly increases the risk for pancreatic 
ductal adenocarcinoma (PDAC) (Lew et al., 2017; Yang and 
Forsmark, 2017). In this respect, epidemiological studies indicate 
that CP patients at 5 years after diagnosis have a nearly eight­
fold increased risk of acquiring PDAC (Kirkegard et al., 2017). 
Currently, there are no effective treatments to prevent or 
attenuate pancreatitis or to prevent RAP and CP from progressing 
to PDAC, as occurs in some patients.
The precise mechanisms of initiation and progression of CP 
are unclear. CP is considered to result from unresolved, recurrent 
fibroinflammation and is characterized by extensive loss of the 
normal exocrine parenchyma, widespread fibrosis and 
inflammation, and impairment of both exocrine and endocrine 
pancreatic functions (Majumder and Chari, 2016; Yang and 
Forsmark, 2017; Gukovskaya et al., 2019). Accumulating evidence 
supports the concept that pancreatitis is initiated in the pancreatic 
acinar cell, the main cell type in the exocrine parenchyma, 
with stresses causing cellular dysfunction that triggers activation 
of pro-inflammatory signaling, activation of neighboring quiescent 
pancreatic stellate cells (PaSC), and immune cell infiltration 
into the pancreas (Gukovskaya et al., 2019).
PaSC are mesenchymal cells residing in the pancreas. In 
the normal pancreas, quiescent, non-proliferative PaSC reside 
in the periacinar space and are estimated to represent about
5-7%  of the exocrine parenchymal cells (Omary et al., 2007). 
Upon pancreas damage, or during the neoplastic transformation 
of acinar and ductal cells, PaSC acquire a myofibroblast phenotype, 
a process termed “activation” (Omary et al., 2007; Apte et al.,
2013). Characteristics of activated PaSC include high proliferation 
and growth rates; and expression of marker proteins such as 
alpha-smooth muscle actin (aSMA), a contractile cytoskeleton 
protein organized in stress fibers that confer mechanical tension, 
and cadherin 11 (CDH11), which regulates extracellular matrix 
(ECM) synthesis and matrix properties (Row et al., 2016). 
Activated PaSC produce and secrete large quantities of various 
ECM proteins, cytokines, and growth factors that regulate matrix 
physical properties, ECM remodeling, and fibrogenesis, as well 
as immune cell infiltration and inflammatory responses in RAP, 
CP, and PDAC tumors (Apte et al., 2012, 2013; Erkan et al., 
2012; Pandol et al., 2012; Dawson et al., 2013; Chang et al., 
2017). Intensive research has demonstrated that PaSC exhibit 
great plasticity that allows reprogramming in response to multiple 
inputs from the matrix, neighboring acinar, cancer and immune
cells, and local and systemic factors (Ohlund et al., 2017). 
Recent work has also shown that PaSC play pivotal roles in 
other pancreatic disorders including diabetes (Yang et al., 2016). 
However, despite the critical role of PaSC in pancreas 
pathobiology, the mechanisms governing their activation, growth, 
and phenotypic plasticity remain unclear.
Recent studies indicate that Yes-associated protein 1 (YAP) 
and its homolog WWTR1/TAZ are expressed in pancreatic 
cells including PaSC during tissue remodeling and PDAC 
initiation (Morvaridi et al., 2015; Rozengurt et al., 2018; Ansari 
et al., 2019; Eibl and Rozengurt, 2019). YAP and TAZ are 
transcriptional regulators that modulate cell proliferation, 
migration, and apoptosis in developing organs and adult tissues 
and support aberrant cell growth in many cancers (Eibl and 
Rozengurt, 2019). By virtue of their sensitivity to mechanical 
cues such as extracellular matrix rigidity, YAP/TAZ act as 
mechano-transducers coupling cell-cell and cell-matrix signals 
with gene expression (Dupont et al., 2011). YAP is found in 
the cytoplasm and in the nucleus where it interacts with TEF-1/ 
TEC1/abaA (TEA) domain 1-4 (TEAD1-4) and other transcription 
factors including SMADs involved in cell proliferation, matrix 
remodeling, and apoptosis (Zheng and Pan, 2019). YAP functions 
are regulated in a cell type- and context-dependent manner. 
In myofibroblasts and other cell types, YAP expression and 
subcellular location are regulated by the Hippo pathway, matrix 
rigidity, and the mechanical properties of the cellular cytoskeleton 
(Dupont et al., 2011). Indeed, increased matrix stiffness and 
high cytoskeletal tension promote YAP nuclear accumulation 
and transcriptional activity in cancer associated myofibroblasts 
(Calvo et al., 2013). Recent studies indicate that YAP regulates 
activation in liver of pro-fibrotic hepatic stellate cells (Mannaerts 
et al., 2015), a cell type phenotypically similar to PaSC, but 
the role of YAP in PaSC activation and fibroinflammatory 
responses has not been defined.
Here, we examined YAP expression and activity during RAP 
and CP and in quiescent and activated PaSC derived from mouse 
and human pancreas. We also investigated the effects of agents 
that we found promote PaSC quiescence, and siRNA-mediated 
YAP knockdown, on PaSC growth signaling, fibroinflammatory 
responses, and signaling crosstalk between YAP and two well 
characterized PaSC activators, platelet-derived growth factor 
(PDGF) and transforming growth factor beta 1 (TGFß1).
MATERIALS AND METHODS 
Antibodies and Chemicals
The following antibodies were used for Western blotting (WB) 
and/or immunofluorescence (IF): AKT (#4691), phospho-AKT
(Ser473; #4060), Cadherin11 (CDH11; #4442S), GAPDH (#5174S), 
CK19 (#12434), p44/42 MAPK (#9102), LATS1 (#3477), phospho- 
LATS1 (Thr1079; #8654), phospho-p44/42 MAPK (Thr202/Tyr204; 
#9101), phospho-p70S6 Kinase (ttr389 ; #9234), SMAD2/3 (#8685), 
phospho SMAD2 (Ser465/467)/SMAD3(Ser423/425); #8828), YAP 
(#14074 for WB and IF, #4912 for WB), phospho-YAP (Ser127; 
#13008), YAP/TAZ (#8418), Caspase-3 (#14220), and corresponding 
HRP-linked secondary antibodies were from Cell Signaling 
Technology (Danvers, MA). Antibodies directed against aSMA 
(#A2547), P4HA2 (#SAB1100773), and ß-actin (#A1978) were 
purchased from Sigma-Aldrich (St. Louis, MO), against GFAP 
(#ab68428) from Abcam (Cambridge, MA), and against PDGFR-ß 
(#sc-432) from Santa Cruz Biotechnology (Dallas, TX).
Recombinant rat PDGF-BB (PDGF; #520-BB-050), recombinant 
mouse TGFß1 (#7666-MB-005), and recombinant human TGFß1 
(#240-B-002) were from R&D Systems, Inc. (Minneapolis, MN). 
iBet151 (#SML0666) was purchased from Sigma-Aldrich (St. 
Louis, MO); U0126 (#662005), LY294002 (#440202) and SB203580 
(#559389) from MilliporeSigma (Burlington, MA). SuperSignal™ 
West Pico (or Femto) Chemiluminescent Substrate reagent, 
4',6-diamidino-2-phenylindole (DAPI), ProLong Gold antifade 
mounting medium, and fluorescence-conjugated secondary 
antibodies were from ThermoFisher Scientific (Waltham, MA).
Tissue digestion for primary PaSC isolation was performed 
using Pronase (Roche, #10165921001), Collagenase P (Roche, 
#11213857001), DNase I (#10104159001) and bovine serum 
albumin fraction V (BSA; Roche, #3116956001), all obtained 
from Sigma-Aldrich. Density gradients for PaSC separation 
were prepared using Nycodenz (#AN1002423; Accurate Chemical 
& Scientific Corp; Westbury, NY) and Gey’s balanced salt 
solution (GBSS; #G9779; Sigma-Aldrich). Cell culture DMEM/ 
F12 medium (#11330-032), L-Glutamine (#25030-081) were 
from ThermoFisher Scientific; antibiotics/antimycotics (1% 
Penicillin-Streptomycin; #25030-081) and fetal bovine serum 
(FBS; #FB11) were from Omega Scientific (Tarzana, CA). All 
chemicals and kits were used according to the manufacturer’s 
recommendations, unless otherwise indicated.
Assessment of Yes-Associated Protein 1 
Levels in Pancreatic Tissues From Mice 
Subjected to Cerulein-Induced 
Pancreatitis
C57BL/6 male mice (Envigo, Placentia, CA) were subjected to 
repeated episodes of acute cerulein pancreatitis starting at
6 -7  weeks of age. Each acute pancreatitis (AP) episode consists 
of 7 hourly intraperitoneal injections of saline or 50 ^g/kg 
cerulein (Lugea et al., 2006). Recurrent AP (RAP) was 
characterized in mice subjected to two episodes of cerulein 
AP, the first one at day 1 (d1) and the second at day 3 (d3). 
In this RAP model, mice were sacrificed during the acute 
phase of pancreatitis (1 h after the last cerulein injection, at 
d1 and d3) and during the recovery phase (at d5). Chronic 
pancreatitis (CP) was induced by repeated cerulein AP episodes 
(twice a week for 4 weeks; total eight episodes), and mice 
were sacrificed 4 days after the last AP episode. At sacrificed, 
pancreatic tissues were collected and snap-frozen for subsequent
Western blotting analysis (as indicated below) or formalin-fixed 
for histological assessment of pancreatitis severity, PaSC activation 
and immunofluorescence analysis of YAP and PaSC activation 
markers aSMA, Cadherin 11 (CDH11) and PDGF receptor 
beta (PDGFRß) expression.
Mice were fed standard chow diet with free access to clean 
drinking water and maintained at controlled temperature 
(19-22°C) and 12:12-h light/dark cycle during the duration 
of the study. Animal studies were approved by the Institutional 
Animal Care and Use Committee at Cedars-Sinai Medical 
Center (Los Angeles, CA) in accordance with the NIH Guide 
for the Care and Use of Laboratory Animals.
Assessment of Yes-Associated Protein 1 
Levels in KrasG12D Mice
Wild-type (W T) and Ptf1-Cre;LSL-KrasG12D/+ (KC) mice, a 
genetically engineered mouse model (GEMM) used to study 
pancreatic ductal adenocarcinoma (PDAC), were generated by 
breeding as previously described in our studies (Dawson et al., 
2013; Chang et al., 2017). Mice were fed standard chow diet 
and maintained in standard housing conditions [controlled 
temperature (19-22°C) and 12:12-h light/dark cycle] during 
the duration of the study. Mice were sacrificed at 3 months 
and pancreas tissues harvested for histological and Western 
blotting protein analysis of YAP and PaSC markers as described 
before (Morvaridi et al., 2015; Chang et al., 2017). Animal 
studies were approved by the Institutional Animal Care and 
Use Committee at Cedars-Sinai Medical Center (Los Angeles, 
CA) in accordance with the NIH Guide for the Care and Use 
of Laboratory Animals.
Immunofluorescence Analysis of Yes- 
Associated Protein 1 and Alpha-Smooth 
Muscle Actin in Mouse Pancreatic Tissues 
and Cultured Pancreatic Stellate Cells
Formalin-fixed, paraffin-embedded (FFPE) mouse pancreatic 
tissues were obtained from W T mice subjected to RAP or CP 
as described above. Four micrometer tissue sections were stained 
by IF using specific antibodies against YAP (#14074, Cell 
Signaling Technology) and aSMA (#A2547, Sigma-Aldrich; 
marker of activated PaSC). Alexa Fluor 488 or Alexa Fluor 
594 was used as conjugated secondary antibodies, and 
4'6'-diamidino-2-phenylindole (DAPI) as nuclear counterstain. 
Digitalized images were captured using a Leica TCS SP5 spectral 
confocal microscope (Leica Microsystems, IL) and analyzed 
with the Leica Application Suite Advanced Fluorescence Lite 
2.6.0 software (LAS-AF-lite; Leica Microsystems Inc., Buffalo 
Grove, IL) with the assistance of the Cedars-Sinai Medical 
Center (Los Angeles, CA) Imaging Core. Similar IF  procedures 
were used to assess YAP and aSMA in cultured PaSC.
Cellular localization of YAP in cultured PaSC was assessed 
using Image J by measuring the ratio of nuclear-to-cytoplasmic 
fluorescence intensity, expressed in each region as integrated 
intensity per unit area. In these studies, YAP quantification 
was performed in 70-90 cells from three to five representative 
microscopic fields.
Pancreatic Stellate Cells Isolation 
and Culture
Primary mouse PaSC (mPaSC) were obtained from wild-type 
and KC pancreas tissues as previously described (Pandol et al., 
2012; Su et al., 2016; Yang et al., 2016). Briefly, pancreata 
from one to two mice were excised, minced, and digested in 
GBSS containing a mixture of pronase, collagenase P and DNase
I. ^ e  cell suspension was filtered through a 100 ^m nylon 
cell strainer and washed in GBSS supplemented with 0.3% 
BSA. ^ e n ,  PaSC were separated by Nycodenz density gradient 
centrifugation (20 min at 1,400 g). Quiescent PaSC were collected 
from a fuzzy band at the interface near the top of the gradient 
and expanded in culture up to passage 2. Myofibroblast-like 
activated mPaSC were characterized by the presence of aSMA 
stress fibers, high production of fibronectin, and reduced 
expression of the quiescent marker GFAP.
Immortalized mouse PaSC (imPaSC) were initially obtained 
from Dr. Raul Urrutia and characterized in our previous 
studies (Su et al., 2016; Yang et al., 2016). Human primary 
PaSC (hPaSC) were obtained from pancreatic cadaveric tissues 
from organ donors or PDAC surgical resections. Briefly, 
cadaveric pancreata were digested at City of Hope (Duarte, 
CA) to isolate islets for clinical transplantation to diabetic 
patients as described (Song et al., 2015; Lugea et al., 2017). 
Remnant pancreatic cells after islet isolation (mainly pancreatic 
acinar, ductal, and PaSC) were further processed at the Cedars- 
Sinai Medical Center (Los Angeles, CA) to isolate hPaSC 
following similar procedures indicated above for primary 
mPaSC. hPaSC from PDAC tissues were obtained by the 
outgrowth method as previously described (Bachem et al., 
2005; Lugea et al., 2006). The studies were performed in 
accordance with regulations and IRB protocols approved by 
the Institutional Review Board at Cedars-Sinai Medical Center 
(Pro31101 and Pro32114).
Primary mPaSC and hPaSC, and imPaSC were grown in 
DMEM/F12 media supplemented with 10% FBS, 2 mM 
L-glutamine, and antibiotics/antimycotics, in a humidified 5% 
CO2 atmosphere. For experiments, cells were seeded in 60-mm 
tissue culture dishes in DMEM/F12 and starved in serum-free 
medium for 12 h, and then treated with the experimental agents 
at 60-80% confluency, unless otherwise stated.
Knockdown of Yes-Associated Protein 1 
Via siRNA Transfection
siRNA targeted against mouse YAP1 mRNA were obtained from 
^erm oFisher Scientific (#4390771Waltham, MA). Control 
transfections were carried out with Silencer Select Negative Control 
No. 1 (#4390843, ThermoFisher Scientific). For siRNA transfection, 
imPaSC (1.5 x 105 cells/plate) were cultured in 60 mm plates 
until 60% confluence. Silencer nontargeting negative control 
(10 nmol/L; Mock transfection) or YAP siRNA (10 nmol/L) were 
mixed with Lipofectamine RNAiMAX (#13778075 ^erm oFisher 
Scientific) according to the manufacturer’s recommendations and 
added to the cells. After transfection, imPaSC were cultured in 
DMEM/F12 medium containing 10% FBS for 24 h and then 
used for experiments.
Western Blot Analysis
Cells or tissues were homogenized in RIPA buffer containing 
50 mmol/L Tris (pH 7.4), 150 mmol/L NaCl, 1% deoxycholic 
acid, 1% Triton X-100, 0.1% SDS, and a mix of protease and 
phosphatase inhibitors (Roche Applied Science, Basel, 
Switzerland). Protein extracts were resolved by SDS-PAGE for 
immunoblot analysis. The primary and horseradish peroxidase- 
conjugated secondary antibodies used here are indicated in 
the Antibodies and chemicals section. Immunoreactive bands 
were visualized by chemiluminescence (ThermoFisher Scientific) 
and densitometrically quantified using the PXi 6 Touch Imaging 
System (Syngene). To estimate protein levels, optical density 
values in each blot were expressed relative to those of the 
loading control (ERK, ß-actin or GAPDH).
RNA Analysis by Qualitative Polymerase 
Chain Recation
Cellular RNA from quiescent and culture-activated PaSC was 
extracted using the RNeasy® Plus Mini Kit (#74034; Qiagen, 
Germantown, MD). Reverse transcription was performed with 
the iScript Reverse Transcription Supermix (#170-8,840; Bio-Rad, 
Hercules, CA) using 1 ^g of total RNA, and the synthesized 
cDNA samples were used as templates for quantitative real-time 
PCR (qPCR) analysis. Kits were used according to the manufacturers 
instructions. All reactions were performed using the Bio-Rad CFX 
ConnectTM Real-Time PCR Detection System and the amplifications 
were done with the iTaq™ Universal SYBR® Green Supermix 
(Bio-Rad). ^ e  gene-specific primers used are listed in Table 1. 
Relative transcript levels were calculated using the comparative 
2 -aaq method and normalized to the housekeeping gene, 18S rRNA.
MTT Assay
MTT (Thiazolyl Blue Tetrazolium Bromide) assay was used as 
indicator of cellular metabolic activity and cell proliferation. PaSC 
were seeded in 24-well plates at 1 x 104 cells per well. After 
the indicated treatments, M TT was added to the culture medium 
to a final concentration of 0.5 mg/ml, and cells were then incubated 
for 3 h at 37°C in a 5% CO2 incubator. After removing medium, 
DMSO was added to dissolve the formazan product. Absorbance 
was measured at 595 nm using a spectrophotometric plate reader 
(SpectraMax M3, Molecular Devices, San Jose, CA).
Cell Death
Cell necrosis was assessed by PI uptake. Briefly, cells were treated 
with the experimental reagents for up to 72 h, and then labeled 
with PI (2 ^g/ml medium) for 10 min. Both attached and 
floating cells were then collected, washed with PBS to remove 
excess PI, and lysed in RIPA buffer [50 mmol/L Tris (pH 7.4), 
150 mmol/L NaCl, 0.25% deoxycholic acid, 1% Triton X-100, 
0.1% SDS containing a mixture of protease and phosphatase 
inhibitors (Roche Applied Science, Basel, Switzerland)]. PI 
fluorescence was measured by fluorometry at 535ex/617em nm, 
and values normalized to those of total protein concentration 
in cell lysates. Caspase 3-dependent apoptosis was assessed by 
measuring levels of total and cleaved Caspase 3 by Western blotting.
TABLE 1 | Primer sequences for qRT-PCR.
Target F o rw ard  (5' to  3 ) R everse  (5' to  3')
mActa2 (aSMA) GTTCAGTGGTGCCTCTGTCA ACTGGGACGACATGGAAAAG
mCol1a1 TAGGCCATTGTGTATGCAGC ACATGTTCAGCTTTGTGGACC
mCcn1 (Cyr61) TGCTGTAAGGTCTGCGCTAA GGTCTGCCTTCTGACTGAGC
mCcn2 (Ctgf) CTGCCTACCGACTGGAAGAC CATTGGTAACTCGGGTGGAG
mGfap AAGAAAACCGCATCACCA ACAACTTGTATTGTGAGCCT
mHgf C IIIIIG C C TT C G A G C TA TC GGTCATGCATTCAACTTCTG
mIl6 ACCAGAGGAAATTTTCAATAGGC TGATGCACTTGCAGAAAACA
mMmp3 AGCCTTGGCTGAGTGGTAGA CGATGATGAACGATGGACAG
mSerpine1 (PAI-1) ATCCTGCCTAAGTTCTCTCTG ATTGTCTCTGTCGGGTTGTG
mTgfb1 CAACCCAGGTCCTTCCTAAA GGAGAGCCCTGGATACCAAC
mYap1 GCTGCAGCAGTTACAGATGG GCGCAGAGCTAATTCCTGAC
hACTA2 (aSMA) CCAGAGCCATTGTCACACAC CAGCCAAGCACTGTCAGG
hWWTR1 (TAZ) GTCCTACGACGTGACCGAC CACGAGATTTGGCTGGGGA
hYAP1 TAGCCCTGCGTAGCCAGTTA TCATGCTTAGTCCACTGTCTGT
18S rRNA AGTCCCTGCCCTTTGTACACA CGATCCGAGGGCCTCACTA
Statistical Analyses
All experiments were performed in triplicate unless otherwise 
stated. Data are presented as mean ± SD or mean ± SEM. 
Data were subjected to analysis of variance (ANOVA) followed 
by Tukey’s post hoc test, and two tailed Student t-test for 
comparison between 2 groups. Differences between treatments 
were considered to be statistically significant at p  <  0.05 as 
indicated in the figure legends.
RESULTS
Yes-Associated Protein 1 Upregulation 
During Experimental Pancreatitis and 
Pancreatic Ductal Adenocarcinoma 
Progression Parallels Pancreatic Stellate 
Cells Activation
Previous studies indicate that effectors of the Hippo signaling 
system including TEAD1 and its transcriptional activator YAP 
are integral components of the embryonic development of human 
pancreas (Cebola et al., 2015) and its expression is recapitulated 
during progression of pancreatic disorders (Kapoor et al., 2014; 
Zhang et al., 2014; Morvaridi et al., 2015; Hao et al., 2017). 
Histological analysis of pancreatic tissues from PDAC patients 
and murine models of pancreatic cancer shows that YAP is 
upregulated in precancerous lesions (Pancreatic Intraepithelial 
Neoplasia, PanIN) and cancer cells as well as in activated PaSC 
in the stroma (Kapoor et al., 2014; Zhang et al., 2014; Morvaridi 
et al., 2015; Hao et al., 2017). These findings highlight the 
therapeutic potential of targeting YAP signaling to prevent PaSC 
activation and fibrosis in PDAC and CP, two pancreatic disorders 
showing extensive desmoplastic reaction.
To evaluate the relationship between YAP and PaSC activation 
during pancreatitis, we used experimental mouse models of AP, 
RAP, and CP. AP was induced by administration of high doses 
of the cholecystokinin analogue cerulein (50 pg/kg; 7 hourly 
intraperitoneal injections) and tissues collected during the acute 
phase (1 h after the last cerulein injection). RAP was induced
by two episodes of AP (at days 1 and 3), and mice sacrificed 
during the acute phase (1 h after the last cerulein injection; 
day 3) and during the recovery phase (day 5), when pancreas 
undergo extensive remodeling. CP was induced by repeated 
episodes of cerulein AP (two episodes per week, for 4 weeks) 
and mice sacrificed 4 days after the last episode, when marked 
PaSC activation is evident (Lugea et al., 2006). Supplementary 
Figure S1A shows representative H&E micrographs of pancreas 
histology in control- and cerulein-treated mice. As shown, repeated 
cerulein AP leads to loss of normal exocrine parenchyma, acinar 
cell death, inflammatory cell infiltration and stromal expansion.
In pancreas of control (saline-treated) mice or mice subjected 
to one episode of AP (day 1), YAP protein expression was negligible 
(Figures 1A- C). YAP levels increased moderately after the second 
episode of AP (day 3) but markedly 2 days after RAP induction 
(day 5) and remained elevated during CP (Figures 1A,B). YAP 
upregulation was concomitant with upregulation of the PaSC 
markers CDH11 and PDGFRß (Figure 1A). Moreover, aSMA 
positive, activated PaSC in RAP (Figure 1C) and CP pancreas 
(Morvaridi et al., 2015) exhibited marked YAP nuclear staining, 
suggesting YAP transcriptional activity in these cells.
As our group previously reported (Morvaridi et al., 2015), 
YAP was markedly upregulated in pancreas of KC mice. Illustrated 
in Supplementary Figure S1B, pancreas tissues of KC mice 
display abundant PanIN surrounded by stroma enriched in aSMA- 
positive PaSC. In these mice, pancreatic levels of YAP increased 
in parallel with PanIN and stromal progression. Figure 1D shows 
significant upregulation of YAP, the PaSC markers PDGFRß and 
CDH11, and the ductal marker cytokeratin 19 (CK19) in pancreatic 
extracts of KC mice compared with wild-type mice.
Yes-Associated Protein 1 Is Expressed in 
Activated but Not Quiescent Pancreatic 
Stellate Cells
To further explore the role of YAP in PaSC biology, we measured 
levels and cellular location of YAP in quiescent and activated 
cultured PaSC obtained from human (hPaSC) and mouse 
(mPaSC) tissues. We first used a model of acinar-ductal-metaplasia
FIGURE 1 | YAP levels increase in pancreas during parenchyma remodeling in pancreatic disease. (A) Representative immunoblots showing protein levels of YAP and 
the PaSC markers Cadherin 11 (CDH11) and the PDGF receptor PDGFRß in pancreas of mice subjected to repeated episodes of cerulein acute pancreatitis: RAP; two 
episodes, 1 day apart; CP, chronic pancreatitis, two episodes per week for 4 weeks. As indicated in the "Methods” section, mice were sacrificed during the acute phase 
of pancreatitis (d1, day 1, one AP episode; d3, day 3, two AP episodes), 2 days after two AP episodes (d5) or 4 days after the last episodes in the CP model. ERK1/2 
was used as loading control. Each lane shows data from an individual mouse; two mice per group are shown. Data are representative of five mice per group. (B) Graph 
shows quantitation of optical density of YAP bands in immunoblot shown in panel A  relative to  those of ERK1/2. Data are mean ± SEM, n = 5 mice/group. (C) Paraffin- 
embedded pancreatic tissues obtained from mice subjected to  two episodes of AP (days 1 and 3) and sacrificed at day 5 (RAP-d5) or saline-treated mice (Control) 
were analyzed for the PaSC marker aSMA and YAP by immunofluorescence. Nuclei were counterstained with DAPI. Panels a - f  show representative immunofluorescence 
staining; Scale bar = 25 pm. Dotted box in panel f  shows aSMA-positive PaSC displaying YAP staining in the nucleus; the dotted area is shown higher magnified in panel g. 
Arrows in panel g show positive YAP nuclei. Scale bar = 10 pm. Control tissues (panels a -c) do not exhibit activated PaSC or significant YAP staining. Data are 
representative of three mice per group. Representative H&E stained images from control and RAP-5d mice pancreas are shown in S upp lem enta ry F igure S1A.
(D) Representative immunoblots showing protein levels of YAP, the PaSC markers CDH11 and PDGFRß, the ductal marker Cytokeratin 19 (CK19) in pancreas of 
2-month-old wild-type (WT) and Ptf1-Cre;LSL-KrasG12D/+ (KC) mice. GAPDH was used as loading control. Each lane shows data from an individual mouse; three mice 
per group are shown. Representative photomicrographs from KC mouse pancreas showing a-SMA positive PaSC are included in S upp lem enta ry  Figure S1B .
(ADM) generated by culturing pancreatic exocrine cells from 
human cadaveric donor pancreata without pancreas pathology 
(Lugea et al., 2017). In this model that mimics parenchymal 
remodeling during CP initiation and progression, acinar cells 
rapidly die or dedifferentiate into ductal cells (not shown) and 
quiescent PaSC become activated and expand. In this system, 
PaSC exhibited marked upregulation of aSMA and concomitant 
upregulation of YAP and its homolog TAZ (Figure 2A).
We further found that YAP expression is linked to the 
activated state of PaSC. As shown in Figures 2B,C , quiescent, 
freshly isolated hPaSC, and mPaSC did not express YAP, but 
YAP levels markedly increased during cell activation in culture 
and remained elevated during passages. Moreover, as we observed 
in pancreas tissues, activated PaSC displayed robust YAP nuclear 
staining in culture conditions, likely associated with YAP 
transcriptional activity. As illustrated in Figure 2D , aSMA- 
positive PaSC obtained from normal human organ donor 
pancreata, resected human PDAC tumors or KC mice, all exhibit
nuclear YAP. This staining pattern was also found in culture- 
activated mPaSC isolated from wild-type mice (not shown). 
We also found that, unlike reports using cancer and other cell 
types (Zhao et al., 2007; Hao et al., 2017), the number of PaSC 
displaying nuclear YAP is not affected by cell density (60-100%; 
not shown), a property likely related to tension induced by 
the contractile aSMA filaments in PaSC (Calvo et al., 2013).
Pancreatic Stellate Cells Quiescence 
Induced by Inhibition of p38 MAPK 
Signaling and the Bromodomain and 
Extra-Terminal Bromodomain Family 
Proteins Results in Yes-Associated 
Protein 1 Downregulation
We next examined the effects of pharmacologic treatments that 
induce reversal of PaSC activation state into a quiescent state. 
This reversion was characterized by downregulation of the
FIGURE 2 | PaSC activation is associated with sustained YAP upregulation. (A) Activated PaSC were obtained in culture from an acinar-ductal-metaplasia (ADM) 
experimental model using pancreatic acini from cadaveric pancreata from human donors. As sown in the graphs, upregulation of YAP and its homolog TAZ in the 
ADM system was concomitant with upregulation of aSMA, a recognized maker of activated PaSC. aSMA and YAP mRNA expression were determined by qPCR.
(B) Quiescent PaSC isolated from cadaveric human pancreata (hPaSC) did not express YAP, but YAP levels markedly increased during PaSC activation in culture in 
parallel with upregulation of aSMA. Similar results were obtained in PaSC obtained from WT mouse pancreas (mPaSC) (C). Graphs in A-C show mean ± SEM; 
n = 3. (D) Immunofluorescence analysis of YAP (red) and aSMA (green) in hPDAC obtained from cadaveric human pancreata (organ donor) or pancreatic 
adenocarcinoma tumors (PDAC patient) and in mPaSC obtained from KC mice; nuclei were stained with DAPI (blue). Primary cells were expanded in culture using 
DMEM/F12 medium containing 10% FBS until 70-90%  confluency and then immunostained with the indicated targets. Under these culture conditions, both hPaSC 
and mPaSC display YAP nuclear staining. Similar results were obtained in two additional independent experiments; Scale bar, 50 pM.
activation markers aSMA (encoded by the Acta2 gene) and 
collagen type I alpha 1 (encoded by the Col1a1 gene), upregulation 
of the quiescence marker glial fibrillary acidic protein (GFAP) 
and decrease in cell proliferation (Omary et al., 2007). We found 
that treatment with the p38 MAPK inhibitor SB203580 (Masamune 
et al., 2003) and with iBET151, a pan-specific inhibitor of the 
epigenetic transcriptional regulators Bromodomain and 
Extraterminal domain (BET) proteins (Kumar et al., 2017), 
induced quiescence in mPaSC (Figure 3A). By contrast, treatment 
with the known PaSC activator TGFß1 resulted in marked 
upregulation of aSMA and Col1a1 in mPaSC (Figure 3A). 
Interestingly, both pharmacological inhibitors also significantly 
reduced YAP expression levels (62% reduction with 1 pM iBET151, 
and 48% with 0.5 pM SB203580; Figure 3B). Moreover, iBET151 
reduced in a dose-dependent manner protein levels of the YAP 
homolog TAZ and the PaSC markers aSMA, CDH11, PDGFRß 
and P4HA2, a collagen synthesizing enzyme (Figures 3B,C ).
Compared to controls, iBET151 treatment also reduced PaSC 
metabolic activity, as assessed by M TT assay (Figure 3D ), and
cell numbers (Figure 3E). Differences in M TT absorbance 
values may reflect changes in cell proliferation and/or cell 
viability when metabolic events lead to necrosis or apoptosis. 
To determine whether iBET151 induces cell death, we assessed 
necrosis by measuring propidium iodide (PI) uptake and 
apoptosis by measuring protein levels of total and cleaved 
caspase-3. Our data indicate that iBET151 treatment did not 
change necrosis (Figure 3F) or apoptosis (Supplementary 
Figure S2A), suggesting that the BET inhibitor reduces cell 
proliferation, an effect consistent with a quiescent state.
Yes-Associated Protein 1 Knockdown Via 
siRNA Transfection Reduces Cell Growth 
in Pancreatic Stellate Cells and Alters 
Expression of Genes Involved in 
Matrix Remodeling
To gain insights into the role of YAP on activated PaSC, 
we transiently knocked down YAP mRNA in immortalized
FIGURE 3 | PaSC quiescence induced by a p38 MAP Kinase inhibitor or a BET family inhibitor is associated with YAP downregulation. Immortalized mouse PaSC 
(imPaSC) were treated with DMSO (control), the p38 MAPK inhibitor SB203580 (5 pM) or the BET inhibitor iBET151 (1 pM) for different times. In selected 
experiments, TGFßl (5 ng/ml) was used as positive control to induce upregulation of proteins found increased in activated PaSC (aSMA and C o lla l) . (A,B) Graphs 
show mRNA levels of Acta2 (aSMA), C o lla l,  GFAP (a marker o f quiescent PaSC) and YAP measured by qPCR in imPaSC treated for 24 h with the indicated 
agents. Data is representative of three independent experiments. *p < 0.05 vs. DMSO; #p  < 0.05 vs. TGFßl treatment. (C) Protein extracts from imPaSC treated for 
24 h with different concentrations of iBET151 were analyzed to  determine levels of YAP and TAZ and the indicated PaSC markers; representative immunoblots are 
shown. ß-actin was used as loading control. As shown, BET inhibition decreases protein levels o f several markers of PaSC activation but does not affect levels of 
the quiescent marker GFAP. Data is representative of three independent experiments. (D-F) imPaSC were treated for 72 h with iBET151 at the indicated 
concentrations, and metabolic activity (MTT assay), cell number and cell necrosis (PI uptake) were assessed. Additionally, S u p p le m en ta ry  Figure S2A shows 
protein levels o f caspase-3 as a marker o f caspase-dependent apoptosis. (D) Graph shows MTT assay data after 72 h treatment. (E) Graph shows number of 
imPaSC after 72 h treatment with or w ithout 1 pM iBET151. The number of cells at 0 and 72 h were assessed by trypan blue exclusion using a hemocytometer; 
data are expressed as fold increase over the cell number at time 0 (1.25 x 104). (E) PI uptake was measured as indicated in "Materials and Methods” section. 
Graphs show *p < 0.05 vs. no-iBET151 control. Data in graphs (D-F) represent the means ± SD; n = 3.
mPaSC via  siRNA transfection as indicated in the Materials 
and Methods section. siRNA treatment resulted in 82% 
reduction in YAP mRNA levels at 24 h and 49% reduction 
at 48 h post-transfection (Figure 4A ). At 48 h, we found 
in YAP siRNA-treated cells a 50% reduction in M TT 
absorbance values (M TT assay; Figure 4 B ), and a marked 
decrease in cell counts (Figure 4C ). We did not observe 
morphological evidence of cell death in YAP siRNA-treated 
cells (not shown), necrosis (Figure 4D ) or caspase-3-dependent 
apoptosis (Supplem entary Figure S 2B ). Taken together, these 
data suggest that YAP regulates cell proliferation in 
activated PaSC.
As illustrated in Figure 4E, YAP siRNA knockdown in PaSC 
reduced a subset of genes including the previously identified 
YAP gene targets connective tissue growth factor (Ctgf) and 
cysteine rich angiogenic inducer 61 (Cyr61) that are involved 
in cell adhesion and ECM remodeling; the PaSC markers aSMA 
and C o lla l that participate in PaSC morphology, matrix tension 
and collagen deposition, and TG Fßl, that stimulates 
fibroinflammatory responses in these cells. Interestingly, YAP
siRNA treatment markedly increased levels of metalloproteinase 
3 (MMP3), a protease involved in degradation of collagens 
and other ECM proteins during tissue remodeling. These findings 
support the concept that YAP represses MMP3 transcription 
in PaSC while promoting the expression of genes favoring 
collagen deposition and fibrosis. YAP knockdown also led to 
moderately increased expression of hepatocyte growth factor 
(HGF; Figure 4C), a growth factor that is secreted by PaSC 
and acts on epithelial and cancer cells regulating angiogenesis, 
tissue regeneration and cancer cell growth (Pothula et al., 2017). 
Overall, our findings indicate that YAP controls a variety of 
transcriptional gene networks in PaSC.
PDGF Activates the Hippo Pathway and 
Increases Yes-Associated Protein 1 
Phosphorylation in Pancreatic 
Stellate Cells
Rapid upregulation of PDGFRß is a major event in the activation 
of PaSC from the quiescent phenotype, and PDGF binding
FIGURE 4 | YAP siRNA decreases PaSC expansion in culture and alters expression of genes involved in matrix remodeling. imPaSC were transfected with 
nontargeting negative control (NT, 10 nmol/L) or a target siRNA (YAP, 10 nmol/L) mixed with lipofectamine RNAiMAX, and 24 h later cells were used for experiments.
(A) Graph shows quantitation of YAP mRNA expression relative to negative control at 48 h post-transfection. Data are mean ± SD, n = 3; *p < 0.05 vs. NT. (B) MTT 
assay for YAP siRNA-treated cells relative to NT. (C) The graph shows imPaSC numbers counted 0 and 48 h after treatment with either NT or YAP siRNA. The cell 
numbers were assessed by trypan blue exclusion using a hemocytometer, and expressed as a fold increase over time 0 (1.5 x 105). (D) PI uptake was measured in 
cells treated with siRNA to detect any disrupted plasma membrane integrity. After incubation, a portion of cells was permeabilized for 5 min with 0.1% Triton X100 to 
establish a positive control. Data in graphs (B-D ) are mean ± SD, n = 3 -6  independent experiments; *p < 0.05 vs. NT. S up p le m en ta ry  F igure S2B shows protein 
levels o f caspase-3 as a marker o f caspase-dependent apoptosis. (E) Graph shows mRNA levels of the indicated genes in YAP siRNA treated cells compared to NT. 
Data is mean ± SD, n = 5.
to this receptor acts as a potent mitogen and induces migration 
in PaSC (Kordes et al., 2005). PDGF is secreted by different 
cell types including platelets, endothelial cells, and macrophages. 
In PDAC tissues, cancer cells and macrophages are likely a 
main source of PDGF and TGFß1 with distinct effects on 
PaSC proliferation, migration and production of ECM and 
cytokines (Bachem et al., 2005; Omary et al., 2007; Apte et al., 
2013; Biffi et al., 2019). PDGF induces cell growth and 
proliferation, in part by activating MAPK and PI3K/AKT 
signaling pathways (Heldin, 2013).
Here, we investigated potential crosstalk between PDGF and 
YAP pathways in regulating PaSC growth in culture. Serum- 
starved imPaSC were treated with 2 or 5 ng/ml PDGF for 
different times. As expected, we found that PDGF induced 
rapid (within minutes) activation of ERK1/2 and AKT signaling 
in imPaSC, as indicated by increased phosphorylation of ERK1/2 
at Thr202/Tyr204 and AKT at Ser473 (Figure 5A). Similar 
effects were found in primary human and mouse PaSC (not 
shown). PDGF treatment also led to rapid phosphorylation of
YAP at Ser127, a site previously reported to be phosphorylated 
by the Hippo pathway kinase large tumor suppressor kinase 
1 (LATS1) and to promote cytoplasmic retention and inactivation 
of YAP in several cell types (Zhao et al., 2007). In agreement, 
we found that PDGF induced LATS1 activation in imPaSC 
(Figure 5A).
Serum is a potent growth factor in activated PaSC and 
was reported to decrease YAP Ser127 phosphorylation and 
promote YAP nuclear translocation in HEK293A (Yu et al.,
2012). To compare the effects o f serum and PDGF on YAP 
activation, we cultured serum-starved imPaSC for 24 h in 
media containing different concentrations of FBS, and then 
treated the cells for 30 min with or without 2 ng/ml PDGF 
As shown in Figure 5 B , levels o f p-YAP Ser127 decreased 
in cells treated with 5 and 10% FBS while PDGF increased 
YAP phosphorylation in both serum-starved and 10% FBS 
treated imPaSC (Figure 5B ). To determine whether kinases 
downstream of ERK1/2 and AKT pathways mediate serum 
and PDGF effects on YAP phosphorylation at Ser127,
FIGURE 5 | PDGF induces rapid phosphorylation of YAP and activation of growth signaling in imPaSC. (A) imPaSC cultured in DMEM containing 10% FBS, were 
serum-starved for 12 h and then treated with PDGF (2 and 5 ng/ml) for 15- and 30-min. Levels of total and phosphorylated forms of the indicated targets were 
measured by western blotting. As shown in the immunoblots, PDGF induced rapid activation of ERK1/2, AKT, and Hippo kinases (LATS1) and significantly increased 
levels of phosphorylated YAP (at Ser127). (B) Cells cultured in DMEM containing 10% FBS were serum-starved for 12 h and then cultured in media containing 
different concentrations of FBS. Twenty-four hours later, cells were treated for 30 min with and w ithout 2 ng/ml PDGF. As shown in the immunoblots, 5 and 10%
FBS reduced levels of total and phosphorylated YAP while PDGF markedly induced YAP phosphorylation. (C) imPaSC were serum-starved for 12 h, pre-treated with 
the MEK inhibitor U0126 (10 pM) or the PI3K/AKT inhibitor LY294002 (20 pM) for 1 h and then treated with or w ithout 2 ng/ml PGDF or 10% FBS for 30 min. Levels 
of the indicated targets were measured by Western blotting. (D) Cells treated with 2 ng/ml PDGF for up to 60 min were IF stained using a YAP specific antibody; 
Scale bar, 50 pm. Quantified nuclear/cytoplasmic YAP fluorescence intensity is shown in (E). Fluorescence was measured as indicated in Materials and Methods 
and expressed as nuclear/cytoplasmic ratio (mean ± SEM, n = 70-90  cells). As shown in the pictures, YAP staining was preferentially located in the nucleus in both 
control and PDGF-treated cells, and PDGF treatment did not alter YAP nuclear/cytoplasm ratios. Data in panels A -E  are representative of three independent 
experiments.
we pre-treated imPaSC with the MEK inhibitor U0126 (10 pM) 
or the PI3K/AKT inhibitor LY294002 (20 pM) for 1 h, and 
then treated the cells with or without PGDF or 10% FBS 
for 30 min. As shown in Figure 5C , U0126 and LY294002
inhibited ERK 1 / 2  and AKT activation, respectively in both 
PDGF- and serum treated imPaSC but did not alter levels 
of p-YAP. ^ e s e  data indicate that, at least at the time-point 
measured, YAP Ser127 phosphorylation elicited by PDGF is 
independent of ERK and AKT activation and is likely regulated 
by LATS1.
We next investigated whether PDGF-induced YAP Ser127 
phosphorylation was associated with changes in YAP cellular 
localization or translocation of YAP from the nucleus to the 
cytoplasm. Surprisingly, we found that PDGF-induced YAP 
phosphorylation did not change YAP nuclear location, as 
determined by immunofluorescence staining (Figure 5D ) and 
quantification of nuclear-to-cytoplasm YAP fluorescence intensity 
ratios (Figure 5E).
Yes-Associated Protein 1 siRNA 
Knockdown Reduces PDGF-Induced 
Proliferation and Blunts the Persistent 
Activation of AKT and ERK Induced by 
Long-Term Stimulation With PDGF
^ e  data illustrated in Figure 4 suggest that YAP 
downregulation diminishes PaSC proliferation. To examine 
the potential involvement of YAP in PDGF-induced PaSC 
proliferation, we measured ERK1/2 and AKT activation state 
and PaSC proliferation in YAP siRNA- vs. mock-transfected 
cells treated with PDGF for up to 48 h. We found that in 
mock-transfected cells (Figure 6A), PDGF induced YAP 
Ser127 phosphorylation and phosphorylation-dependent 
activation of ERK1/2, AKT and p70S6K, an effector protein 
kinase in the mTORC1 pathway that we found regulates cell 
growth in PaSC (Yang et al., 2016). ^ e s e  PDGF effects 
persisted for at least 48 h. Compared to mock-transfected 
cells, YAP siRNA treatment did not affect early activation
FIGURE 6 | YAP knockdown blunts the persistent activation of AKT and ERK induced by long-term stimulation with PDGF and reduces PDGF-induced proliferation 
in imPaSC. Mock and YAP-transfected cells were treated with 2 ng/ml PDGF for the indicated times. (A) Levels of phosphorylated and total AKT, ERK1/2 and 
p70S6K (a kinase in the mTOR pathway) were assessed by Western blotting. aSMA was tested as a marker of activation. (B) Graphs show optical density (OD) of 
the immunoblots depicted in panel A  determined by densitometry. As indicated in the graphs, YAP knockdown did not affect PDGF-induced early activation of AKT, 
ERK1/2 and mTOR signaling but reduced the long-term (48 h) PDGF effects on growth signaling. (C) YAP siRNA treatment also reduced basal and PDGF-induced 
cell proliferation as indicated by MTT assay. Data in graphs are mean ± SEM; n = 3. *p < 0.05 vs. control (-); #p < 0.05 vs. NT.
of AKT and ERK (at 30 min) but blunted long-term effects 
(at 48 h) of PDGF (Figures 6A,B ). Compared to mock- 
transfected cells, YAP siRNA knockdown also diminished 
PDGF-induced proliferation (Figure 6C) but did not completely 
block PDGF effects, supporting YAP-dependent and 
-independent pathways regulating cell growth in imPaSC.
Crosstalk Between Yes-Associated Protein 
1 and Transforming Growth Factor Beta 1 
Signaling in Cultured Pancreatic 
Stellate Cells
TGFß1 is a potent activator of fibroinflammatory responses 
in PaSC (Apte et al., 1999; Xue et al., 2015). TGFß1 effects 
on gene transcription are mediated via SMAD transcription 
factor signaling, and mounting evidence supports the existence 
of crosstalk between the Hippo pathway and SMAD signaling 
(Chen et al., 2019). For example, YAP and TAZ bind to 
SMAD2/3 within transcriptional complexes and regulate gene 
expression (Piersma et al., 2015), and YAP was reported to 
affect TGFß1 signaling by upregulating the SMAD2/3 inhibitor 
SMAD7 (Qin et al., 2018).
Here, we first evaluate whether TGFß1 modulates YAP levels 
and phosphorylation state in activated PaSC. We found that, 
unlike PDGF (Figures 5, 6), TGFß1 (5 ng/ml) did not alter 
YAP protein levels or phosphorylation at Ser127 at any of the 
time-points examined (30 min, 24 h, and 48 h) (Figure 7A).
Like PDGF, TGFß1 stimulation had no perceptible effect on 
YAP nuclear localization. In this respect, we found that 100% 
of aSMA-positive hPaSC exhibit nuclear YAP both before 
(Figure 2D ) and after 60 min treatment with TGFß1 
(Figure 7B ) and that TGFß1 treatment did not modify the 
nuclear-to-cytoplasmic YAP immunofluorescence ratios observed 
in non-treated hPaSC (Figure 7C). ^ e s e  findings suggest that 
under our culture conditions, YAP cellular localization in 
activated PaSC is not controlled by YAP Ser127 phosphorylation.
We next studied whether siRNA-mediated YAP knockdown 
would alter TGFß1-induced SMAD2/3 activation and fibrosing 
responses in imPaSC. After 24 h of transfection, imPaSC 
were treated with TGFß1 (5 ng/ml) for up to 6 h and levels 
of phosphorylated or total SMAD2/3 proteins were measured 
in cell lysates by Western blotting. We found that TGFß1 
induces rapid SMAD2/3 phosphorylation in non-transfected 
cells that persists for at least 6 h (not shown). As expected, 
YAP knockdown (Figure 8C) did not affect TGFß1-induced 
Smad2/3 phosphorylation in imPaSC (Figures 8A,B ). However, 
YAP knockdown almost completely abolished TGFß1-induced 
Ctgf, and significantly diminished interleukin 6 (IL6) expression 
in these cells (Figure 8D ). Interestingly, YAP knockdown did 
not affect the marked upregulation of plasminogen activator 
inhibitor 1 (PAI-1) elicited by TGFß1 (Figure 8D ), implying 
that YAP and TGFß1 cooperate in the transcription of distinct 
gene networks in PaSC.
5 ng/ml TGFßl
FIGURE 7 | TGFß1 does not affect does not affect YAP phosphorylation at Ser127 or YAP cellular localization in PaSC. (A) imPaSC were cultured in DMEM 
containing 10% FBS, starved in serum-free media for 12 h before experiment and then left untreated or treated with PDGF (2 ng/ml) or TGFß1 (5 ng/ml). Immunoblots 
show protein levels of the indicated targets; ß-actin was used as loading control. As shown in the pictures, PDGF induced sustained YAP phosphorylation at Ser127, 
whereas TGFß1 had no effect. Similar results were found in primary PaSC obtained from mouse or human tissues (not shown). (B) hPaSC isolated from cadaveric 
pancreata (organ donors) or pancreatic tum or surgical resections (PDAC patients; see F igure 2D) were expanded in culture using DMEM/F12 medium containing 
10% FBS until 70-90%  confluency (as in F igure 2D) and then treated with 5 ng/ml TGFß1 for 60 min. As observed in untreated cells (F igure 2D), YAP 
immunofluorescence was also mainly restricted to  the nucleus in TGFß1-treated cells. Data are representative of three independent experiments. Scale bar, 50 pm.
(C) Graph shows relative YAP localization in untreated and TGFß-treated cells obtained from donors or PDAC patients. Cellular YAP fluorescence is expressed as the 
nuclear/cytoplasmic ratio (mean ± SEM, n = 70-90 cells). As shown in the graph, TGFß1 treatment had little effect on cellular localization of YAP
DISCUSSION
CP and PDAC are devastating pancreatic diseases characterized 
by high morbidity and mortality and limited treatment options 
(Garrido-Laguna and Hidalgo, 2015; Adamska et al., 2017; 
Kleeff et al., 2017). It is widely accepted that activated, 
myofibroblast-like PaSC modulate disease states and are major 
contributors to the extensive pancreatic desmoplasia and fibrosis 
observed in CP and PDAC (Apte et al., 2013). However, the 
mechanisms that govern PaSC activation, proliferation and 
fibroinflammatory responses during disease initiation and 
progression are not completely understood. Moreover, the 
contribution of key cellular pathways such as the Hippo/YAP 
pathway, that is involved in CP and PDAC progression (Murakami 
et al., 2017; Zhao et al., 2017), to the pathobiology of PaSC 
is poorly defined. ^ i s  area of research is important because 
therapies directed to those specific pathways may have an 
impact on PaSC responses and PaSC modulation of the disease.
A previous study from this laboratory showed 
immunohistochemical evidence of YAP expression within 
activated, aSMA-positive PaSC in human CP and PDAC tumors,
and KC mice (Morvaridi et al., 2015). In this study, we found 
that YAP expression upregulates in the diseased pancreas in 
parallel with PaSC activation. Moreover, YAP expression in 
cultured PaSC is linked to the cell activation state. Activated 
PaSC obtained either from normal mouse or human pancreas, 
or from human or mouse PDAC tumor tissues exhibit preferential 
YAP nuclear staining, suggesting that YAP is transcriptionally 
active in these cells. Preferential YAP nuclear localization was 
a constant feature in cultured PaSC regardless of cell confluency 
(60-100% ). ^ e s e  findings are consistent with previous studies 
demonstrating that YAP cellular localization is regulated by 
cell morphology and the F-actin cytoskeleton (Wada et al., 
2011; Calvo et al., 2013). Cell spreading, a feature of 
myofibroblasts including PaSC, leads to YAP activation and 
translocation to the nucleus (Wada et al., 2011). Moreover, it 
was reported that incorporation of aSMA into stress fibers in 
mesenchymal cells promotes YAP nuclear translocation and 
YAP transcriptional activity (Talele et al., 2015).
Recent studies observed that treatment with BET inhibitors 
effectively reduced fibrosis and PDAC progression in mice, 
and implied that the activated state of PaSC was attenuated
FIGURE 8  | YAP siRNA significantly reduced TGFß1-induced upregulation of C tgf and IL-6 in imPaSC. (A) Twenty-four hours after transfection, m ock and YAP- 
transfected imPaSC were treated with 5 ng/ml TGFß1 for 6 h. As shown in the immunoblots, TGFß1-induced activation of the SMAD2/3 pathway was similar in mock 
and YAP siRNA-treated cells. Similar results were obtained in three independent experiments. (B) Graph shows optical density (OD) of the immunoblots depicted in 
panel A  determined by densitometry. (C,D) Twenty-four hours after transfection, mock (NT) and YAP-transfected imPaSC were treated with 5 ng/ml TGFß1 for 6 h. 
mRNA levels of Yap (C), Ccn1 (Ctgf), Il6, and the TGFß1 target gene Serpine 1 (PAI-1) (D) were measured by qPCR and quantified relative to  those of 18S rRNA. Data 
in graphs in panels B -D  represent means ± SEM from three to five independent experiments; *p < 0.05 vs. NT-not treated (-); #p < 0.05 vs. NT-TGFß1.
(Ding et al., 2015; Mazur et al., 2015). BRD4, a major BET 
protein, has also been implicated as a modulator of YAP/TAZ 
transcriptional activity at distinct promoters in cancer cells 
(Zanconato et al., 2018). Consistent with these reports, we found 
that treatment with the pan-specific BET protein inhibitor 
iBET151 reduced both mRNA and protein levels of YAP, and 
induced quiescence in PaSC, extending the mechanisms by 
which BET proteins regulate YAP/TAZ activities to the level 
of YAP/TAZ expression. Like BET inhibitors, we found that 
the p38 MAPK inhibitor SB 203580 also induced quiescence 
and reduced YAP expression in PaSC, further supporting a 
close association between YAP levels and PaSC activation state. 
Treatment with the mTOR inhibitor, KU63794, that decreased 
proliferation and ECM production in PaSC (Yang et al., 2016), 
also reduced YAP levels by 70% (data not shown). These findings 
support a key role of YAP in the activated PaSC phenotype. 
Further studies are needed to elucidate the mechanisms whereby 
p38 MAPK and mTOR pathways may intersect with BET 
proteins and other regulators of YAP/TAZ expression and activity.
Growth factors such as PDGF, IGF1, and TGFß1 were 
identified as inducers of PaSC activation into proliferative 
myofibroblasts (Apte et al., 1999, 2013; Luttenberger et al., 2000; 
Schneider et al., 2001; Mews et al., 2002; Yang et al., 2016). 
This study addresses crosstalk between PDGF or TGFß1 signaling
and YAP in PaSC. PaSC activation is associated with rapid 
and marked upregulation of PDGFRß, and PDGF is a potent 
mitogen in PaSC. As expected, we found that PDGF induced 
sustained activation of AKT and ERK signaling. We also found 
that PDGF enhanced LATS Ser473 and YAP Ser127 
phosphorylation. In other cell types, negative regulation by 
LATS protein kinases that phosphorylate YAP Ser127 typically 
restrict nuclear translocation and decrease co-transcriptional 
activity. Here, PDGF treatment dramatically enhanced YAP 
Ser127 phosphorylation but had no perceptible effect on 
preferential YAP nuclear localization in PaSC. These findings 
are consistent with a previous report demonstrating that 
pharmacological inhibition of PDGFRß or PDGFRß siRNA 
silencing decreased levels of YAP Ser127 and induced YAP 
translocation to the cytoplasm in cholangiocarcinoma cells 
(Smoot et al., 2018), suggesting a distinct role for PDGF signaling 
in regulating YAP activation. In this study, we found that YAP 
knockdown blunted the PDGF-induced persistent activation of 
AKT and ERK, and reduced PDGF-induced proliferation, further 
supporting a crosstalk between PDGF and YAP signaling.
TGFß1 treatment on the other hand had no effect on the 
levels of total or Ser127-phosphorylated YAP. Further, whereas 
TGFß1-induced Smad2/3 pathway activation was unaffected, and 
TGFß1-induced of CTGF and IL-6 upregulation were markedly
blocked by YAP knockdown in PaSC. Thus, YAP modulates gene 
transcription elicited by TGFß1/SMAD pathways in PaSC, as 
previously shown in other cell types (Zheng and Pan, 2019). 
These findings support YAP activity in PaSC as an important 
regulator of TGFß1-induced fibroinflammatory responses in CP 
and PDAC.
Taken together, our data further substantiate the importance 
of nuclear YAP previously detected in PaSC in CP and PDAC 
stroma (Morvaridi et al., 2015). In particular, our novel findings 
clarify a key role for YAP in regulating PaSC activation state, 
proliferation, and fibroinflammatory responses conducive to 
CP and PDAC progression. These results highlight YAP signaling 
as an important therapeutic target to prevent or halt the 
expansion of desmoplasia in pancreatic disorders. Further studies 
are necessary to explore the complex crosstalk between distinct 
signaling systems including YAP, TGFß1, and mitogenic signals 
regulating the activation state of PaSC in these disorders.
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SUPPLEM ENTARY FIGURE S1 | (A) Pancreas damage in mice during 
recurrent acute pancreatitis (RAP). C57BL/6 mice were subjected to  two 
episodes of acute cerulein pancreatitis (days 1 and 3; 1 day apart). Each episode 
consisted of 7 hourly intraperitoneal injections of 50 pg/kg cerulein or saline as 
vehicle control. Tissues were collected 2 days after the second episode of 
pancreatitis (day 5; d5). Panels show representative H&E-stained pancreatic 
tissue sections from mice treated with saline (control; panels a,b) or cerulein 
(RAP-d5; panels c,d); five to six mice per group. Dotted boxes in panels a,c 
(scale bar, 200 pm) are shown at higher magnification (scale bar 50 pm) in panels 
b,d, respectively. As shown in the images, pancreas from control mice (panels 
a,b) exhibit a normal exocrine parenchyma composed of groups of acinar cells 
(acini) enriched in digestive enzymes (zymogen granules). Islets (endocrine cells) 
are also observed in the pictures. At day 5 after RAP (panels c,d), pancreatic 
tissues display acinar cell necrosis, loss of normal parenchyma, and stromal 
expansion enriched in immune cells and PaSC. As shown in F igure  1C , a-SMA- 
positive PaSC were found in RAP-5d but not in control tissues. (B) Pancreas 
histology in wild type and Kras mice. Representative IHC images showing aSMA 
staining (brown) in pancreas tissues of 3 month-old w ild-type and Ptf1-Cre; 
LSL-KrasG12D/+ (KC) mice. In w ild-type mice, precancerous lesions (pancreatic 
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The stomach has unique embryologic and anatomic properties, making the study of 
the parietal cell technically challenging. Numerous individuals have devoted decades of 
research to unraveling the pathophysiological basis of this cell type. Here, we perform 
a scoping review of novel in vitro and in vivo methodology pertaining to the parietal 
cell. First, we evaluate early in vitro methods of parietal cell analysis. This section 
focuses on three major techniques: gastric gland isolation, parietal cell isolation, and 
parietal cell culture. We also discuss parietal cell physiology and pathophysiology. 
Second, we discuss more contemporary efforts involving confocal microscopy and 
gastric organoids, a new technique that holds much promise in unveiling the temporal- 
spatial dynamics of the cell. Finally, we will discuss findings from our laboratory where we 
identified an active gastric vacuolar H+-ATPase as a putative mechanism for refractory 
GERD. Overall, this review aims to highlight the major milestones in understanding an 
elusive yet important cell. Though in no way comprehensive, we hope to provide a 
birds-eye view to the study of this unique cell type in the gastrointestinal tract.
K eyw ords: pa rie ta l ce ll, m e thodo logy, in vitro te chn iques , g a s tr ic  g land  iso la tio n , in vivo c o n fo c a l im ag ing
INTRODUCTION
The human stomach is composed of approximately one billion parietal or oxyntic cells (Naik et al., 
1971) . The stomach itself is lined by columnar epithelium and punctuated by various gastric glands 
where specialized cells reside. These specialized cell types that are regionally distributed based on 
the anatomic region. Broadly, the stomach has two functional units (Schubert, 2012) . The larger, 
oxyntic region comprises the cardia, fundus, and corpus and accounts for 80% of the stomach, 
whereas the pyloric region comprises the remaining 20% via the pylorus and antrum (Figure 1A) . 
As the name implies, the oxyntic portion of the stomach is where the oxyntic or parietal cell resides. 
A gastric gland is divided into the pit, isthmus, neck, and base and has at least five specialized cell 
types based on location (Figure 1B) . In the oxyntic fundus or body, parietal cells are particularly 
abundant and secrete acid. Neighboring cells in the gland may include chief cells, enterochromaffin 
cells, D  cells, and mucous cells.
A single parietal cell can concentrate hydrogen up to 4 million times, from pH 7.4 -  0.8 (Rabon 
et al., 1983) . It undergoes a series of well-orchestrated events to generate HCl through the H +, K+ 
ATPase and the associated Cl-  and K+ channels (Schubert, 2012) . When stimulated, tubulovesicles
fuse with the membrane to form an extensive network of 
canaliculi, increasing the surface area of the parietal cell’s 
apical membrane (Sachs, 2003; Sachs et al., 2007) . Following 
stimulation, the H +, K + ATPase appears in the microvilli. 
When stimulation ceases, the canaliculi break down and the 
tubulovesicles are restored, as the parietal cell transitions back 
to the non-secretory state. These changes have been captured 
at the ultrastructural level. Figure 2 demonstrates BCECF- 
loading of parietal cells from our laboratory (Figures 2A -C , 
unpublished). Parietal cells not only govern gastric acid secretion, 
but also produce growth factors crucial for cell maturation. Our 
current knowledge of the parietal cell, however, has evolved from 
rudimentary beginnings.
In the early 1800’s, people were fascinated by stomach 
digestion but were puzzled by the agent responsible for degrading 
food matter (Baron, 1979) . Since food could not be broken 
down by common acids, it was postulated that the stomach 
possessed a certain “vital force” (Kousoulis et al., 2012). In 1824, 
William Beaumont studied the gastric contents of a gunshot 
wound victim through a gastric fistula, further proving that the 
stomach generated acidic contents (Baron, 1979), Figure 3 . Over 
a century later, little remained known about the stomach. In 1968, 
the editors of Gastroenterology mused, “The major questions 
in the field.. .are still unanswered. We cannot formulate the 
reactions within the parietal cell which result in hydrogen ion 
production. We are unable to state the etiology of peptic ulcer” 
(Davenport, 1968).
Later that year, critical findings on the parietal cell began 
to unfold. Sachs studied hog gastric mucosa and first described 
the K+-stimulated ATPase (Sachs et al., 1976) . Subsequently, a 
wave of studies emerged to further characterize this transporter 
(Ganser and Forte, 1973; Lee et al., 1974; Rabon et al., 1982). 
In the latter half of the twentieth century, three in vitro 
techniques emerged, permitting investigative studies on the 
parietal cell: (1) Gastric gland isolation. (2) Parietal cell isolation. 
(3) Parietal cell cultures.
As we shine a spotlight on supporting gastrointestinal cell 
types, we hope to illuminate the efforts that have led to our 
current understanding of the parietal cell. Figure 3 and Table 1 
may serve as visual guides during the narrative.
GASTRIC GLAND ISOLATION
Berglindh and Obrink (1976) developed a method for isolating 
gastric glands from the corpus of rabbit mucosa, as delineated 
in methodology of their 1976 paper. Briefly, after appropriate 
anesthetization, they harvested the stomach. Next, they stripped 
off the corpus mucosa, minced the tissue, and exposed it 
to collagenase. To demonstrate gland viability, they measured 
oxygen consumption and evaluated electrolyte content. Gastric 
gland cells were identified through staining and electron 
microscopy (Berglindh and Obrink, 1976) .
With this technique, scientists were able to expose isolated 
gastric tissue to various secretagogues to assess gastric acid 
production. For example, the effects of histamine, acetylcholine 
(ACh) and gastrin were found by measuring the degree of
oxygen consumption in gastric glands. They also employed 
an aminopyrine (AP) uptake assay to indirectly measure HCl 
excretion (Sack and Spenney, 1982) . The ratio of the accumulated 
14C-AP in the intra- versus extra glandular compartments 
served as an index of parietal cell function, quantified via 
a scintillation counter. AP is a weak base with a pKa of 
5.0. In an unprotonated state, the weak base freely diffuses 
across membranes. In a protonated state, the aminopyrine 
remains in a particular compartment. Impurities in the base and 
variations in centrifugation falsely lowered aminopyrine ratios 
and underestimated the parietal cell activity (Sack and Spenney, 
1982) . Nevertheless, the technique was an invaluable tool to 
quantify gastric acid secretion.
Overall, gastric gland isolation was an important scientific 
technique with advantages and disadvantages (Table 1) . Gastric 
gland isolation was beneficial in that the tight junctions and 
polarity of the cells were unperturbed. As a result, scientists 
could study cell-cell interactions. However, the presence of 
collagenase affected the transport proteins and limited studies 
on signal transduction pathways. In addition, isolated glands 
contained non-parietal cells, preventing experimentation on 
individual parietal cells. These limitations paved the way for 
parietal cell isolation.
PARIETAL CELL ISOLATION
The parietal cell is particularly challenging to isolate, due 
to its thick connective tissue. As a result, a combination of 
mechanical and chemical digestants was used to isolate the 
cells. Susceptibility of the gastric tissue to separation is species- 
dependent (Walder and Lunseth, 1963) . For example, collagenase 
fully disperses all gastric cells in dogs and guinea pigs yet has 
poorer dissociating power in rabbits and rats. Pronase and EDTA 
are alternative agents for cellular separation. Early attempts 
to isolate parietal cells involved excessive damage to the cells 
(Walder and Lunseth, 1963; Blum et al., 1971; Romrell et al., 
1975) .
The first landmark study in parietal cell isolation was that 
performed by Soll (1978) on canine stomachs (Soll, 1978) . His 
technique was unique in that he (a) completely isolated the 
mucosa from the submucosa and (b) introduced a calcium 
chelation step to facilitate disruption of cell junctions thereby 
minimizing exposure to chemical digestants.
In the first part of the experiment, the mucosa of the oxyntic 
part of the stomach was stripped from the submucosa and 
incubated in collagenase, EDTA, and collagenase again. The 
mucosal cells were then serially centrifuged and resuspended 
before being passed through a nylon mesh.
In the second part of the experiment, the parietal cell 
population was purified with a Beckman elutriator rotor. 
The rotor separated cells by counter-flow centrifugation based 
on varying sedimentation velocities. Parietal cell yields were 
obtained up to 85%.
Another method of parietal cell isolation was the Percoll 
method. In this technique, polyvinyl pyrrolidone-coated colloidal 
silica particles (Percoll, Pharmacia Fine Chemicals, Uppsala,
FIGURE 1 | Schematic representations of the stomach (A) and oxyntic gland (B). (A) The stomach is divided into two functional regions, the oxyntic region 
(composed of the cardia, fundus, and corpus) and the pyloric region (composed of the antrum and pylorus). (B) A  representative oxyntic gland from the oxyntic region 
o f the stomach features a gastric pit, isthmus, neck, and base. A  variety o f stomach cell types exist, including parietal cells, enterochromaffin cells, and mucous cells.
Sweden), were mixed with isolated cells to a specified density 
(Pretlow and Pretlow, 2014) . Afterward, the cells underwent 
15 min of 190 G centrifugation in a swinging bucket. The surface 
layer consists of parietal cells, while the bottom layer consisted of 
non-parietal cells.
Overall, isolated cells are advantageous, because they are easy 
to manipulate in the absence of a connective tissue diffusion 
barrier. However, the in vitro technique has numerous limitations 
(Table 1) . In the isolation process, the cell loses its polarity and 
its capacity to secrete HCl. In fact, many scientists preferred 
studying gastric glands as they were the smallest functional unit of 
the stomach. In addition, parietal cell isolation is time consuming 
and can result in cell clumping. The repeated centrifugation 
process concentrates the number of parietal cells but does not 
obtain a pure parietal cell population. To overcome some of these 
limitations, investigators focused on culturing cells.
PARIETAL CELL CULTURES
A working parietal cell culture was long sought after though 
difficult to attain (Chew, 1994) . Even after serial centrifugation 
to enrich the cell pool, parietal cells dwindled with cell passages. 
Scientists initially hypothesized that parietal cells dedifferentiated 
over time. It later became apparent that the more rapidly dividing 
mucous cells out-populated the parietal cells.
Chew et al. (1989) were able to obtain a nearly 100% parietal 
cell yield by combining centrifugation and density gradient 
techniques. When they placed highly enriched parietal cells in 
culture lacking serum, the parietal cells persisted. The cells were 
also responsive to known secretagogues, thus exhibiting the 
parietal phenotype. For the parietal cells to survive, they were 
placed in a unique basement membrane extract called Matrigel. 
The cells required high water quality with a specific resistivity and
FIGURE 3 | Key Events and Studies Involving the Parietal Cell and Gastric Acid Production.
TABLE 1 | Pros and cons of parietal cell methodology
Technique Pros Cons
Gastric gland isolation 
Parietal cell isolation
Parietal cell cultures 
Permeabilized gastric gland models 
In vivo confocal microscopy 
Gastric gland dissection
Gastric organoids
-  Able to  study smallest functional unit of stomach
- Easy to  manipulate pH, ion composition w /o  diffusion barrier 
Study on a single cell type
Can attain high yields of parietal cells 
Study on a single cell type
Allows for assessment of signal transduction in the Parietal cell
Allows for real-time pH monitoring during acid secretion
- Evaluates effects in vivo
- Can monitor effects of various drugs on H + , K+ ATPase through 
changes in intracellular pH, Ca, Cl
Can selectively inactivate sodium and potassium dependent 
transporters by exposing it to  0 -N a  and 0 -K  solutions
- A  near physiological three-dimensional model
- More accurate representation of in vivo system
- Can sustain H. py/or/m icroinjections
-  Indirect method of measuring H+ secretion
-  Collagenase affected transport proteins
-  Also contains non-parietal cells 
-T im e  consuming
-  Inconsistent parietal cell yields
-  Chemical digestants damage the cell
-  Isolated parietal cells behaves differently
-  Loss of parietal cells over time
-  Unable to  see cell-cell interactions
-  Digitoxin: cells lose secretagogue sensitivity
-  Alpha toxin: only smaller proteins were permeable
-  Not accurate for pH < 2
-  Restricted to  in vitro analysis
-  Difficult to  maintain high population parietal cells
-  Lack of immune cells, neurons, vascularization
inclusion of antibiotics and antimycotics (Pretlow and Pretlow, 
2014). Issues with the parietal cell culture included inevitable loss 
of cell numbers, around 10% per day. In addition, the presence of 
the parietal cell was verified only indirectly through its response 
to known secretagogues and the accumulation of aminopyrine.
In the wake of parietal cell cultures, Forte and colleagues 
applied high-pressure freezing (HPF) techniques to
capture ultrastructural changes during acid secretion
(Sawaguchi et al., 2002). Cultured parietal cells were mounted 
on aluminum plates and frozen at high pressures to prevent
crystal formation. Ice in the frozen specimen was substituted
with an organic solvent, gradually warmed to 20° C, embedded 
in Epon, and cut into thin sections. The nucleus and cytoskeletal 
were better preserved with HPF than conventional chemical
fixation. In addition, the tubulovesicle changes were captured by 
pre-exposure to histamine. The presence of the cell membrane in 
parietal cell cultures made it difficult for investigators to evaluate 
signal transduction pathways. Scientists sought to introduce 
protein fragments into the cytoplasm to evaluate downstream 
effects. To facilitate this, permeable parietal cell models emerged 
(Yao and Forte, 2003).
PERMEABILIZED MODELS
One of the earlier permeabilized models using the detergent 
digitoxin was introduced by Hersey and Steiner (1985). 
Digitoxin permeabilized the parietal cell by creating pores
in the membrane to permit protein entry. A downside 
was that the cell was no longer sensitive to secretagogue 
stimulation. Subsequently, Thibideau introduced the alpha toxin 
permeabilized model (Thibodeau et al., 1994) . Alpha-toxin was 
isolated from Staphylococcus aureus to create pores in the parietal 
cell membrane. Here, the parietal cell was still receptive to 
secretagogues while maintaining permeability. A downside was 
that the alpha-toxin generated narrow pore sizes, so only small 
nucleotides could pass through. Gentler detergents like Beta- 
escin were introduced that permitted entry of larger molecules 
without disrupting the parietal cell (Akagi et al., 1999) . Overall, 
these three in vitro methods -  gastric gland isolation, parietal cell 
isolation, and parietal cell cultures with permeabilization -  paved 
the way for newer techniques to emerge.
IN VIVO CONFOCAL MICROSCOPY
The stomach’s ability to resist damage from its own highly acidic 
fluid has been a topic of interest. Through in vivo confocal 
imaging on an everted rat stomach, Montrose and colleagues 
quantified pH changes at the gel-mucous gastric surface 
(Chu et al., 1999) . First, they used a surgical exteriorization 
technique. The stomach was exteriorized, opened along the 
greater curvature, and everted to expose the mucosa. Baseline 
luminal pH measurements of the gastric contents were recorded. 
The everted stomach was secured to the abdominal wall with 
sutures and the rat was placed prone on the microscope stage. The 
stomach tissue was maintained at physiological temperatures and 
continuously perfused with solutions of varying pH’s.
To measure pH changes in real time, they used a fluorescent 
extracellular dye, Cl-NERF in the perfusate. They excited the 
dye with an argon laser and calculated fluorescence intensity 
ratios of the emissions (Chu et al., 1999) . As an internal 
reference, Lucifer yellow was added to the perfusate and Cl- 
NERF/Lucifer ratios were converted to various pH’s at the 
level of the gastric surface. As hypothesized, when the gastric 
mucosa was perfused with acidic solutions, the gastric surface 
pH was relatively alkaline. When the rats were injected with 
pentagastrin, the pH of the perfusate decreased, while the pH at 
the gastric surface remained alkaline. These studies confirmed 
that the gel-mucous stomach layer provides a self-protective 
mechanism from the acidic contents it secretes. With confocal 
microscopy, high resolution images were obtained at various 
depths of a tissue specimen without sectioning and processing. 
Overall, this technology has permitted significant advances in the 
understanding of stomach physiology.
PARIETAL CELL PHYSIOLOGY
Parietal cells carry the H, K ATpase in cytoplasmic tubulovesicles 
that are eventually shuttled to the apical membrane through 
various routes of activation. Three primary pathways, the 
neurocrine, paracrine, and endocrine, are involved in inducing 
parietal cell acid secretion (Schubert, 2012) . With regards 
to the neurocrine pathway, the neurotransmitter ACh is
responsible for acid secretion. Ach directly activates the 
parietal cell by attaching to the muscularinic M3 receptor. This 
activation triggers downstream phospholipase C’s conversion 
of phosphatidylinositol bisphosphate (PIP2) into inositol 
trisphosphate (IP3), leading to release of intracellular calcium 
stores and activation of calmodulin kinases that activate acid 
secretion (Figure 4A ).
In the endocrine activation pathway, antral endocrine G cells 
secrete gastrin which directly binds to type B cholecystokinin 
receptors, triggering the same pathway generating increased 
intracellular calcium as that of ACh. Indirectly, gastrin also 
stimulates histamine secretion from ECL cells.
In the paracrine pathway, enterochromaffin cell releases 
histamine, which separately activate acid secretion. By binding 
to H2-specific receptors on the parietal cell, histamine triggers 
a signal transduction pathway through activation of adenylyl 
cyclase, which increases intracellular cAMP that serves. 
Indirectly, histamine acts through H3 receptors which suppress 
somatostatin secretion, thereby abolishing any inhibition of acid 
secretion by somatostatin.
Overall, there are multiple interactions amongst ACh, gastrin, 
and histamine and their associated pathways to regulate 
acid secretion. While these are the three main mediators 
of acid production, a variety of other stimulants have been 
identified, including gastrin-releasing peptide, nitric oxide 
in specific amounts, pituitary adenylate cyclase activating 
polypeptide, ghrelin, atrial natriuretic peptide, and even coffee 
(Schubert, 2012).
As the parietal cell is activated by one or more pathways 
previously described, the hydronium ion is generated and HCl 
secreted. In order to maintain the H +, K+ ATPase pump, a 
careful interplay of channels, exchangers, and transporters is 
required (Figure 4B ) . On the apical side is the H +, K+ ATPase, 
which is a dimeric protein and member of the P-Type family 
of ATPases. The alpha subunit spans the membrane 10 times, 
whereas the beta subunit spans once. This transporter is typically 
stored in tubulovesicular elements (TVE) that fuse with the 
apical membrane under parietal cell stimulation to deliver the 
transporter machinery to the membrane (Schubert, 2012) . To 
maintain the potassium gradient, the apical KCNQ1 channel is 
nearby (Heitzmann and Warth, 2007) . Other apical K+  channels 
include Kir 2.1 and Kir 4.1 (Forte, 2004). The bicarbonate that 
is generated from the hydrogen that is extruded by the H+ , 
K+ ATPase is generated along with H+ from the intracellular 
carbonic anhydrase reaction exits the cell through the SCL4A2. 
For each hydrogen that is secreted, bicarb leaves the cell 
basolaterally. To maintain electroneutral acid secretion, chloride 
is also apically secreted along with hydrogen, generating HCl. On 
the apical side, the CFTR allows for chloride entry into the gastric 
lumen (Sidani et al., 2007) . Basolaterally, chloride enters the cell 
through SLC4A2, SLC26A7, and NKCC1 (Kosiek et al., 2007). 
Overall, various cations and anions are involved in transcellular 
movement to maintain the H +, K+ ATPase pump. Though 
calcium is not directly involved in transcellular movement, 
its release from the sarcoplasmic reticulum is essential for 
parietal cell stimulation. The identification ofthe calcium sensing 
receptor (CaSR) on the surface of freshly isolated rat gastric tissue
FIGURE 4 | Schematic representations of the parietal cell (A) gastric acid stimulants (B) exchangers, transporters, channels. (A) The H, K ATPase is stimulated 
through three primary inputs: acetylcholine (ACh), gastrin, and histamine. ACh and gastrin bind to  their receptors and trigger activation of phospholipase C (PLC), 
which converts PIP2 to  IP3 and triggers release of Ca2+from the sarcoplasmic reticulum. This leads to  downstream activation of the H, K ATPase. Histamine binds 
to  the H2 receptor, triggering activation of adenylyl cyclase and activation of PKA. (B) Multiple apical and basolateral anion and cation movements occur to  maintain 
the gradient and electroneutral transport of Hydrogen.
has also been associated with an increase in intracellular calcium 
release and parietal cell activation (Dufner et al., 2005) .
PARIETAL CELL PATHOPHYSIOLOGY
A spectrum of diseases emerges when any of the well-regulated 
pathways in parietal cell function go awry. There may be 
disorders of increased and decreased gastric acid secretion. On 
one end of the spectrum, gastric hypersecretion can result from 
various pathologic disease states, ranging from gastrinoma to 
peptic ulcer disease. On the other end, achlorhydria or the 
absence of HCl, can result from autoimmune disease states 
or from surgical interventions like vagotomies. As explained 
previously, three main inputs -  gastrin, ACh, and histamine -  are 
known to stimulate the parietal cell. Thus, perturbations of this 
inputs result in altered gastric acid secretion (Figure 5) .
Pathophysiological elevations in gastrin can occur in patients 
with gastrinomas, a type of neuroendocrine tumor that can arise 
sporadically or as part of the familial syndrome, MEN1 (Kitagawa 
and Dempsey, 2005). The state of having elevated gastric acid 
secretion due to a gastrinoma is Zollinger Ellison syndrome, 
which manifests as intractable ulcers, weight loss, and abdominal 
pain (Isenberg et al., 1973; De Angelis et al., 2018) . Surgery is the 
mainstay of treatment, though preoperative and intraoperative 
identification of the small gastrinomas can be difficult. Over 90% 
of tumors are found in the gastrinoma triangle, an anatomical 
zone defined by the junction of the pancreatic neck and body, 
the junction of the second to third parts of the duodenum, and 
the junction of the cystic and common bile duct (Figure 5) .
Acetylcholine is the other main stimulator of parietal cell 
secretion, which has been a primary target for surgically reducing 
acid hypersecretion. Shown in Figure 5 are the three different
FIGURE 5 | Pathophysiologic basis o f gastric acid hypersecretion. Illustrated 
are selected examples of changes to physiological acid secretion. Lines a,b,c 
represent surgical transection lines for truncal, selective, and highly selective 
vagotomies. This reduces cholinergic input for acid secretion. Triangle d is the 
anatomical region where a gastrinoma is most likely to exist. A  gastrinoma 
provides constitutively high levels of gastrin, leading to overactive parietal 
cells, and hyperplastic changes in morphology.
types of vagotomies that can be performed: truncal vagotomy (a), 
selective vagotomy (b), and highly selective vagotomy (c). The 
more selective vagotomies leave parts of the vagus nerve, which 
helps facilitate gastric emptying problems associated with the 
truncal vagotomy. Due to the advent of proton pump inhibitors, 
the need for surgical vagotomies has declined.
One of the most common disease states linked to altered 
gastric acid homeostasis is peptic ulcer disease. Peptic ulcers are 
focal lesions in either the stomach or duodenum that can emerge 
for a variety of reasons, most commonly H elicobacter pylori. 
H. pylori is a spiral shaped bacterium that can protect itself from 
the damaging effect of nearby HCl through its local production 
of urease, which converts urea into ammonium and bicarbonate 
(Kitagawa and Dempsey, 2005). Various mechanisms by which
H. pylori causes damage has been studied and is discussed at 
length in other reviews (Camilo et al., 2017; Kamboj et al., 
2017. As it pertains to acid hypersecretion, H. pylori inhibits 
the antral D cells that produce somatostatin, thereby leading to 
hypergastrinemia and acid overproduction. Therapy for H. pylori 
include a combined course of antibiotics as well as proton pump 
inhibitors (PPI, Yang et al., 2014; Strand et al., 2017) .
AN EXPLANATION OF PPI FAILURE
A better understanding of stomach physiology has led to major 
advances in the treatment of gastric disease. Characterization of 
the H +, K+ ATPase resulted in the development of proton pump 
inhibitors that irreversibly inhibit the transporter. However, 
many patients still suffer from acid hypersecretion. Using the 
ammonium prepulse technique, our lab identified the vacuolar 
ATPase as a constitutively active H+ -ATPase that is not 
susceptible to proton pump inhibitors (Kitay et al., 2018) . In 
this experiment, we performed gastric gland dissection to isolate 
tissue. We then loaded parietal cells in the gastric tissue with acid 
and flushed them with solutions that were free of sodium and 
potassium in order to eliminate activity of the endogenous H+ , 
K+  ATPase and the sodium hydrogen exchanger (NHE). We then 
exposed cells to omeprazole and identified persistent efflux of 
hydrogen, as measured by intracellular pH (pHi). The subsequent 
recovery of pHj was attributable to H + -ATPase, the only 
remaining pathway for the extrusions of protons. In addition, we 
discovered that the activity of the H+-ATPase was upregulated 
when exposed to calcium (Kitay et al., 2018; Figure 4B ) .
GASTRIC ORGANOIDS
Organoids are three-dimensional, stem cell-derived cell models 
first developed in murine intestines. In 2009, Sato placed 
intestinal stem cells into an extracellular matrix enriched 
with intestine-specific niche factors. They obtained cells that 
differentiated into intestinal cell types ranging from goblet to 
Paneth cells (Sato et al., 2009). The first gastric organoids 
were developed as an extension of the intestinal organoid 
protocol (Barker et al., 2010). Adult stem cells from murine 
antral glands were embedded into extracellular matrices and 
exposed to stomach-specific niche factors (Barker et al., 2010). 
Gastric organoid cells differentiated into chief, neck, pit and 
enteroendocrine cells. The one cell type that was elusive was the 
parietal cell. Though present in the initial culture, the parietal 
cells decreased with multiple passages.
To counteract this problem, scientists used pluripotent 
stem cells (PSCs). Noguchi cultured corpus organoids from
mouse ESCs, which generated all three germ layers (Noguchi 
et al., 2015). The embryoid bodies from primordium spheroids 
were embedded into matrix and allowed to differentiate over 
60 days with exposure to selected niche factors. These gastric 
organoids developed functional parietal cells. McCracken and 
colleagues then exposed human PSC-derived foregut progenitors 
to beta catenin to create human, fundic-type gastric organoids 
(hFGOs) (McCracken et al., 2017) . From here, they exposed 
the hFGOs to a variety of putative parietal cell agonists and 
measured expression of ATP4A and ATP4B, known parietal 
cell markers (McCracken et al., 2017) . Interestingly, mature, 
terminal parietal cells have dedifferentiating capacity; Notch 
activation in parietal cells can be de-differentiated into stem 
cells (Kim and Shivdasani, 2011). Other transgenic mice that 
have been engineered to overexpress Noggin, led to the 
development of dedifferentiated cells at the cost of the parietal 
cell lineage (Tetreault and Katz, 2012). What is most notable 
in transgenic studies on parietal cells is that genetic alterations 
more frequently lead to parietal cell loss than parietal cell 
gain. Overall, the embryonic properties of parietal cells remains 
under investigation.
Overall, organoids unite the positive aspects of both in vitro 
and in vivo systems in that they allow for easy experimental 
manipulation, while maintaining the cellular diversity of native 
tissue (Engevik et al., 2018) . Nevertheless, it is still difficult to 
maintain organoids with high populations of parietal cells. New 
studies are evaluating the effects of H. pylori microinjections into 
gastric organoids. It is important that gastric organoids maintain 
parietal cells over time.
COMPUTER MODELING OF THE 
PARIETAL CELL
Another new concept in the understanding of the parietal 
cell is computer modeling using Berkeley Madonna Software 
(Crothers et al., 2016) . The software is a mathematical modeling 
package and a differential equations solver. Crothers et al. 
(2016) created a dynamic model of the parietal cell based 
on known features of Na+ , K+ ATPase, AE2, and the H+ , 
K+  ATPase. It quantitatively represents the activity of all 
parietal cells located within 1 cm2 of adult mammalian 
tissue. Voltage measurements from classical studies in a 
resting and stimulated parietal cell were entered into the 
software to recapitulate a model of the cell. The model 
adequately predicted flux and potential differences but also 
provided novel insight into the role of canalicular potassium in 
parietal cell secretion.
DISCUSSION
Clearly, we have made significant strides in the understanding of 
the parietal cell. Historically, the study of the parietal cell plagued 
the most ambitious and astute researcher. Since the stomach 
consists of a variety of cell types, it was particularly challenging to 
isolate the parietal cell. In this chronological review, we described
some of the various methodological milestones that helped shape 
our current understanding of the parietal cell.
The parietal cell is a small component of the alimentary 
tract, yet immense research has been devoted to the topic. 
This phenomenon may be twofold. First, dysfunctional parietal 
cells lead to human disease with a large socioeconomic burden, 
which has galvanized research efforts (Banic et al., 2011). 
With the discovery of proton pump inhibitors, gastroesophageal 
reflux disease is now manageable. Second, the parietal cell has 
historically been challenging to study. The stomach has multiple 
cell types that are affected by autocrine, endocrine, and paracrine
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The microbes in the gastrointestinal tract are separated from the host by a single layer 
of intestinal epithelial cells (IECs) that plays pivotal roles in maintaining homeostasis 
by absorbing nutrients and providing a physical and immunological barrier to potential 
pathogens. Preservation of homeostasis requires the crosstalk between the epithelium 
and the microbial environment. One epithelial-driven innate immune mechanism that 
participates in host-microbe communication involves the release of reactive oxygen 
species (ROS), such as hydrogen peroxide (H2O2), toward the lumen. Phagocytes 
produce high amounts of ROS which is critical for microbicidal functions; the functional 
contribution of epithelial ROS, however, has been hindered by the lack of methodologies 
to reliably quantify extracellular release of ROS. Here, we used a modified Amplex Red 
assay to investigate the inflammatory and microbial regulation of IEC-generated H2O2 
and the potential role of Duox2, a NADPH oxidase that is an important source of H2O2. 
We found that colonoids respond to interferon-y and flagellin by enhancing production 
of H2O2 in a Duox2-mediated fashion. To extend these findings, we analyzed ex vivo 
production of H2O2 by IECs after acute and chronic inflammation, as well as after 
exposure to dysbiotic microbiota. While acute inflammation did not induce a significant 
increase in epithelial-driven H2O2, chronic inflammation caused IECs to release higher 
levels of H2O2. Furthermore, colonization of germ-free mice with dysbiotic microbiota 
from mice or patients with IBD resulted in increased H2O2 production compared 
with healthy controls. Collectively, these data suggest that IECs are capable of H2 O2 
production during chronic inflammation and dysbiotic states. Our results provide insight 
into luminal production of H2O2 by IECs as a read-out of innate defense by the mucosa.
K eyw ords: c o litis , in tes tin a l in fla m m a tio n , in fla m m a to ry  bow e l d isease, m ic rob iom e , h o s t-m ic ro b e  in te ra c tio n s
Abbreviations: AO M , azoxymethane; D PI, diphenyleneiodonium; DSS, dextran sodium sulfate; Duox, dual oxidase; 
GF, germ free; HRP, horseradish peroxidase; HS, healthy subjects; H 2O 2 , hydrogen peroxide; IBD, inflammatory bowel 
diseases; IEC, intestinal epithelial cells; IFN y , interferon-y ; M PO, myeloperoxidase; Nox, NADPH oxidase; PMSF, 
phenylmethylsulfonyl fluoride; ROS, reactive oxygen species; V EO -IBD , very early onset IBD ; W T, wild-type.
INTRODUCTION
The gut epithelial barrier consists of a single layer of IECs that 
separates the largest compartment of the host’s immune system 
from an environment with a high microbial and antigenic load 
(Mowat and Agace, 2014; Sender et al., 2016). This epithelial 
monolayer acts as a physical, chemical, and immune barrier, 
minimizing the contact between the host and the microbiota and 
therefore maintaining homeostasis. While epithelial-dependent 
immune functions, such as the secretion of mucus, the 
production of antimicrobial peptides, and the transportation of 
immunoglobulin A, have been widely investigated, the functions 
of IEC-generated ROS as signaling intermediates in host defense 
are still not well understood due to the lack of reliable 
methodologies to measure extracellular release ofROS.
Reactive oxygen species are reduced metabolites of oxygen 
that can oxidize other molecules and have microbicidal or 
signaling functions depending on their concentration in the 
microenvironment (Mittal et al., 2014) . High levels of ROS 
produced by neutrophils and other phagocytes play important 
microbicidal functions during an oxidative burst. Under such 
conditions, ROS are likely to act as microbicidal agents in 
conjunction with MPO, which uses H2O2 to oxidize chloride 
forming the antimicrobial hypochlorous acid (Klebanoff et al.,
2013) . On the other hand, in steady-state conditions, low 
amounts of ROS released by non-phagocytic cells activate 
both host and microbial signaling pathways by altering 
the phosphotyrosine signaling network and inducing certain 
transcription factors (Holmstrom and Finkel, 2014). ROS are 
generated either as byproducts of mitochondrial oxidative 
phosphorylation or through NADPH oxidases, including Nox 
1 through 5 as well as Duox 1 and 2 (Mittal et al., 2014; 
Aviello and Knaus, 2017) . In the gut epithelium, the two major 
NADPH oxidases are Nox1 and Duox2 (Grasberger et al., 2015; 
Aviello and Knaus, 2018). Duox2 generates H2O2, whereas Nox1 
produces superoxide (O2- ), which can in turn be converted 
into H2O2 by superoxide dismutase (Dikalov and Harrison,
2014) . Given its stability and diffusibility, H2O2 produced by 
epithelial NADPH oxidases can diffuse to the extracellular milieu 
and act as a messenger to communicate with neighboring host 
and microbial cells (Aviello and Knaus, 2017) . Indeed, IEC­
generated ROS participate in mucosal healing processes by 
inactivating diverse phosphatases that regulate cell migration 
(Swanson et al., 2011; Leoni et al., 2013; Moll et al., 2018). 
Furthermore, ROS interact with microbes, modifying bacterial 
proteins involved in signal transduction, virulence, motility, and 
invasiveness, ultimately restraining colonization of the mucosa 
(Botteaux et al., 2009; Corcionivoschi et al., 2012; Grasberger 
et al., 2013; Hayes et al., 2015) .
Inflammatory bowel diseases are characterized by dysbiosis, 
disproportionate immune responses against the microbiota, and 
high levels of ROS (McKenzie et al., 1996; Gitter et al., 2001; 
Hussain et al., 2003; Itzkowitz and Yio, 2004; Tamboli et al., 
2004; Luceri et al., 2019). Even though the high oxidative stress 
in IBD patients is likely due to the oxidative burst of infiltrating 
neutrophils, epithelial Nox1 and Duox2 are overexpressed in 
IBD patient biopsies (MacFie et al., 2014; Chu et al., 2017).
Furthermore, Duox2 is an early upregulated gene in very early 
onset (VEO) IBD and loss of function mutations in both Nox1 
and Duox2 have been associated with such disease (Haberman 
et al., 2014; Hayes et al., 2015; Parlato et al., 2017). Although it 
is still unclear whether the upregulation of epithelial NADPH 
oxidases in IBD perpetuates inflammation, some models have 
proposed a role for Nox1 and Duox2 in facilitating dysbiosis 
by providing anaerobic substrates for facultative anaerobes to 
bloom (Winter et al., 2013; Zhu et al., 2019) . However, the 
fact that Duox2 is upregulated after humanization of germ-free 
mice with human dysbiotic microflora and prevents microbes 
from invading the mucosa suggests that epithelial ROS may 
be necessary to control dysbiosis and promote epithelial repair 
(Grasberger et al., 2013, 2015) .
Given that ROS mediate the communication between the 
epithelial barrier and the mucosa-associated microbiota and have 
also been associated with dysbiosis and inflammation, we sought 
to characterize the extracellular release of H2O2 by IECs in these 
settings. To this end, we measured the oxidation of 10-Acetyl- 
3,7-dihydroxyphenoxazine (Amplex Red) into resorufin in the 
presence of HRP and H2O2 in IECs. This method, which is highly 
sensitive, allowed for real time measurement of H2 O2 produced 
by IEC in the nanomolar range (Zhou et al., 1997) . To overcome 
the technical difficulties posed by carboxylesterases, which are 
expressed in IECs and oxidize Amplex Red (AR) in an HRP- 
independent way, we supplemented our reaction buffers with the 
serine protease inhibitor PMSF, as previously described in other 
cell types from liver and kidney (Miwa et al., 2016) . Here, we 
demonstrate that upon inflammatory and microbial challenge, 
primary IECs in culture release H2O2 to the extracellular milieu 
in a Duox2-mediated mechanism. Furthermore, we report that 
freshly isolated IECs synthesize H2 O2 in response to chronic 
inflammation and dysbiosis. Our findings support a key role for 
Duox2 in mediating mucosal responses to dysbiosis.
MATERIALS AND METHODS 
Human Tissue and Stool Acquisition
The acquisition and use of human data, biopsies, and stool 
samples were approved by the University of Miami, Miller School 
of Medicine Institutional Review Board. At the time the patient 
samples were collected, a complete history and assessment of 
disease was completed (Supplementary Table 1). Colonoscopic 
biopsies were obtained from 6 non-inflamed IBD patients and 
processed the same day for organoid culture. Stool from IBD 
patients in remission and HS was aliquoted in an anaerobic 
chamber (Coy) the same day of collection and stored in —80°C.
Animals
C57Bl/6 and Nox1 total knock-out (Nox1-KO; Nox1TM1Kkr) 
mice were purchased from Jackson Laboratory. Epithelial 
DuoxA1/A2-KO mice, which are functionally deficient in Duox1 
and Duox2, were obtained by crossing the DuoxA1/A2-floxed 
mice generated at Dr. Kaunitz’s laboratory (UCLA) with villin-cre 
(Tg(Vil1-cre)997Gum) mice purchased from Jackson Laboratory. 
Even though these mice are double knock-out for Duox
isoenzymes, they are widely accepted as a model to investigate 
the role ofDuox2 in the colon given that the expression ofDuox1 
in the gut is exceedingly low (Grasberger et al., 2015; Aviello 
and Knaus, 2018; van der Vliet et al., 2018) . Villin-TLR4 mice, 
which express a transgene that renders TLR4 constitutively active 
under the villin promoter, were generated as previously described 
(Shang et al., 2008) . Germ-free adult C57Bl/6 mice were bred 
and housed at the University of Miami Gnotobiotic Facility in 
Class Biologically Clean flexible film isolators and transferred to 
Biocontainment Unit (BCU) cage system after microbial transfer. 
All mice were generated on a C57Bl/6 background, housed in 
either specific pathogen-free or germ-free conditions with a 
controlled temperature of 20 ±  2°C, and allowed free access to 
food and water, either regular or autoclaved for specific pathogen­
free and germ-free mice, respectively. All experiments were 
performed with the approval of the Institutional Animal Care and 
Use Committee (IACUC) at the University of Miami (Protocols 
17-196 and 18-169). The University of Miami is internationally 
accredited by the Association for Assessment and Accreditation 
of Laboratory Animal Care (AAALAC).
Experimental Design, Colitis Induction, 
and Collection Samples
Mice between 8 to 16 weeks of age, of both sexes, were 
randomly assigned cages and then adapted for at least 5 days 
prior to starting experiments. In order to induce colitis, 3% of 
DSS (40-50 kDa; Affymetrix/USB, ThermoFisher Scientific) was 
added to the drinking water for either 2, 4, or 6 consecutive 
days and replaced every other day. To minimize variability 
in our determinations, all mice were euthanized on the same 
day (Figure 3B ) . The AOM-DSS model of colitis-associated 
cancer (CAC) was utilized in order to investigate chronic 
inflammation and tumorigenesis. AOM (7.4 mg/kg; Sigma- 
Aldrich) was injected intraperitoneally 1 week before beginning 
a 5-day cycle of 3% DSS. After the first cycle of DSS, the mice 
were allowed to recover for 2 weeks before subsequently starting 
a second 5-day cycle of 3% DSS. Mice were euthanized on day 56 
(Figure 3E) . The weight loss for each mouse was assessed daily 
during the DSS cycles and the first week of recovery for the CAC 
model as previously described to evaluate the severity of colitis. 
Mice losing more than 30% of initial body weight or displaying 
severe bloody diarrhea with lack of exploratory behavior were 
immediately euthanized. No animals died or met the endpoint 
criteria prior to the end of the study.
Mice were euthanized by cervical dislocation under isoflurane 
(Piramal Critical Care) anesthesia. Subsequently, the colon was 
removed, flushed, cut along the mesenteric border, and pinned 
flat on a Sylgard TM-coated Petri dish. One longitudinal section 
of the colon was prepared for histology by rolling it into a Swiss 
roll and fixing it in 4% paraformaldehyde. The rest of the colon 
was utilized for either IEC isolation, MPO determination, or 
preparation of mucosa-associated microbiota homogenates.
Microbial Engraftment
Mucosa-associated microbiota homogenates were prepared from 
C57Bl/6J or villin-TLR4 mice by homogenizing flushed colons in
Hank’s balanced salt solution (HBSS) using a BeadBlasterTM24 
(Benchmark) in a vinyl anaerobic chamber (Coy). One mL 
of HBSS was used for every 50 mg of colon. To prepare 
the human stool samples, frozen stool was mixed with sterile 
HBSS (1:10 ratio of stool weight:HBSS) and filtered with a 
40 ^m  strainer in an anaerobic chamber. GF mice were then 
orally gavaged with 200 uL of either the resulting mucosa- 
associated microbiota or stool slurry and housed in separate 
iso-cages depending on the donor microbiome (C57Bl/6J vs. 
vilin-TLR4; HS vs. IBD). After a 3-week engraftment (Figures 4A , 
5A), mice were euthanized as indicated above. The colon of 
these mice was used for same histopathological, enzymatic, and 
transcriptomic determinations.
DNA Extraction and 16S Sequencing
Total bacterial DNA was extracted, quantified, and sequenced 
at the University of Minnesota Genomic Center (UMGC) 
as previously described (Gohl et al., 2016) . Briefly, DNA 
was extracted using PowerSoil/fecal DNA Isolation Kit 
(MoBio Laboratories) and the 16S-V4 region was amplified 
using Meta_V4_515F and Meta_V4_806R primers, and 
KAPAHiFidelity Hot Start Polymerase PCR. After a first 
amplification, the products were diluted 1:100, 5 uL of which 
were used for the second round of amplification. Various 
different combinations of forward and reverse indexing primers 
were used for the second PCR. For sequencing, pooled samples 
were denatured with NaOH, diluted to 8 pM in Illumina’s 
HT1 buffer, spiked with 15% PhiX, and denatured at 96°C 
for 2 min. A MiSeq600 cycle v3 kit was used to sequence
the DNA, and Nextera adapter sequences were used for
post-run trimming.
Microbiome Data Analysis
The paired-end sequences were obtained as forward and 
reverse demultiplexed fastq files from the Illumina MiSeq. 
CosmosID bioinformatics software package (CosmosID 
Inc.) was used to identify bacterial species, quantify the 
relative abundance, calculate alpha diversity, and generate 
a principal component analysis. Briefly, CosmosID pipeline 
uses a high-performance data-mining k-mer algorithm 
that rapidly disambiguates millions of short sequencing 
reads into the discrete genomes engendering the particular
sequences. This pipeline has two separable comparators that
include a pre-computation phase that matches a k-mer to 
a uniquely identified reference database and a per-sample 
computation that statistically scores the entire read to verify 
the identification and to avoid false positive identifications. 
For the pre-computation phase, the input is microbial genome 
databases, and the output is phylogeny trees and variable length 
k-mer fingerprints (biomarkers) that uniquely identify nodes 
generating branches and leaves of the tree. While the second 
per-sample computation phase searches 100s of millions of 
short sequence reads or contigs from a draft assembly against 
fingerprint sets. Finally, to obtain fine-grain taxonomic and 
relative abundance estimates for the microbial datasets, the 
resulting statistics are analyzed.
Isolation of IECs and Colonoid 
Preparation
In order to isolate IECs, the murine colonic sections and human 
biopsies were shaken at 150 rpm for 45 min at room temperature 
in a chelation buffer prepared with 10 mM EDTA in HBSS. The 
residual EDTA was then gently washed with HBSS, and the crypts 
were released by gentle agitation for 30 min. The remaining 
longitudinal tissue was removed and snap frozen for future MPO 
experiments. The released crypts were either used to generate 
colonoids, utilized for the direct measurement of H2O2, or lysed 
in Trizol (ThermoFisher) for qPCR. To generate colonoids, the 
IECs were pelleted and resuspended in ice-cold Cultrex reduced 
growth factor basement membrane, type R1 (R&D systems). For 
2 days, mouse colonoids were grown in 50% conditioned medium 
containing wnt3a, R-spondin-3, noggin, and 20% fetal bovine 
serum (WRNC medium) (Miyoshi and Stappenbeck, 2013) 
supplemented with 5 ^M  Chir99021 (Cayman Chemical), 2.5 
^M  Thiazovivin (Cayman Chemical), and 100 ^g/mL Primocin 
(Invivogen). Human colonoids were grown in a mixture of 
Human Intesticult Organoid Growth Medium (STEMCELL 
Technologies) and WRNC medium (1:3 ratio) and supplemented 
with 5 ^M  Chir99021, 2.5 ^M  Thiazovivin, 0.5 ^M  A83-01 
(Cayman Chemical), 10 ^M  SB202190 (Cayman Chemical), 
100 ^g/mL Primocin, and 1x gentamicin-amphotericin B 
(ThermoFisher). After 2 days, colonoids were switched to 
a growth factor-restricted, less reactive medium containing 
DMEM/F12, 10% R-spondin-2 (Bell et al., 2008) and 10% 
noggin-conditioned media (Heijmans et al., 2014), 10% fetal 
bovine serum, mouse epidermal growth factor (50 ng/mL; Life 
Technologies), Primocin (100 ^g/mL) and Chir00921 (5 ^M ) 
(RENC medium). Colonoids stimulated on day 6 for 24 h with or 
without 100 ng/mL interferon (IFN)y (Biolegend) or 100 ng/mL 
ultrapure Salmonella typhimurium  flagellin (Invivogen) in RENC 
were utilized for H2O2 measurement.
Real-Time Measurement of Hydrogen 
Peroxide Production
Intestinal epithelial cells or colonoids seeded in 96 well 
plates were incubated in Dulbecco’s PBS (DPBS) solution 
containing Ca2+, M g2+, 0.1 U/mL HRP (Sigma Aldrich), 30 
10-Acetyl-3,7-dihydroxyphenoxazine (Biotium), and 100 
PMSF (Sigma-Aldrich). The real-time formation of fluorescent 
resorufin (Ex 530 nm/Em 590 nm) was read at 60 s intervals 
for 10 min at 37°C in a Synergy H1 fluorometer (BioTek). 
In order to assess the amount of H2O2 produced by NADPH 
oxidases, DMSO (vehicle; EMD Millipore) or 10 ^M  of the 
NADPH oxidases inhibitor DPI (Cayman Chemical) were added 
after the first 10 min of kinetic reading. The reaction was then 
run for another 20 min at 60 s intervals. Immediately after 
H2 O2 measurement, M TT (ATCC) assay was performed (per 
manufacturer’s instructions) to normalize H2 O2 production to 
the amount of viable cells. All samples were assayed in triplicates. 
The amount of H2O2 was determined using a standard curve of 
H2 O2 prepared fresh for each experiment. Data are expressed 
as the rate of H2O2 release over the last 8 min for non-DPI 
experiments or 18 min for experiments using DPI.
Myeloperoxidase Activity
Snap-frozen longitudinal colon sections were homogenized 
in 50 mM phosphate buffer containing 13.7 mM of 
hexadecyltrimethylammonium bromide (Sigma Aldrich) by 
means of a GentleMACS dissociator (Miltenyi Biotec). MPO 
activity of the supernatants was determined by measuring their 
ability to oxidize o -dianisidine (Sigma Aldrich) in the presence 
of H2O2 and interpolating their values to those of a known MPO 
standard. The MPO activity was finally normalized to the initial 
weight of each sample.
Quantitative PCR Analysis
RNA from colonoids or IECs lysed in Trizol was isolated 
using phenol-chloroform extraction (Chomczynski and Sacchi, 
1987) . 50 and 500 ng RNA, respectively, were retrotranscribed 
using PrimeScript RT reagent Kit (Takara Bio Inc.), and the 
resulting cDNA was amplified on a LightCycler 480 II instrument 
(Roche Applied Science) in the presence of selected primers 
(Supplementary Table 2 ) using the SYBR Premix Ex Taq 
(Takara). mRNA expression levels were calculated by means of 
the AACt method (Livak and Schmittgen, 2001) and normalized 
to the geometric mean of the housekeeping genes ß-actin and 
glucuronidase-ß.
Statistical Analysis
Results are presented as mean values and standard deviation 
(SD). Except for the microbiome data, all of the other data 
analysis and plots were performed using Prism8 (GraphPad 
Software, Inc.) and compared using Student’s t-test, one­
way ANOVA, or two-way ANOVA, as indicated. For the 
microbiome analysis, MicrobiomeAnalyst was used to perform 
non-parametric multivariate ANOVA (PEMANOVA) to 
assess the statistical significance of the principal component 
analysis (Dhariwal et al., 2017) . A P  value of <  0.05 was 
considered to be significant. All datasets can be found in 
Supplementary Data Sheet 1.
RESULTS 
Accurate Measurement of Epithelial 
H2O2 Release Requires the Inhibition of 
Carboxylesterases
Cultured cells and tissues, such as liver and kidney, contain 
carboxylesterases that oxidize AR to resorufin even in the 
absence of HRP (Miwa et al., 2016) . Given that IECs express 
carboxylesterases (Jones et al., 2013), we first sought to determine 
whether these enzymes impact the oxidation of AR distorting 
the measurement of epithelial-released H2O2. In order to 
inhibit carboxylesterase-mediated oxidation, freshly isolated 
IECs from mouse colon were incubated with PMSF and used 
to determine the formation of resorufin. In the absence of 
PMSF, colonic IECs induced a high rate of oxidation of AR 
that was significantly reduced upon addition of PMSF to the 
reaction buffer (untreated = 149.5 (SD 32.9) vs. PMSF = 9.44 
(SD 3.5) pmol/min/MTT unit, P <  0.0001; Figures 1A,B),
FIGURE 1 | Carboxylesterase activity can obscure measurement of H2O2 released by IECs. IECs were assayed for their ability to oxidize AR in the presence or 
absence of PMSF ex vivo and in vitro. (A) Representative experiment showing real-time oxidation kinetics of AR in freshly isolated IECs with or w ithout PMSF. 
Samples were run in triplicate. RFU, relative fluorescence units. (B) AR oxidation rate by freshly isolated IECs in the presence or absence of PMSF. PMSF vs. 
untreated, * * * P < 0.001 as determined by two-tailed Student’s t-test (n = 6 -8  mice). (C) Real-time oxidation kinetics o f AR in cultured colonoids. (D) AR oxidation 
rate by cultured colonoids in response to inflammatory and microbial stimuli in the presence or absence of PMSF. IFNy vs. control, **P  < 0.01; Flagellin vs. control, 
*P  < 0.05 as determined by one-way ANOVA followed by Dunnett’s p os t hoc  test (n = 6 colonoid cultures). Two-way ANOVA additionally identified a significant 
overall effect for PMSF, P < 0.001 (n = 4 -6  colonoid cultures).
demonstrating that carboxylesterases affect the quantification of 
H2O2 production when using this method. Indeed, the high rate 
of oxidation of AR in the absence of PMSF was in fact HRP- 
independent, as similar rate values were obtained without the 
addition of HRP (data not shown). This was also seen in IECs 
from other sections of the gastrointestinal tract, including the 
duodenum, jejunum, and ileum, indicating that the distortion 
of H2O2 measurements by carboxylesterases is not only limited 
to the colon (Supplementary Figure 1A) . Indeed, we found that 
inhibition of carboxylesterases revealed significant differences in 
the production of ROS between duodenum, jejunum, and colon 
(Supplementary Figure 1A) .
To determine whether carboxylesterases also obscure 
differences in H2O2 production upon microbial and 
inflammatory challenge in vitro, we treated organoid 
cultures from mouse colonic IECs (colonoids) with IFNy 
and flagellin, and measured oxidation of AR with or without 
PMSF. Similar to freshly isolated IECs, untreated colonoids 
caused a high oxidation of AR in the absence of PMSF
that was dramatically reduced with the addition of PMSF 
(Figure 1C) . Moreover, inhibition of carboxylesterase activity 
with PMSF revealed that mouse colonic IECs respond to 
stimulation with IFNy and flagellin by releasing H2O2 to 
the extracellular milieu (ctrl =  6.3 (SD 2.3) vs. IFNy = 18.08 
(SD 4.8) vs. flagellin = 15.19 (SD 5.6) pmol/min/MTT unit; 
P <  0.01 for IFNy and P <  0.05 for flagellin; Figure 1D) . 
These differences were not observed in colonoids incubated 
without PMSF (Figure 1D) . We additionally characterized 
the basal production of H2 O2 in human colonoids isolated 
from biopsies of IBD patients in remission and in human 
epithelial cell lines. While incubation of PMSF was necessary 
to quantify the actual production of H2 O2 in steady-state 
conditions in human colonoids, human IEC lines HT-29 and 
SW480 did not require neutralization of carboxylesterase 
activity (Supplementary Figures 1B,C) . Human colonoids 
were also assayed for their responses to IFNy and flagellin. 
Whereas we did not observe a consistent increase in H2 O2 
upon stimulation with IFNy, flagellin did cause a higher
production of epithelial H2O2 (ctrl =  7.57 (SD 4.08) vs. 
flagellin = 11.66 (SD 5.91) pmol/min/MMT unit; P <  0.05; 
Supplementary Figure 1D), demonstrating that human 
colonoids also respond to microbial stimuli by producing 
ROS. Taken together, these results suggest that the presence 
of carboxylesterases in primary IECs masks the actual release 
of ROS in steady-state and in response to microbial and 
proinflammatory stimuli.
Duox2 Mediates Epithelial H2O2 
Production in Response to 
Proinflammatory and Bacterial Stimuli
Previous work has demonstrated that human airway 
epithelial cells produce H2O2 in response to IFNy and 
flagellin in a NADPH oxidase-dependent manner (Gattas 
et al., 2009) . Furthermore, increased mucosal abundance 
of Enterobacteriaceae in the gut has been associated with
a higher expression of the NADPH oxidases Duox2 and 
DuoxA2 (Grasberger et al., 2015). Given that many species of 
enterobacteria are flagellated, we asked whether the structural 
component of flagella, flagellin, and IFNy induced these enzymes 
in IECs to produce H2O2 and whether our modified assay could 
accurately quantify the resulting H2O2 production. Colonoids 
in culture were incubated overnight with IFNy or flagellin, 
and the conversion of AR to resorufin was measured in the 
presence of PMSF. To test the dependence of H2O2 production 
on NADPH oxidases, we added the inhibitor DPI to colonoid 
cultures. Our results demonstrate that incubation with IFNy 
and flagellin elicited an increase in the production of H2O2 in 
colonoids that was totally inhibited by treatment with DPI but 
not by its vehicle, DMSO (Figures 2A -C ) . These results suggest 
that colonoids respond to proinflammatory stimuli and bacterial 
motifs by producing ROS in a NADPH oxidase-mediated 
fashion. Furthermore, these results validate the specificity of this 
modified AR assay in measuring IEC-released H2O2.
FIGURE 2 | Intestinal epithelial cells in culture respond to inflammatory and microbial stimuli by inducing the synthesis of H2 O2 via Duox2. The involvement of 
NADPH oxidases Nox1 and Duox2 in epithelial responses to  IFNy and flagellin was determined in cultured colonoids. (A) Representative experiment showing 
real-time production of H2 O2 in response to  IFNy before and after the addition of the NADPH oxidase inhibitor DPI o r its vehicle, DMSO. (B) H2 O2 production rate in 
response to  IFNy and in the presence of DPI/DMSO. IFNy-DMSO vs. IFNy-DPI, ł ł * P < 0.001 as determined by two-way ANOVA followed by Tukey’s post hoc  test 
(n = 3 colonoid cultures). (C) H2 O2 production rate in response to  flagellin and in the presence of DPI/DMSO. Flagellin-DMSO vs. Flagellin-DPI, #P = 0.063 as 
determined by two-way ANOVA followed by Tukey’s post hoc  test (n = 3 colonoid cultures). (D) NADPH oxidase expression in cultured IECs stimulated with IFNy or 
flagellin. Nox1-flagellin vs. Nox1-control, *P  < 0.05; Duox2-IFNy vs. Duox2-control, #P = 0.085; Duox2-flagellin vs. Duox2-control, * * * P  < 0.001; DuoxA2-IFNy vs. 
DuoxA2-control, *P < 0.05; DuoxA2-flagellin vs. DuoxA2-control, *P < 0.05 as determined by two-way ANOVA followed by Tukey’s post hoc test (n = 4 colonoid 
cultures). (E) Nox1 involvement in IEC responses to  IFNy and flagellin. WT-IFNy vs. WT-control, * *P  < 0.01; WT-flagellin vs. WT-control, *P  < 0.05; Nox1-KO-IFNy 
vs. Nox1-KO-control, *P  < 0.05; Nox1-KO-flagellin vs. Nox1-KO-control, *P  < 0.05 as determined by two-way ANOVA followed by Tukey’s post hoc test (n = 4 
colonoid cultures). (F) Duox2 involvement in IEC responses to  IFNy and flagellin. DuoxA2 control-IFNy vs. DuoxA2 control-control, t ł ł P < 0.001; DuoxA2 
control-flagellin vs. DuoxA2 control-control, **P  < 0.01 as determined by two-way ANOVA followed by Tukey’s post hoc test (n = 4 colonoid cultures).
FIGURE 3  | Intestinal epithelial cells upregulate Duox2 and increase their production of H2O2 during chronic inflammation. The expression of NADPH oxidases and 
the production of H2O2 were analyzed in mice undergoing models of acute colitis and tumorigenesis. (A) Representative micrographs demonstrating patchy 
inflammation on day 4 that was extended to most of the colon on day 6. AOM-DSS also induced the formation of dysplastic lesions (56-day inset). Inset scale 
bar = 50 ^m ; micrograph scale bar = 1 mm. (B) Acute colitis experiments diagram. (C) MPO activity in colon of DSS-treated mice. Day4 vs. day0, #P = 0.09; day 6 
vs. day 0, * * * P < 0.001 as determined by one-way ANOVA followed by Dunnett’s p o s t hoc test (n = 5 mice). (D) H2O2 production rate in IECs isolated from colon of 
DSS-treated mice. (E) Tumorigenesis experiments diagram. (F) NADPH oxidase expression in IECs isolated from non-involved areas of AOM-DSS-treated mice on 
day 56. Duox2-non-involved vs. Duox2-untreated, *P  < 0.05 as determined by two-tailed Student ’s t-test. (G) H2O2 production rate in IECs isolated from 
non-involved areas of AOM-DSS-treated mice on day 56. Non-involved vs. untreated, **P  < 0.01 as determined by two-tailed Student ’s t-test (n = 5 mice).
Nox1 and Duox2 are the two main inducible NADPH oxidases 
in the intestinal epithelium (Grasberger et al., 2015; Aviello 
and Knaus, 2018). To interrogate whether these enzymes are 
associated with the redox responses that we observed toward 
IFNy and flagellin, we stimulated wild type colonoids with 
these molecules and analyzed the expression of Nox1, Duox2, 
and the Duox2 maturation factor DuoxA2. Stimulation with 
the proinflammatory cytokine IFNy slightly upregulated Duox2 
(ctrl = 1.01 (SD 0.16) vs. IFNy = 3.12 (SD 0.76) folds, 
P =  0.085) and significantly increased the expression of DuoxA2 
transcripts (ctrl =  1.04 (SD 0.34) vs. IFNy = 18.15 (SD 10.83) 
folds, P <  0.05; Figure 2D ) . Moreover, the bacterial ligand 
flagellin significantly upregulated Nox1 (ctrl = 1 . 4  (SD 1.14) vs. 
flagellin = 7.34 (SD 2.01) folds, P <  0.05), Duox2 (ctrl = 1.01 
(SD 0.16) vs. flagellin = 6.04 (SD 1.46) folds, P <  0.001) 
and DuoxA2 (ctrl = 1.04 (SD 0.34) vs. flagellin = 24.13 (SD
10.07) folds, P <  0.05; Figure 2D ) . These findings suggest 
that both Nox1 and Duox2 might participate in enhancing the 
release of epithelial H2O2 upon proinflammatory challenges. 
To further determine whether Nox1 and Duox2 drive these 
responses, we prepared colonoids from Nox1-KO mice, epithelial 
DuoxA2-KO mice and their corresponding wild type littermates 
and incubated them with IFNy or flagellin. We observed 
that Nox1- and Duox2-deficient colonoids displayed a similar 
basal production of H2O2 compared to their matched control 
colonoids. However, while Nox1-KO colonoids responded to 
IFNy and flagellin by significantly increasing H2O2 production 
(ctrl = 11.41 (SD 7.43) vs. IFNy = 25.13 (SD 9.49) vs. 
flagellin = 22.92 (SD 7.85) pmol/min/MTT unit, P <  0.05 for 
both molecules; Figure 2E ) , DuoxA2-KO colonoids failed to 
respond to these stimuli (ctrl = 8.08 (SD 1.56) vs. IFNy = 11.35 
(SD 5.49) vs. flagellin = 11.19 (SD 1.45) pmol/min/MTT unit;
FIGURE 4 | Dysbiosis induces upregulation of Duox2 and enhances the epithelial release of H2 O2 . Germ-free mice were colonized with the mucosa-associated 
microbiota o fW T  or dysbiotic (villin-TLR4) mice and their epithelial responses were analyzed after a 3-week engraftment. (A) Engraftment experiments diagram.
(B) Representative micrographs showing no signs of inflammation and no major morphological differences between WT- and dysbiotic-m icrobiota recipient mice. 
Inset scale bar = 50 ^m ; micrograph scale bar = 1 mm. (C) MPO activity in colon from engrafted mice. (D) NADPH oxidase expression in IECs isolated from 
engrafted mice. Duox2-dysbiotic vs. Duox2-WT, *P  <  0.05 as determined by two-tailed Student ’s t-test (n = 3 mice). (E) H2 O2 production rate in IECs isolated from 
engrafted mice. Dysbiotic vs. WT, * *P  < 0.01 as determined by two-tailed Student ’s t-test (n = 3 mice).
Figure 2F ). These results demonstrate that the increase in the 
epithelial production of ROS in response to proinflammatory and 
microbial stimuli is mediated by Duox2.
Chronic but Not Acute Inflammation 
Results in Intestinal Epithelial Production 
of H2 O2
Various studies have implicated Duox2 in intestinal inflammation 
and as an early signal in VEO-IBD (Haberman et al., 2015; 
Sommer and Backhed, 2015). However, the functional 
consequences of Duox2 overexpression has not been addressed. 
To determine whether increased epithelial-driven H2O2 
production is an early event in intestinal inflammation, 
we treated mice for various lengths of time with DSS and 
interrogated the timing of H2O2 release in response to 
inflammation (Figure 3B ) . W e confirmed that DSS induced 
inflammation on days 4  and 6 by histology and using an MPO 
assay. Histological sections on day 4 were characterized by 
discrete areas of crypt destruction, edema and immune cell 
infiltration of the mucosa and submucosa, which became 
extensive and involved most of the colon by day 6 (Figure 3A ). 
Accordingly, while on day 4 we saw a trend of increased MPO 
activity, there was a significant increase in MPO on day 6 (day
0 = 1.01 (SD 0.3) vs. day 4 = 3.81 (SD 0.63) vs. day 6 = 9.1 
(SD 3.54), P  =  0.089 and P <  0.0001, respectively; Figure 3C ). 
In spite of acute inflammation, we did not find that isolated 
IECs increased production of H2O2 (Figure 3D ) . This was 
corroborated by a lack of induction of NADPH oxidases at 
the mRNA level (Supplementary Figures 2A -C ) . These data 
demonstrate that the intestinal epithelium does not contribute to 
an oxidative environment during acute inflammation.
We next asked whether chronic inflammation or neoplasia 
changed the potential of IECs to release H2O2. To address 
this question, we challenged mice with AOM-DSS (Figure 3E ) 
and isolated IECs from specific segments of the mucosa -  
either from dysplastic tumors or surrounding non-involved 
(non-dysplastic and non-inflamed) mucosa. Our modified AR 
assay measured significantly higher levels of H2O2 in freshly 
isolated IECs from polypoid tumors compared with surrounding 
IECs (Supplementary Figure 2D ), corroborating previous 
findings that tumorigenic cells have a higher redox activity 
than steady-state cells (Schieber and Chandel, 2014). Following 
AOM-DSS, IECs isolated from non-involved areas expressed 
significantly higher levels of Duox2 transcripts when compared 
to IECs in untreated mice (untreated = 1.03 (SD 0.24) vs. 
non-involved = 4.35 (SD 3.13), P <  0.05; Figure 3F ). This 
upregulation in NADPH oxidases translated into a significantly
FIGURE 5 | Intestinal epithelial cells increase H2 O2 synthesis in response to  the microbiota of IBD patients. The epithelial production of H2 O2 was evaluated in 
humanized germ-free mice engrafted with the stool microbiota of HS or IBD patients. (A) Humanization experiments diagram. (B) Representative micrographs 
showing no signs of inflammation and no major morphological differences between mice engrafted with healthy subjects (HS) or IBD patient stool microbiota. Inset 
scale b a r=  50 ^m ; micrograph scale b a r=  1 mm. (C) MPO activity in colon from engrafted mice. (D) H2 O2 production rate in IECs isolated from engrafted mice. 
IBD vs. HS, *P  < 0.05 as determined by two-tailed Student ’s t-test (n = 9 mice).
increased production of H2O2 (untreated = 7.33 (SD 0.83) vs. 
non-involved = 14.89 (SD 3.97), P <  0.01; Figure 3G) . Taken 
together, these data demonstrate that animal models of colitis- 
associated neoplasia have increased epithelial production of 
H2O2 along with increased expression of NADPH oxidases. Even 
though all the AOM-DSS-treated mice had higher H2 O2 levels in 
IECs from non-involved areas, MPO activity was not significantly 
different between non-involved areas of AOM-DSS-treated and 
untreated mice (Supplementary Figure 2E ) . These data suggest 
that IECs produce H2O2 in the setting of chronic injury even in 
the absence of inflammation.
Intestinal Epithelial Cells Upregulate 
Duox2 and Release H2 O2 in Response to 
Dysbiosis
Dysbiosis is an indirect consequence of both acute and 
chronic inflammation and has been shown to upregulate 
Duox2 (Grasberger et al., 2015; Fritsch and Abreu, 2019). 
However, whether this translates into a functional increase 
in the synthesis of ROS by IECs has not been directly 
demonstrated. We hypothesized that the overexpression of 
Duox2 during dysbiosis is associated with an increased epithelial 
H2 O2 production. To investigate dysbiosis as a stimulus for 
H2 O2 , we used dysbiotic mucosa-associated microbiota from 
our transgenic villin-TLR4 mice (Shang et al., 2008; Dheer 
et al., 2016) . We transferred mucosa-associated microbiota
from a pool of W T or villin-TLR4 donor mice to W T 
GF recipient mice (Figure 4A ). After a 3-week engraftment, 
the microbial populations were analyzed for the stability of 
engraftment, and the IECs from recipient mice were analyzed 
for the expression of NADPH oxidases as well as H2O2 
production. 16s rRNA sequencing of donor and recipient 
mucosa-associated microbiota samples revealed a stable transfer 
of more than 80% of the phylum, class, order, and genus-level 
taxa (Supplementary Table 3) that resulted in a similar overall 
clustering pattern between the donors and their corresponding 
recipients (Supplementary Figure 3A) . The GF mice that 
received dysbiotic mucosa had a decreased Shannon alpha 
diversity, an indicator of dysbiosis (Supplementary Figure 3B ) . 
Transference of mucosa-associated microbiota did not cause 
inflammation, as demonstrated by the normal histology of the 
colon in all recipient mice (Figure 4B ) and the low values of MPO 
activity (Figure 4C ) .
At a transcriptional level, we found that transfer of mucosa- 
associated microbiota led to similar expression levels of Nox1 in 
IECs regardless of donor type. Conversely, the microbiota of the 
dysbiotic mice elicited an increased expression of Duox2 when 
compared to W T microbiota in colonic IECs of recipient mice 
(W T recipient = 1.0 (SD 0.08) vs. dysbiotic recipient = 1.91 (SD 
0.53) folds, P <  0.05; Figure 4D ). Consistent with these findings, 
IECs isolated from dysbiotic microbiota-recipient mice had a 
higher production of H2O2 when compared to W T microbiota- 
recipient mice (W T recipient = 6.53 (SD 0.6) vs. dysbiotic
recipient = 9.42 (SD 0.24) pmol/min/MTT unit, P <  0.01; 
Figure 4E ) . These findings indicate that, in the absence of 
inflammation, IECs respond to dysbiosis by upregulating Duox2 
and by subsequently inducing the production of H2O2.
We next asked whether engraftment of GF mice with dysbiotic 
human microbiota increased epithelial production of H2 O2 . We 
humanized GF mice with stool of either healthy subjects (HS) 
or IBD patients with no signs of inflammation (Figure 5A ) 
and studied epithelial responses to human dysbiosis. 16s rRNA 
sequencing revealed that, compared to HS donors, IBD donors 
had a higher proportion of facultative anaerobes, particularly 
Proteobacteria and Actinobacteria (Supplementary Figure 4A ). 
Engraftment of human microbiota did not induce inflammation, 
as determined by histological examination and MPO activity 
(Figures 5B,C ). Previous work has shown that humanization of 
GF mice with the dysbiotic microbiota from IBD patients induces 
an increase in Duox2 expression in IECs (Grasberger et al., 2015). 
We found that IBD dysbiosis induced IECs to increase their 
production of H2O2 compared to HS microbiota (HS = 10.49 
(SD 4.75) vs. IBD = 16.68 (SD 4.36), P <  0.05; Figure 5D ). 
One healthy subject (HS2) with no known disease had dysbiotic 
microbiota with a decreased proportion of Firmicutes and an 
increased proportion of facultative anaerobes (Actinobacteria) 
that was accompanied by a higher, although not significant, 
production of H2O2 compared to the other healthy donors 
(HS1 = 8.15 (SD 6.28) vs. HS2 = 14.63 (SD 2.81) vs. HS3 = 8.68 
(SD 1.99); Supplementary Figure 4B ) . Our data demonstrate 
that dysbiosis can lead to increased local production of H2 O2 
even in the absence of histologic or biochemical inflammation. 
These data suggest that dysbiosis can be a first step toward 
abnormal immune activation in the gut and that IECs may play 
an active role in this process.
DISCUSSION
To maintain gut homeostasis, IECs recognize microbial motifs 
and metabolites and respond by producing peptides and other 
molecules that interact with microbes. One form ofbidirectional 
epithelial-microbial interaction involves the synthesis and release 
of ROS. However, the short half-life of these molecules and 
the inadequacy of common methodologies to measure epithelial 
H2 O2 at low nanomolar ranges hinders the ability to study 
ROS as signaling intermediates. Here, we took advantage of a 
modified AR assay to demonstrate that, in vitro, inflammatory 
and microbial stimuli induce the epithelial release of H2 O2 in 
a Duox2-dependent manner. Furthermore, we report that IECs 
release H2O2 into the extracellular milieu in animal models of 
chronic inflammation and dysbiosis. To our knowledge, this is 
the first report that shows a direct production of epithelial H2O2 
in response to murine and IBD-driven dysbiosis, supporting 
the idea that epithelial ROS is a potential mechanism of host- 
microbe crosstalk in the intestine. Moreover, our results suggest 
that Duox2 plays a key role in mediating the production of H2O2 
in response to dysbiotic microbiota and chronic inflammation.
Non-phagocytic cells, including IECs, produce ROS at low 
nanomolar concentrations. The only common method that
determines extracellular ROS at the nanomolar level measures 
the oxidation of AR into resorufin in the presence of HRP 
and H2O2 (Dikalov and Harrison, 2014) . Even though this 
method is highly specific and sensitive, it is hindered by the 
presence of carboxylesterases, which oxidize AR to resorufin in 
an HRP- and H2O2-independent manner. While it is known 
that these esterases distort H2O2 determination in other cell 
types from liver and kidney (Miwa et al., 2016), it is not 
known whether they impact the measurement of H2O2 in 
IECs. Our findings demonstrate that modification of the AR 
assay with PMSF is necessary to quantify H2O2 released by 
primary IECs isolated from duodenum, jejunum, ileum, or colon, 
which are known to express several types of carboxylesterases 
(Jones et al., 2013) . We were able to validate the specificity 
of H2O2 release by demonstrating increased production with 
inflammatory mediators and using a pan-NADPH oxidase 
inhibitor, DPI, to inhibit epithelial H2O2 production. In addition, 
the production of H2O2 was markedly increased in IECs isolated 
from tumors, which are known to have high redox activity 
(Schieber and Chandel, 2014) . In contrast to primary IECs, 
the human IEC lines we tested did not require the inhibition 
of esterases for the measurement of H2O2 in steady-state 
conditions. This observation supports why previous studies 
were able to determine the H2 O2 release of IEC lines in 
response to enteric bacteria without modifying the AR assay 
(Corcionivoschi et al., 2012; MacFie et al., 2014; Alvarez et al., 
2016) . However, the use of 3D primary cultures is likely to 
gradually displace cell lines given their increased genetic stability 
and their functional similarity to normal IECs in vivo . Our 
data strongly support that this modified AR assay provides a 
valuable tool to precisely quantify the amounts of H2O2 released 
by primary IECs, both ex vivo and in vitro. This method 
will contribute to improved understanding of the host-microbe 
interactions mediated through the release of ROS.
IECs are in constant interaction with the microbiota and 
lam ina propria  cells. Here, we challenged IECs in vitro and 
in vivo with stimuli coming from the host (IFNy/inflammation) 
and the microbiota (flagellin/dysbiosis) and found a release of 
epithelial H2O2 at nanomolar concentrations. At these levels, 
H2 O2 is likely to participate in host and microbial signaling 
transduction by altering the phosphotyrosine signaling network 
and inducing redox-sensitive transcription factors (Kumar et al., 
1992; Xanthoudakis and Curran, 1992; Glineur et al., 2000; 
Leslie et al., 2003; Aviello and Knaus, 2018) . For example, in 
the host, increased levels of H2 O2 have been shown to either 
enhance inflammation (Chu et al., 2017) or mediate mucosal 
healing by promoting stem cell proliferation and IEC migration 
(Buchon et al., 2009; Leoni et al., 2013; Pircalabioru et al., 
2016) . In bacteria, H2 O2 can have bacteriostatic effects and 
alter bacterial enzymes involved in the synthesis of virulence 
factors, reducing the bacterial fitness advantage (Ha et al., 2005; 
Corcionivoschi et al., 2012; Grasberger et al., 2013; Hayes et al., 
2015; Alvarez et al., 2016). Gaining insight into the type of IEC 
that drives epithelial H2O2 and its location could potentially 
provide clarification of the cellular targets and downstream 
implications of H2O2. Given that Duox2 is expressed in the tips 
of the crypt (MacFie et al., 2014; Sommer and Backhed, 2015),
we believe that the IECs driving this dysbiosis-induced H2 O2 
production are either absorptive enterocytes or goblet cells. These 
are the most exposed IECs to the microbiota due to their location 
in the crypt. Conversely, Nox1, which is expressed in the lower 
two-thirds of the colon crypts, did not play a major role in 
mediating dysbiosis-induced H2O2 production (Geiszt et al., 
2003; Moll et al., 2018) . Therefore, Duox2-mediated ROS is 
probably more involved in regulating the microbiota opposed to 
having host inflammatory effects.
In the intestinal epithelium, Duox2 is upregulated by 
microbial stimuli, including dysbiotic flora and segmented 
filamentous bacteria (Haberman et al., 2014; Grasberger et al.,
2015) . Here, we demonstrate that the upregulation of NADPH 
oxidases in response to inflammatory and microbial stimuli 
translates into a Duox2-dependent epithelial increase in the 
production of H2O2. Indeed, Duox2-deficient colonoids failed 
to increase H2 O2 synthesis in response to both types of stimuli. 
Our findings also suggest that the upregulation of Duox2 
and subsequent functional increase in H2O2 requires chronic 
inflammation or chronic exposure to dysbiotic microbiota. Even 
though there was apparent inflammation on days 4 and 6, 
we did not see an increase in epithelial H2O2 production. By 
contrast, after chronic inflammation, non-involved areas without 
inflammation had an increase in the production of H2O2. Taken 
together, these observations suggest that there is another driver 
of Duox2-mediated H2O2 production in IECs that is not acute 
inflammation. Our results support that one such driver could 
be dysbiosis, which is a known inducer of Duox2 expression 
(Grasberger et al., 2015) . Indeed, we saw that not only murine 
and IBD dysbiosis but also dysbiosis from a HS enhanced 
the production of epithelial H2 O2 . Since time-course studies 
in the DSS model of colitis have demonstrated that dysbiosis 
occurs later on day 8, the lack of a significant increase in 
H2 O2 production during acute inflammation at day 6 would be 
expected if dysbiosis were the main driver (Schwab et al., 2014).
The importance of maintaining ROS in homeostasis is 
exemplified by the fact that IBD patients either have loss of 
function mutations or an upregulation of Duox2 (Haberman 
et al., 2014; MacFie et al., 2014; Hayes et al., 2015; Levine et al., 
2016; Chu et al., 2017; Parlato et al., 2017) . The fact that missense 
mutations in Duox2 in VEO-IBD patients results in an increased 
invasiveness of bacteria suggests that the upregulation of this 
enzyme during inflammation is an attempt to contain dysbiosis 
(Hayes et al., 2015) . Since dysbiosis is intimately linked to IBD 
(Day and Lopez, 2015; Nagao-Kitamoto et al., 2016; Fritsch 
and Abreu, 2019; Zhu et al., 2019), it is possible that dysbiosis 
enhances inflammation through the induction of epithelial ROS. 
Inflammation subsequently exacerbates dysbiosis by providing 
ROS-generated substrates for facultative anaerobes to bloom
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generating a feed-forward inflammatory loop. Our results 
provide the methodology to tease apart epithelial production of 
H2 O2 and its role in a feed forward inflammatory cycle seen in 
IBD and IBD-associated neoplasia.
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Distinct Cell Types With the Bitter 
Receptor Tas2r126 in Different 
Compartments of the Stomach
Patricia W idm ayer1*, Vanessa Partsch1, Jonas Pospiech1, Soumya Kusumakshi2,
Ulrich Boehm 2 and  Heinz B reer1
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Cells expressing bitter taste receptors (T2Rs or Tas2rs) in extraoral tissues are 
considered to be chemosensory cells mediating protective responses to potentially 
harmful or even antiinflammatory or antimicrobial compounds. In a previous study the 
activity of the Tas2R143/Tas2R135/Tas2r126 cluster promoter in the stomach was 
monitored using a Cre-reporter mouse line. Reporter gene expression and Tas2r126 
mRNA were found in brush cells located at the distal wall of the gastric groove. In 
this study, we explored whether brush cells and epithelial cells of the stomach in fact 
contain the Tas2r126 receptor protein. Using immunohistochemistry, we demonstrate 
the presence of Tas2r126 immunoreactivity in different cell populations in the glandular 
stomach, in a subset of brush cells at the gastric groove and in unique glandular units 
as well as in certain enteroendocrine cells. In brush cells at the gastric groove, a strong 
immunofluorescence signal for the Tas2r126 receptor was observed at the most apical 
region of the cells, i.e., the microvillar tuft. In addition, we found a high density of 
Tas2r126-positive brush cells in the unique glandular units. These invaginations are 
located distally to the groove, open directly into the furrow and are enwrapped by 
smoothelin-immunoreactive muscles. In the corpus, Tas2r126 immunoreactivity was 
found in histamine-producing ECL cells and in ghrelin-producing X/A-like cells, the 
main enteroendcrine cells of this compartment. In the antrum, Tas2r126 labeling was 
observed in serotonin-storing EC cells and ghrelin cells, both representing only minor 
populations of enteroendocrine cells in this compartment. In conclusion, our data 
provide evidence for the presence of the Tas2r126 receptor protein in distinct cell types 
in the epithelium lining the mouse stomach which render the stomach responsive to 
agonists for bitter receptors.
K eyw ords: T2R, Tas2r, b it te r  sensing , b rush  ce ll, g a s tr ic  g roove , g la n d u la r un its , e n te roe n do c rin e  ce lls
Abbreviations: CgA, chrom ogranin A; C O X-2, cyclooxygenase 2; DAPI, 4/,6-diamidino-2-phenylindole; D CLK1, double 
cortin-like kinase; EC, enterochromaffin cell; ECL, enterochromaffin-like cell; H DC, histidine decarboxylase; IP 3, inositol- 
1,4,5-trisphosphate; IP3R, inositol-1,4,5-trisphosphate receptor; PLCß2, phospholipase C ß2; TFF1, trefoil factor 1; TRPM 5, 
transient receptor potential cation channel, subfam ilyM , m em ber 5; 5-HT, 5-hydroxytryptamin.
INTRODUCTION
Bitter compounds, such as secondary plant substances, strongly 
influence food intake (Fraenkel, 1959) as well as metabolic 
processes (Dotson et al., 2008; Vegezzi et al., 2014; Avau 
et al., 2015) . In addition, several studies have shown their 
antiinflammatory or antimicrobial effects (Kaji et al., 2009; Prandi 
et al., 2013, 2018; Hariri et al., 2017) as well as their effect on 
hormone release in the gastrointestinal (GI) tract (Chen et al., 
2006; Rozengurt et al., 2006; Jeon et al., 2008, 2011; Janssen et al., 
2011; Kim et al., 2014) . As a prerequisite for the induction of these 
characteristic effects, it is assumed that cells exist, which can sense 
such compounds and are positioned in distinct compartments 
of the GI tract.
Recognition of bitter compounds is based on a large family 
of G protein coupled receptors, the Tas2r receptors (Adler 
et al., 2000; Chandrashekar et al., 2000; Matsunami et al., 
2000) . The mouse genome comprises 35 genes encoding distinct 
Tas2R receptor types (Shi et al., 2003; Hayakawa et al., 2014; 
Li and Zhang, 2014). Meanwhile, there are several reports 
indicating that genes encoding receptors for bitter compounds 
are not only expressed in taste cells, but also in solitary cells 
interspersed in the epithelium lining the GI tract (see for review: 
Rozengurt, 2006; Sternini et al., 2008; Behrens and Meyerhof, 
2011; Xie et al., 2018) . However, very little is known about 
the expression of bitter receptors in the stomach. The current 
information is mainly based on PCR analyses (W u et al., 2002, 
2005; Vegezzi et al., 2014; Prandi et al., 2018); only recently 
immunohistochemical evidence was presented for the presence 
of TAS2R10 receptor protein in parietal and chief cells of human 
stomach (Liszt et al., 2017).
In a previous study, the activity of a promoter that 
controls the gene cluster Tas2R143/Tas2R135/Tas2r126 was 
visualized by fluorescent marker protein (EGFP) expression in 
a transgenic reporter mouse line and revealed EGFP-labeled 
cells in the epithelium of the stomach (Liu et al., 2017). 
These were mostly located at the boundary between fundus 
and corpus and found to express DCLK1, a marker for brush 
cells, which are also called tuft, caveolated, multivesicular, 
or fibrillovesicular cells (Luciano and Reale, 1992). In fact, 
~15%  of all DCLK1-positive brush cells were EGFP-positive; 
furthermore, in isolated brush cells only mRNA for the 
receptor gene Tas2r126 was found (Liu et al., 2017) . However, 
it remained elusive whether these cells indeed comprise the 
Tas2r126 receptor protein. Based on previous studies, brush 
cells at the gastric groove, a tissue fold at the boundary 
between fundus and corpus, are considered to be putative 
taste-like chemosensory cells (Höfer et al., 1996; Eberle et al., 
2013) . These cells are arranged in a palisade-like manner 
and express elements of the canonical taste signaling cascade, 
including gustducin (Höfer et al., 1996; Hass et al., 2007), 
PLCß2 (Eberle et al., 2013) and TRPM5 (Kaske et al., 2007) 
as well as receptors for nutrients (Hass et al., 2010; Janssen 
et al., 2012; Eberle et al., 2014; Widmayer et al., 2015, 
2019) . Situated at a strategic position between the storage 
compartment fundus and the digestive compartment corpus, 
brush cells supposedly act as sensor cells monitoring the
constituents of the luminal content and consequently influencing 
the regulation of gastric processes, such gastric motility, 
secretion and hormone release. Based on the results of RNA- 
seq analysis by Liu et al. (2017), we set out to analyze 
whether the Tas2r126 receptor protein is in fact present in 
gastric cells, to determine their localization in the stomach 
epithelium and to characterize the cell types which express the 
receptor Tas2r126.
MATERIALS AND METHODS 
Mice
Studies were performed with adult C57/BL6J and TRPM5-IRES- 
Cre/eR26-xGFP (Kusumakshi et al., 2015) mice. Animals were 
fed ad  libitum  with standard laboratory chow and had free 
access to water. For tissue preparations, animals were killed 
with carbon dioxide.
Tissue Preparation
For immunohistochemistry and Western blotting, tongues and 
stomachs were removed and washed in ice-cold PBS (0.85% NaCl,
1.4 mM KH2 PO4 , 8 mM Na2 HPO4 , pH 7.4). For immersion 
fixation of the stomach, the fundus was cut off, the stomach 
opened along the greater curvature and washed with ice-cold 
PBS. For plane sectioning, the opened stomach was mounted 
on a piece of rubber and fixed with needles (Eberle et al.,
2013) . For longitudinal sectioning, a transverse strip of the entire 
stomach wall including the fundus, cardia, corpus and antrum 
was excised.
All tissues were fixed using 4% paraformaldehyde 
(in 150 mM phosphate buffer, pH 7.4) for 2 h. After 
fixation, tissues were cryoprotected by incubation in 25% 
sucrose overnight at 4°C. Then, tissues were embedded in 
Tissue Freezing Medium (Leica Microsystems, Bensheim, 
Germany) and quickly frozen on liquid nitrogen-cooled 
metal covers.
Western Blotting
Total protein was extracted from pooled posterior papillae. 
30 ^g  of the homogenate were loaded onto a 12.5% SDS- 
PAGE gel and transferred to a nitrocellulose membrane. The 
immunoblot was blocked with 6% milk powder in PBS buffer 
containing 0.1% Tween 20 (TBST) for 1 h and then probed 
with a rabbit anti-Tas2r126 antiserum (SAB signaling antibody, 
#44656, Baltimore, United States; rabbits were immunized 
with a synthesized peptide derived from human TAS2R41, the 
ortholog of mouse Tas2r126, predicting a species reactivity 
for human, mouse and rat) diluted 1:200 in 5% BSA in 
TBST overnight at 4° C. After washing in TBST, the blot was 
incubated with a goat anti-rabbit horseradish peroxidase (HRP)- 
conjugated IgG antiserum (Sigma-Aldrich), diluted 1:10000 in 
blocking solution and developed using the Amersham ECL Select 
kit (Thermo Fisher Scientific). The membrane was scanned 
using a C-DiGit blot scanner (LI-COR Biotechnology, Bad 
Homburg, Germany).
Immunohistochemistry
Each tissue was serially cut into 6 -8  ^m  thick sections. 
Cryosections were mounted onto Superfrost Plus microscope 
slides (Menzel-Gläser, Braunschweig, Germany) using a 
CM3050S cryostat (Leica Microsystems), air-dried for 1 h 
and stored at —20°C until use. For immunohistochemistry, 
cryosections underwent citrate-antigen-retrieval. Frozen sections 
were incubated in a sodium citrate buffer (10 mM sodium 
citrate, 0.05% Tween 20, pH 6.0) for 45 min at 4° C. Afterward, 
sections were immersed in the same sodium citrate buffer for 
1 min at 100°C. Then slides were rinsed in PBS for 10 min and 
blocked in 0.3% Triton X-100 in PBS containing 10% normal 
donkey serum (NDS; Dianova, Hamburg, Germany) for 1 h 
at room temperature. After three changes of PBS, slides were 
incubated with the primary antisera overnight at 4° C. Antibodies 
were diluted in 0.3% Triton X-100 in PBS containing 10% NDS 
and used in the following dilutions: chicken anti-GFP [1:400; 
ab13970, Abcam, Cambridge, United Kingdom; van der Heijden 
et al. (2016)], rabbit anti-TRPM5 serum73 [1:600; purified 
antibody (AB-321); described in Kaske et al. (2007)], goat anti­
COX-2 [1:200; sc-1747, Santa Cruz, Dallas, TX, United States; 
Widmayer et al. (2019)], rabbit anti-smoothelin [1:200, sc-28562, 
Santa Cruz; Frick et al. (2017)], goat anti-chromogranin A [1:200; 
sc-1488, Santa Cruz; Gerbe et al. (2011)], goat anti-HDC [1:20, 
sc-34458, Santa Cruz; Fricketal. (2017)], goat anti-ghrelin [1:800, 
sc-10368, Santa Cruz; Caminos et al. (2003)], goat anti-5-HT 
[1:3000; ab66047, Abcam, Cambridge, United Kingdom; Lund 
et al. (2018)], and goat anti-somatostatin [1:800, sc-7819, Santa 
Cruz; Frick et al. (2017)]. After washing in PBS, primary antisera 
were visualized using donkey anti-goat IgG (H +  L) Alexa Fluor 
488, Invitrogen (1:500; Fisher Scientific, Goteborg, Sweden), 
donkey anti-rabbit IgG (H +  L) Alexa Fluor 568, Invitrogen 
(1:500; Fisher Scientific), and donkey anti-goat AMCA (1:200; 
Jackson, ImmunoResearch), diluted in PBS with 0.3% Triton 
X-100 containing 10% NDS for 2 h at room temperature. 
After a further three washes with PBS, tissue sections were 
counterstained with DAPI (1.0 ^g/m L, Sigma-Aldrich) 1:1000. 
After incubation for 3 min at room temperature, sections were 
rinsed with double-distilled water and mounted in MOWIOL 
(10% polyvinyl alcohol 4-88 (Sigma-Aldrich), 20% glycerol in 
1x PBS). No immunoreactivity was observed when the primary 
antisera were omitted.
Cell Counting
Digital microscopic images of longitudinal sections were 
acquired at 40 x  magnification. For cell counts in the corpus 
and antrum, a continuous epithelial area of 2000 ^m  x  250 
was defined starting at the edge of the proximal stomach 
and transitional junction from corpus to antrum, respectively. 
Counts were then expressed as cells per 0.5 mm2. To determine 
brush cell numbers in large invaginations, images of three 
consecutive longitudinal sections through the proximal stomach 
were acquired. Then, the average cell counts of immunopositive 
cells were determined. Cells were quantified as percentage of 
DAPI-labeled nuclei of immunoreactive cells. To assess the 
proportion of Tas2r126-expressing cells among enteroendocrine
cells, the number of immunoreactive cells on 3 -5  consecutive 
sections within an area of 355 ^m  x  265 ^m  was counted. 
The percentage and number of positive cells were expressed as 
a mean ±  SD.
RESULTS 
Visualization and Characterization of 
Tas2r126-Immunoreactive Cells
Previous experimental evidence for Tas2r126 expression in 
the stomach is based on EGFP-positive epithelial cells in a 
Cre-reporter mouse line and RNA-seq analysis of isolated 
EGFP-positive cells (Liu et al., 2017) . In order to analyze 
whether the receptor protein is in fact present in epithelial 
cells lining the stomach, we used an antiserum against 
Tas2r126 in immunological approaches. For this, we employed a 
commercially available antiserum raised against human TAS2R41 
sharing an overall amino acid sequence identity of 69% to the 
mouse Tas2r126. The TAS2R41 epitope is localized in the region 
of the extracellular loop 2 and transmembrane domain 5 that 
shares a high number of identical and conserved amino acid 
residues with the mouse one-to-one ortholog (Figure 1A) . To 
evaluate a potential cross-reactivity with related stomach-specific 
bitter receptors (Prandi et al., 2018), the relevant sequence 
motifs were compared. The alignment shows a high degree of 
diversity (Figure 1B) indicating that cross-reactivity is unlikely. 
Since no blocking peptide was provided by the supplier to 
prove the epitope specificity of the antiserum, we experimentally 
validated its specificity by performing Western blot analyses with 
preparations of posterior taste papillae. The result is depicted 
in Figure 1C and demonstrates that the antiserum recognized 
a protein at the expected size. We then probed tissue sections 
through the posterior region of the murine tongue with the 
Tas2r126 antiserum. As shown in Figure 1D, distinct cells 
in taste buds were specifically labeled; in contrast, sections 
incubated only with the secondary antibody were devoid of 
any staining (Figure 1E). Subsequently, tissue sections from the 
mouse stomach were analyzed. As depicted in Figure 1F, the 
epithelium of the aglandular fundus was devoid of any labeled 
cells. Instead, Tas2r126-immunolabeled cells were restricted to 
the glandular compartment of the stomach. Omission of the 
primary antiserum on an adjacent section shows the absence 
of any staining (Figure 1G) . Particularly striking was the high 
density of labeled cells opposite of the limiting ridge, which 
surrounds the entire fundus/corpus border of the stomach as 
well as the esophageal orifice (Wattel and Geuze, 1978; Luciano 
and Reale, 1992) . Beneath the limiting ridge large clusters of 
Tas2r126-positive cells were visible (Figure 1H) . This clustering 
of the antiserum-labeled cells at the so-called gastric groove is 
reminiscent of the pattern of EGFP-positive cells in the Cre- 
reporter mouse line (Liu et al., 2017) . In addition, we also found 
Tas2r126-immunopositive cells in the mucosal glands of the 
corpus (Figure 1F), where the labeled cells were mainly located 
in the basal half of the epithelium.
Upon closer inspection of the labeled cells at the gastric 
groove a variety of staining patterns emerged. While in some
FIGURE 1 | Continued
FIGURE 1 | Sequence alignments and expression of the bitter receptor Tas2r126 assessed by Western Blot analyses and immunohistochemistry in mouse tongue 
and stomach. (A) Comparison of the sequence region for the one-to-one orthologs, human TAS2R41 and mouse Tas2r126, showing the sequence region used for 
the antiserum generation. Identical amino acids are highlighted in gray with bold letters, conservative replacements shaded in gray and divergent residues in white. 
The epitope alignment is marked in the box and indicates a considerable degree of sequence identity and similarity between TAS2R41 and Tas2r126.
(B) Comparison of the corresponding sequence region of Tas2r subtypes which originate from the same phylogenetic clade and which are expressed in the 
stomach. There is a high degree of sequence diversity within the epitope region (boxed area) compared to TAS2R41, thus cross-reactivity with Tas2r subtypes other 
than Tas2r126 seems unlikely. Alignments were performed with the program Clustal Omega, EMBL-EBI. (C) Western blot analysis of whole cell lysates from posterior 
taste papillae revealed that the Tas2r126 antiserum recognized a band with an apparent molecular weight of ~37 kDa corresponding with the expected size of
36.2 kDa. (D) In posterior taste buds the antiserum specifically labeled gustatory cells. (E) A consecutive section of the papilla probed with only the secondary 
antibody showed no labeling. (F) Immunohistochemistry on tissue sections through the whole stomach, longitudinally opened along the greater curvature, to analyze 
the aglandular and glandular gastric regions. In the fundus, no immunopositive cells were detected, whereas opposite the limiting ridge multiple Tas2r126-positive 
cells were labeled. In the corpus mucosa Tas2r126-immunoreactive cells were visible in the basal half of the invaginations. (G) A minus primary antiserum control of a 
consecutive section did not show any staining. (H) Analysis of a perpendicular section through the gastric ridge region showing multiple Tas2r126-positive cells in 
clusters. Scale bars (D ,E), 20 ^m, (F- H), 100 ^m.
FIGURE 2 | Expression of Tas2r126 in cells of the epithelial band at the gastric groove circumscribing the stomach. (A) Cells in the epithelial band displayed different 
staining characteristics. While in some cells the entire cell body was labeled, other cells showed a more punctate staining. (B) Several cells were characterized by a 
strong immunoreactivity at the most apical part; apparently the apical microvillar tuft of brush cells. (C) Omission of the primary antiserum served as negative control. 
(D) The identity as brush cells was confirmed analyzing TRPM5-IRES-Cre/eR26-tGFP mice; the t GFP immunostaining (green) is colocalized with Tas2r126 
immunoreactivity (red) in a subset of brush cells. (E) Omission of the Tas2r126 antiserum resulted only in t GFP immunostaining (green). (F) Some columnar cells with 
a wide microvillar apex were also stained. Beneath the apical cell membrane, punctate staining was visible. Scale bars (A ,D), 20 ^m, (B ,C ,E,F), 5 ^m.
cases the entire cell body was labeled, in other cases only 
a punctate staining was observed (Figure 2A ). For some of 
the cells strong immunoreactivity was selectively visible at 
the apical region; the tuft-like labeling suggests that these 
cells are brush cells (Figure 2B ). To test this hypothesis, we 
used TRPM 5 as a brush cell marker and a transgenic mouse 
line allowing us to visualize TRPM5-expressing cells due to 
their endogenous GFP fluorescence (Kusumakshi et al., 2015). 
The results of double labeling experiments visualizing GFP 
and Tas2r126 immunoreactivity are depicted in Figure 2D . 
As can be seen, several of the TRPM5-positive cells showed 
a strong immunoreactivity for Tas2r126 at the apical region, 
probably at the microvilli. This result indicates that some of 
the Tas2r126-positive cells at the gastric groove are in fact 
brush cells. However, only a subset of the brush cells was 
Tas2r126-immunoreactive consistent with the observations by 
Liu et al. (2017). Additionally, some columnar cells also showed 
Tas2r126 immunoreactivity. These cells are characterized by 
a wide microvillar apex (Figure 2F ). Controls omitting the 
Tas2r126 antiserum on sections from wildtype and transgenic
mice resulted in negative staining (Figure 2C ) and GFP-specific 
labeling (Figure 2E ), respectively, thus indicating the specificity 
of the used antiserum.
Tas2r126-Positive Cells in Large 
Invaginations at the Bottom of the 
Gastric Groove
Upon inspection of sections through the proximal edge of the 
corpus, we identified large invaginations that comprised a large 
number of brush cells (Figure 3A) and often also contained a high 
density of Tas2r126-labeled cells (Figure 3B ). The invaginations 
are located in a narrow region, distally adjacent to the gastric 
groove at both the smaller and the greater curvature; this region 
corresponds to the so-called cardiac zone according to Wattel 
and Geuze (1978). This structure, called first gland, is considered 
to be a unique anatomical entity (O ’Neil et al., 2017). The 
invaginations are often branched, almost ovoid or sometimes 
round in shape and have different sizes (small: 40 ^m  x  40 ^m ; 
large: 100 ^m  x  60 ^m  up to 240 ^m  x  160 ^m ). Those
FIGURE 3 | Analyses of Tas2r126-expressing cells in unique glandular units at the smaller and greater curvature adjacent to the gastric groove. (A) Distribution of 
large invaginations on stomach sections at the level of the esophagus orifice (asterisk). TRPM5 was used as marker for brush cells. In order to prepare the sections 
the stomach was cut along the dotted line as illustrated. (B) Large invaginations were often branched and fused into oval structures with a large lumen; the lining 
epithelium comprised numerous cells with Tas2r126 immunoreactivity (red). An example area at the smaller curvature is shown. The schematic drawing indicates the 
cutting level (dotted line). (C) Invaginations associated with the first gland (marked by arrow heads) which are located very close to the bottom of the gastric groove 
have an open connection to the gastric lumen. The connecting channel of the invagination is encircled by the dotted line. GC, greater curvature, SC, smaller 
curvature, LR, limiting ridge. Scale bars (A), 100 ^m, (B ,C ), 50 ^m.
FIGURE 4 | Cells with Tas2r126 immunoreactivity in glandular units at the bottom of the gastric groove enwrapped by smooth muscles (A) In these invaginations 
Tas2r126 labeling was found at the apex of brush cells (arrowhead) and basally located round cells (yellow arrow); furthermore groups of columnar cells (*) were 
labeled. (B) Brush cells with Tas2r126 immunoreactivity (red) contain the rate limiting enzyme for the synthesis of prostaglandin COX-2 (green). (C) A consecutive 
section was probed with a smoothelin antiserum (blue); the labeled structures surround the invagination so that smooth muscle cells are located next to the COX-2 
positive brush cells (green). Inset: An overlay of the marked regions in (B,C) indicates that brush cells (green) with Tas2r126 immunoreactivity (red) are adjacent to 
smooth muscle cells (blue). Scale bars (A- C ), 20 ^m, (inset), 10 ^m.
invaginations adjacent to the gastric groove open directly into this 
furrow (Figure 3C ) .
Within these invaginations, we detected Tas2r126 labeling at 
the apex of brush cells, at the base of round cells and some
columnar cells (Figure 4A ) . Quantification indicated that within 
the epithelium of these structures 57 ±  5.9% of all brush cells 
were also positive for Tas2r126 (n = 3 mice); whereas at the 
limiting ridge only ~15%  of the brush cells were found to express
Tas2r126 (Liu et al., 2017). At the bottom of the gastric groove, the 
invaginations merged into the thick lam ina muscularis mucosae 
that further extends deep into the limiting ridge (Luciano 
and Reale, 1992) . To explore whether the Tas2r126-expressing 
brush cells might come in close contact with muscle fibers 
in this region, we performed immunolabeling for Tas2r126, 
COX-2 and smoothelin. Figure 4B shows the distribution of 
Tas2r126-expressing brush cells within an invagination, which is 
enwrapped by muscle fibers (Figure 4C ) . At higher magnification 
it becomes apparent that some Tas2r126-immunoreactive brush 
cells are indeed located in close vicinity to smooth muscle cells 
(Figure 4C , inset).
Characterization of Tas2r126-Positive 
Cells in Mucosal Glands
Analyzing corpus and antrum for Tas2r126-immunoreactive cells 
revealed that labeled cells were present in both compartments, 
albeit at quite different densities (Figure 5A) . Whereas 60 ±  9.6 
labeled cells per 0.5 mm2 were counted in the corpus (n = 3 
mice), the antrum only contained 17.3 ±  3.5 cells per 0.5 mm2 
(n = 3 mice). Based on the localization of the cells at the lower 
half of the invaginations the Tas2r126-immunoreactive cells in 
the corpus and antrum glands may be enteroendocrine cells 
(EECs). To test this hypothesis, double labeling experiments were 
performed using the antiserum against Tas2r126 in combination 
with an antiserum against CgA, a general marker for EECs. 
The results depicted in Figure 5B indicate that among the 
CgA-positive cells several were immunoreactive for Tas2r126; 
in fact, this applied to 52 ±  8.4% of the CgA cells (n = 3 
mice). In order to further characterize the molecular phenotype 
of the Tas2r126-expressing EECs in the corpus, we used an 
antiserum against HDC, the key enzyme involved in synthesis 
of histamine, as well as antisera against ghrelin, serotonin, and 
somatostatin. In the corpus glands, subpopulations of Tas2r126- 
positive cells were labeled with antisera against HDC and 
ghrelin, respectively (Figures 5C,D ). The analyses of numerous 
preparations revealed that the proportion of EEC cells, which 
were positive for Tas2r126, decreased from proximal to distal. In 
antral glands, only 21 ±  9.3% of CgA-positive cells were positive 
for Tas2r126 (n = 3 mice) (Figure 6A ); subsets were found to be 
co-labeled for serotonin (5-HT) or for ghrelin (Figures 6B,C ). 
In both compartments, Tas2r126-immunoreactive somatostatin- 
producing D cells were only rarely seen (data not shown).
DISCUSSION
In the present study, we have identified distinct cell types 
in the gastric epithelium expressing a bitter receptor protein; 
thus, confirming and extending the results of previous studies, 
which demonstrated the presence of mRNA for bitter receptors 
in epithelial cells of the stomach (Wu et al., 2002; Vegezzi 
et al., 2014; Liu et al., 2017; Prandi et al., 2018). Expression 
of the Tas2r126 receptor in distinct cell types enables the 
stomach to sense certain bitter compounds and elicit adequate 
responses. Based on the results of PCR experiments one may 
assume that additional types of bitter taste receptors are present
in the stomach. In fact, a recent study identified a set of 
distinct Tas2r receptor types that was expressed in the stomach 
(Prandi et al., 2018) . In view of possible implications it will 
be of great interest to further explore whether individual 
combinations of receptor types may be expressed in distinct 
cell types or in cells at certain positions. This would allow 
defined responses to various bitter compounds and may explain 
diverse effects of bitter compounds on stomach functions, 
such as gastric emptying (Glendinning et al., 2008), antral 
contractility, stimulation of ghrelin release (Janssen et al., 2011, 
2012; Wang et al., 2019) and induction of gastric acid secretion 
(Liszt etal., 2017, 2018) .
The presence of Tas2r126 protein in distinct epithelial cells 
of the stomach is consistent with a functional role of Tas2r126 
agonists in regulating gastric processes. Deorphanization studies 
of mouse Tas2r by heterologous expression using a large variety 
of compounds revealed that the receptor type Tas2r126 has 
an intermediate molecular receptive range; compounds which 
activate Tas2r126 all share a phenyl ring and include arbutin and 
salicin (Lossow et al., 2016) . Interestingly, arbutin is considered 
to have antimicrobial effects (Ma et al., 2019) and salicin to have 
antiinflammatory effects (Li et al., 2015) . Thus, cells equipped 
with a functional Tas2r126 receptor might be involved in gastro- 
protective processes.
The presence of the bitter receptor Tas2r126 in a subset of 
brush cells, which are arranged in a continuous band beneath 
the limiting ridge as demonstrated in this study and by Liu et al. 
(2017), is particularly interesting in view of previous findings 
demonstrating that brush cells at the gastric ridge comprise 
receptor types for short chain fatty acids (Eberle et al., 2014) 
as well as for long chain fatty acids (Widmayer et al., 2015, 
2019) . An obvious question in this context is whether the bitter 
receptor-expressing brush cells also contain short and/or long 
chain fatty acid receptors or whether they constitute separate 
populations. Brush cells with a broad receptor expression profile 
may operate as multisensory cells capable to respond to a 
variety of chemical constituents in the luminal content, whereas 
distinct sets of bush cells with different chemosensory properties 
could point to region-specific functions. Moreover, it is unclear 
whether all brush cells at the gastric ridge have the enzymatic 
capacity to produce the candidate messenger compounds, such 
as nitric oxide, prostaglandins and acetylcholine (Kugler et al., 
1994; Eberle et al., 2013; Widmayer et al., 2019) which could 
operate as paracrine mediators between brush cells and adjacent 
effector cells. The high proportion of brush cells with Tas2r126 
immunoreactivity in the large invaginations at the proximal 
edge of the corpus is a striking observation. Although the 
functional implication is unknown, it is interesting to note that 
these invaginations constitute, together with the so-called first 
gland, a unique glandular unit enriched in brush and mucus 
cells, which are considered to be a source of the mucin MUC4 
(O’Neil etal., 2017).
The arrangement of Tas2r126 cells at the border between the 
reservoir compartment fundus and the digestive compartment 
corpus with secretory epithelial cells might point to an 
involvement of brush cells in defense mechanisms by controlling 
the activity of secretory cells. Interestingly, this zone is separating
FIGURE 5 | Molecular phenotypes of cells with Tas2r126 immunoreactivity in the glandular regions corpus and antrum. (A) On sections of the transition region 
between the corpus and antrum it was apparent that the antrum mucosa contained only very few Tas2r126-positive cells compared to the corpus mucosa. (B- D) 
Double immunohistochemical analyses of the corpus mucosa. (B) Labeling for Tas2r126 (green) and CgA (red) indicates that several CgA-positive cells were also 
positive for Tas2r126. (C) Visualization of histamine-producing cells (red) by an antiserum for histidine decarboxylase (HDC) revealed that several were also 
immunopositive for Tas2r126 (green). (D) A subset of X/A-like cells, identified by ghrelin (red), was also immunoreactive for Tas2r126 (green). Yellow arrows point to 
co-labeled cells (merge). Asterisks mark hormone-producing cells devoid of Tas2r126 staining. Scale bars (A), 100 pm, (B- D), 10 pm.
the luminal content of the two compartments as well as in 
controlling the transfer from the aglandular fundus into the 
glandular part of the stomach. The ingested food stored in the 
fundus is probably separated by an adequate mucus barrier 
generated by the numerous mucus-containing glands (Lee et al., 
1982) and columnar cells secreting the TFF1 (unpublished 
results); the activity of both may be controlled by the sensing 
of brush cells. In this context, it is conceivable that ingested 
secondary plant compounds, such as arbutin, which is present 
in various berries and activate the Tas2r126 receptor, might 
induce such effects.
Stimulation of Tas2r126 in brush cells thus might result in 
the activation of the canonical downstream components of the 
taste signal transduction (Wong et al., 1996; Rössler et al., 1998;
Liu and Liman, 2003), since all functional elements of the 
canonical taste signaling cascade are expressed in the stomach, 
including gustducin, PLCß2, TRPM5 (Höfer et al., 1996; 
Hass et al., 2007; Kaske et al., 2007; Eberle et al., 2013). 
According to the proposed mechanism, it is conceivable that 
an activation of bitter receptors in brush cells will lead to the 
dissociation of the ßy-dimer from the a-subunit gustducin and 
an activation of PLCß2 that in turn generates IP3 that opens 
IP3R channels to release calcium. Elevated calcium levels then 
may activate TRPM5 channels leading to a calcium influx and 
consequently the release of signaling molecules. Such paracrine 
messengers may in turn induce the secretion of mucins, TFF1 or 
antimicrobial peptides from the surrounding epithelial cells. In 
fact, studies by Lee et al. (2014, 2017) demonstrated that in the
FIGURE 6 | Distinct enteroendocrine cell types in the mouse antrum express Tas2r126. (A) Numerous CgA-positive EECs (red) were found to be immunoreactive for 
Tas2r126 (green). (B) Cells which were double labeled for Tas2r126 (green) and ghrelin (red) were also found in the antrum. (C) Dual immunostaining showed the 
presence of Tas2r126 immunoreactivity (green) in serotonin-producing EC cells, identified by 5-HT (red). Yellow arrows point to co-labeled cells (merge). Asterisks 
mark hormone-producing cells devoid of Tas2r126 staining. Scale bars (A- C), 10 pm.
airways bitter agonist-induced activation of brush cells leads to a 
secretion of ß-defensin 1.
Some of the invaginations close to the gastric groove open 
into the furrow and are enwrapped by smooth muscles (Wattel 
and Geuze, 1978). The close vicinity of brush cells and smooth 
muscle cells may suggest some paracrine influence of brush cells 
on the contraction state o f muscles. The interaction between 
brush cells and smooth muscles could for example be involved 
in tightly closing the stomach opening (Montedonico et al., 1999) 
and in guiding ingested food into the fundus. Furthermore, for 
brush cells in the small intestine it has recently been shown that 
they trigger IL-25-mediated type 2 immune responses upon a 
parasite and bacterial infection (Gerbe et al., 2016; Howitt et al., 
2016; von Moltke et al., 2016; Nadjsombati et al., 2018) . It is 
currently unknown whether brush cells in the stomach are also 
involved in the regulation of local immune circuits. Based on 
the afore mentioned examples, Tas2r126-expressing brush cells 
might be considered as sentinel cells of the stomach, however, the 
mechanisms associated with their proposed protective role still 
awaits elucidation.
In this report, we provide evidence that a subpopulation of 
ghrelin-producing X/A-like cells and histamine-storing ECL cells 
in the corpus contain the Tas2r126 receptor. This observation 
is in line with transcriptome analysis of sorted ghrelin cells 
demonstrating enrichment of Tas2r126 RNA when compared to
non-fluoresent cells (Engelstoft et al., 2013). Ghrelin cells are 
typically closed type cells which are assumed to be activated 
via the blood stream. However, it has recently been shown 
that salicin, a potent activator of the Tas2r126 receptor, affects 
the secretion of ghrelin as well as gastric emptying and food 
intake (Janssen et al., 2011). Conversely, the bitter compounds 
denatonium benzoate (DB) or phenylthiocarbamide (PTU) 
evoked opposite effects (Janssen et al., 2011). These differences 
support the notion that additional Tas2R receptor types are 
active in the stomach, possibly in different subpopulations of 
cells. In histamine- and ghrelin-producing cells the stimulation 
with Tas2r126 agonists may elicit an elevation of intracellular 
calcium and thus trigger the release of hormones. Indeed, recent 
studies showed that certain bitter agonists stimulate the secretion 
of ghrelin from human and mouse cells (Janssen et al., 2011; 
Wang et al., 2019). Activation of ghrelin cells via bitter receptors 
may involve gustatory a-subunits, since both gustducin and 
transducin were found to be expressed in subpopulations of 
mouse ghrelin cells and the lack of gustducin affected acyl ghrelin 
(Janssen et al., 2012).
In conclusion, distinct cell types with the receptor Tas2r126 
are located at characteristic positions in the stomach and 
may operate as a specialized surveillance system monitoring 
the luminal content for defined constituents. Moreover, these 
cells might convey the sensed information via paracrine
signaling onto gastric effector systems, adapting the motor and 
secretory activities according to the changing composition of the 
luminal content.
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Protonation of Piezol Impairs 
Cell-Matrix Interactions of Pancreatic 
Stellate Cells
Anna K untze1t, Ole Goetsch n , Benedikt Fels2, Karolina N a jd er1, Andreas U n g er1, 
Marianne W ilhelm i1, Sarah Sargin1, Sandra Schim m elpfennig1, Ilka N eum ann1,
Albrecht S ch w ab 1 and Zoltan P e th o 1*
11nstitute o f Physioiogy II, University o f Münster, Münster, Germany,2 Institute o f Physioiogy University o f Lübeck, Lübeck, 
Germany
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an acidic and fibrotic 
stroma. The extracellular matrix (ECM) causing the fibrosis is primarily formed 
by pancreatic stellate cells (PSCs). The effects of the altered biomechanics and 
pH landscape in the pathogenesis of PDAC, however, are poorly understood. 
Mechanotransduction in cells has been linked to the function of mechanosensitive ion 
channels such as Piezo1. Here, we tested whether this channel plays crucial roles in 
transducing mechanical signals in the acidic PDAC microenvironment. We performed 
immunofluorescence, Ca2+ influx and intracellular pH measurements in PSCs and 
complemented them by live-cell imaging migration experiments in order to assess the 
function of Piezo1 channels in PSCs. We evaluated whether Piezo1 responds to changes 
of extracellular and/or intracellular pH in the pathophysiological range (pH 6.6 and pH 6.9, 
respectively). We validated our results using Piezo1-transfected HEK293 cells as a model 
system. Indeed, acidification of the intracellular space severely inhibits Piezo1-mediated 
Ca2+ influx into PSCs. In addition, stimulation of Piezo1 channels with its activator 
Yoda1 accelerates migration of PSCs on a two-dimensional ECM as well as in a 3D 
setting. Furthermore, Yoda1-activated PSCs transmit more force to the surrounding 
ECM under physiological pH, as revealed by measuring the dislocation of microbeads 
embedded in the surrounding matrix. This is paralleled by an enhanced phosphorylation 
of myosin light chain isoform 9 after Piezo1 stimulation. Intriguingly, upon acidification, 
Piezo1 activation leads to the initiation of cell death and disruption of PSC spheroids. In 
summary, stimulating Piezo1 activates PSCs by inducing Ca2+ influx which in turn alters 
the cytoskeletal architecture. This results in increased cellular motility and ECM traction, 
which can be useful for the cells to invade the surroundings and to detach from the 
tissue. However, in the presence of an acidic extracellular pH, although net Ca2+ influx 
is reduced, Piezo1 activation leads to severe cell stress also limiting cellular viability. In 
conclusion, our results indicate a strong interdependence between environmental pH, the 
mechanical output of PSCs and stromal mechanics, which promotes early local invasion 
of PDAC cells.
K eyw ords: p ie z o i, p an c re a tic  s te lla te  ce lls , p a n cre a tic  cance r, fib ros is , pH hom eostas is , ce ll m igra tion
INTRODUCTION
Pancreatic ductal adenocarcinoma (PDAC) is the most common 
primary malignant tumor of the exocrine pancreas, and credits 
for an abysmal prognosis among all forms of cancer. PDAC 
is characterized by a collagen-rich desmoplastic stroma that 
compresses the tumor, which thereby reaches hydrostatic 
pressure levels of up to 100 mmHg (DuFort et al., 2016). In 
addition, the desmoplastic PDAC microenvironment is markedly 
acidic reaching even below pH 6.5 (Cruz-Monserrate et al., 2014; 
Pedersen et al., 2017). Over time the acidic extracellular pH 
(pHe ) can also lead to an acidification of the tightly regulated 
intracellular pH (pH j ) (Riemann et al., 2013). Consequently 
cellular migration is affected and cell death pathways are initiated 
in most eukaryotic cells (Martin et al., 2011; Justus et al., 2013; 
Schwab and Stock, 2014).
In PDAC, the desmoplastic stroma is mainly produced by 
pancreatic stellate cells (PSCs) (Xue et al., 2018). Activated PSCs 
have a myofibroblast-like phenotype with expression of markers 
such as a-smooth muscle actin (aSMA). They are involved in 
fibrotic remodeling of the extracellular matrix (ECM). In PDAC 
this leads to the formation of a characteristic tumor niche that 
insulates tumor cells from the immune system and from the effect 
of chemotherapeutic drugs (Lonardo et al., 2012). Moreover, 
PSCs invade the surrounding tissues together with PDAC cells, 
thus actively facilitating PDAC metastasis (Liu et al., 2019).
Although not studied as extensively as in PDAC cells, it has 
become clear that Ca2+ signaling plays an important role in 
PSC physiology and pathophysiology (Ferdek and Jakubowska, 
2017; Storck et al., 2017). Ca2+ signals can be elicited through 
multiple mediators, e.g., bradykinin, angiotensin, ATP as well as 
environmental pressure (Hennigs et al., 2011; Won et al., 2011; 
Fels et al., 2016). Ion channels that have been studied to mediate 
Ca2+ influx in PSCs are manifold, ranging from CRAC channel, 
P2X7 receptor to a wide array of TRP channels (TRPV4, TRPM7, 
TRPC1, TRPC3, TRPC6) (Haanes et al., 2012; Fels et al., 2016; 
Jakubowska et al., 2016; Nielsen et al., 2017; Storck et al., 2017).
Recent evidence implies that activation of Piezo1—a 
mechanosensitive cation channel that mediates preferentially 
Ca2+ influx upon mechanical stress—is essential for the 
formation of the fibrotic pancreatic stroma in chronic 
pancreatitis (Romac et al., 2018). In concordance with this 
finding, our previous work shows that PSCs express a large 
amount of Piezo1 mRNA (Fels et al., 2016). Activation of Piezo1 
in PSCs would lead to Ca2+ influx which in turn prompts 
a myriad of cellular responses in cancer (Fels et al., 2018; 
Petho et al., 2019). These responses include phosphorylation 
of regulatory myosin light chains (MYLs) and activation 
of calmodulin-dependent cellular pathways that eventually 
coordinate gene expression, secretion of extracellular matrix,
Abbreviations: aSM A, Alpha-smooth-muscle actin; ECM , Extracellular matrix; 
HE, Hematoxylin-eosin stain; PDAC, Pancreatic ductal adenocarcinoma; MYL, 
Myosin light chain; N M IIA, Non-muscle myosin IIA; P-M YL, Phosphorylated 
myosin light chain; PDGF, Platelet-derived growth factor; PSC, Pancreatic 
stellate cell.
cellular contractility and migration, proliferation and cell death 
(Tsai et al., 2015; Gryshchenko et al., 2016).
Ca2+ influx will also lead to the downstream activation of 
calcium-activated K+ channels (e.g., KCa3.1) which in turn feeds 
back on Piezo1 channels by their impact on the cell membrane 
potential (Storck et al., 2017; Petho et al., 2019). In PDAC 
the characteristic mechanical properties of the desmoplastic 
microenvironment are expected to lead to continuous Piezo1 
activation and hence, to sustained Ca2+ influx. The Ca2+ signals 
could be interpreted by the cells as a stiffness-derived survival 
signal in case of moderate, controlled Ca2+ influx. Another 
possibility could be that the cells get overloaded by an excessive or 
prolonged Ca2+ signal and enter cell death pathways (Harr and 
Distelhorst, 2010).
The open probability of Piezo1 can be allosterically enhanced 
by the small-molecular agonist Yoda1 (Syeda et al., 2015), which 
is known to induce Ca2+ influx in transformed fibroblasts and 
myofibroblasts (Blythe et al., 2019; Chubinskiy-Nadezhdin et al., 
2019). In contrast, Piezo1 can be inhibited by rendering it in 
an inactive conformation by extracellular acidification below pH 
6.9, as demonstrated by a thorough patch clamp study (Bae 
et al., 2015). While Piezo1 is inherently mechanosensitive even 
in artificial lipid bilayers (Syeda et al., 2016), it is widely accepted 
that channel function is fine-tuned in live cells by intracellular 
tethers such as the actin-myosin cytoskeleton as well as by 
extracellular tethers such as the ECM (Ranade et al., 2015; Nourse 
and Pathak, 2017).
We hypothesize that Piezo1-mediated mechanosensation in 
PSCs is heavily dependent on the pH microenvironment and 
is fine-tuned by its interaction with intra- and extracellular 
tethers. In this study, we tested, whether Piezo1 is still active 
in the presence of an acidic pHi and/or pHe, conditions that 
resemble the acidic tumor core. As validation, we inspected 
the pH-dependence of Piezo1-mediated Ca2+ influx in Piezo1- 
transfected HEK293 cells. Lastly, we investigated Piezo1- 
cytoskeleton and Piezo1-ECM interactions in PSCs in 2D and 3D 
systems and whether they are impacted by environmental pH.
MATERIALS AND METHODS 
Animal Experiments
Animal experiments were carried out with the approval of the 
local ethics committee for animal care (Landesam t fü r  Natur, 
Umwelt und Verbraucherschutz Nordrhein-W estfalen, permit 
number 84-02.05.50.15.010).
Murine PSC Isolation and Culture
PSCs were isolated from healthy wild-type C57BL/6J mice 
aged 8-12 weeks as described previously (Fels et al., 2016). 
Briefly, murine pancreata were isolated, and then enzymatically 
digested with 0.1% collagenase P (Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany) for 25 min at 370C. After centrifugation, 
the homogenized tissue was resuspended in cell culture medium 
(DMEM/Ham F12 1:1, supplemented with 10% FCS and 1% 
penicillin/streptomycin) and seeded onto FCS-coated tissue 
culture dishes for 2 h. Afterwards, non-adherent cells were 
forcefully washed off the tissue culture plate, resulting in a
homogeneous PSC culture. PSCs were used for experiments after 
two passages.
Plasmids and Transfection
The pRK9 plasmid containing Piezol-IRES-GFP (size 13,701 bp) 
was kindly provided by Prof. Gary R. Lewin’s laboratory. The 
IRES promoter allows GFP to be transcribed only when Piezol 
has been transcribed, too. To create a suitable control plasmid, 
we removed the Piezol and IRES coding DNA from the plasmid. 
For this, we applied the restriction enzymes Notl and MscI 
(New England Biolabs, Ipswitch, MA, USA) to the Piezol-IRES- 
GFP plasmid for 1 h at 37UC according to the manufacturer’s 
instructions. Thus, the resulting plasmid was a structurally 
analogous control plasmid (size 5,411 bp) coding GFP but not 
the Piezol or IRES. Plasmid fragments were separated by gel 
electrophoresis on 1% agarose gel, then excised and purified using 
the QIAquick Gel Extraction Kit (Qiagen, Elilden, Germany). 
Following purification, DNA ends were blunted using the Klenow 
DNA Polymerase I, and finally, the 3' and S' ends were ligated 
using T4 DNA ligase following the manufacturer’s manual (New 
England Biolabs, Ipswitch, MA, USA).
A total of 25,000 E1EK293 cells were seeded in glass- 
bottom dishes (Cell E&G, San Diego, USA) and after overnight 
incubation in 10% FCS-supplemented DMEM at 37° C, cells 
were transiently transfected with either the pRK9 Piezol-IRES- 
GFP (HEKpiezol+ )  or the pRK9-GFP control plasmid (HEKGFP+) 
using 1 [xg plasmid DNA and 40 pd Lipofectamine® 3000 
(Sigma-Aldrich, Merck KGaA, Darmstadt, Germany) in Opti- 
MEM reduced serum media (Thermo Fisher Scientific, Inc., 
Waltham, MA, USA). Twenty-four to forty-eight hours after 
transfection, ElEKPlezol+ and E1EKGPP+ cells could be identified 
in the GFP channel of the fluorescence microscope (Visitron 
Systems, Puhheim, Germany) and subsequently used for Mn2+ 
quench experiments.
Immunocytochemistry
For immunocytochemistry, 30,000 PSCs were plated onto 
collagen I (Corning, New York, NY, USA) coated glass coverslips 
and cultured for 48 h. Following incubation, PSCs were treated 
with 5 [xM Yodal (Tocris Bioscience, Bristol, UK) or solvent 
(0.2% DMSO) for 1 h. To monitor the effects of blebbistatin, cells 
were additionally treated with 5 [xM blebbistatin (Sigma-Aldrich, 
Merck KGaA, Darmstadt, Germany) for 15 min.
For visualizing Piezol membrane expression, live cell staining 
was performed as described previously by our group (Waschk 
et al., 2011; Storck et al., 2017). First, cells were blocked with 
Ringer’s solution (122.5 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl2 , 
0.8 mM MgCl2 , 5.5 mM d-glucose and 10.0 mM E1EPES, titrated 
to pEl 7.4) supplemented with 1% bovine serum albumin (Sigma- 
Aldrich, Merck KGaA, Darmstadt, Germany) for 1 h on ice. 
This was followed by staining with the primary antibody against 
mPiezol (Proteintech, Manchester, UK, #15939-1-AP, 1:200) for 
2 h  at 4°C. This antibody recognizes an extracellular epitope 
of the channel protein so that cell permeabilization was not 
necessary. After washing five times, coverslips were fixed in 3.5% 
paraformaldehyde for 20 min at 4°C. Afterwards, Alexa 488- 
conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA,
1:500) was applied for 1 h at room temperature. Finally, after 
washing 3 times with PBS, 0.1% DAPI (Sigma-Aldrich, Merck 
KGaA, Darmstadt, Germany) was applied in DAKO mounting 
solution (DAKO Deutschland GmbEl, Elamburg, Germany) and 
coverslips were mounted onto slides.
For other immunofluorescence assays, fixation was performed 
on ice using 3.5% paraformaldehyde for 1 h, followed by washing 
with PBS 3 times. Cells were subsequently permeabilized using 
0.25% Triton-X-100 in PBS, then blocked using 10% goat 
serum for 1 h at room temperature. Primary antibodies against 
aSMA (Sigma-Aldrich, Merck KGaA, Darmstadt, Germany, 
#A2547, 1:200), phosphorylated myosin light chain 9 (P-MYL-9; 
Invitrogen, Carlsbad, CA, USA, 1:100), and non-muscle myosin 
Ha (NMIIA) (Novus Biologicals, Littleton, CO, USA, 1:100) 
were applied overnight at 4°C. After washing three times with 
PBS, Alexa 488-conjugated secondary antibodies against mouse 
(Invitrogen, Carlsbad, CA, USA, 1:500) and rabbit (Invitrogen, 
Carlsbad, CA, USA, 1:500) were applied for 1 h at room 
temperature. Lastly, after washing three times with PBS, 0.1% 
DAPI was applied in DAKO mounting solution and coverslips 
were mounted onto slides.
Fluorescent images were acquired using a Zeiss Axiovert 200 
inverted fluorescence microscope (Zeiss, Oberkochen, Germany) 
a t4 0 x  or lOOx magnification. Quantification of Piezol channel 
density was performed manually by counting bright spots 
representing channels in 10 rectangular regions of 7.6 [xm x  
7.6 ixm per cell and subtracting the mean number of spots 
in equivalent extracellular regions. For P-MYL9 and NMIIA 
immunocytochemistry fluorescence ratios of P-MYL9/NMIIA 
were assessed in an unpaired manner, as both primary antibodies 
originate from the same species (rabbit). First, the total cellular 
P-MYL9 and NMIIA intensities of 30 cells were measured 
using similar exposure and illumination settings. Afterwards, the 
amount of P-MYL9 was normalized to the total NMIIA of a 
randomly assigned cell. To evaluate the effects of blebbistatin, 
a scoring system was used to measure the stress fibers, the 
dendrite-like processes and cellular concavities (Figure 1).
Western Blot
Western blots of Piezol, GAPDE1, MYL2, and phospho- 
MYL2 (P-MYL2) were performed as described previously (Bulk 
et al., 2017). Total protein of PSCs was extracted using 
radioimmunoprecipitation assay (RIPA) buffer [50 mmol/1 Tris, 
150 mmol/1 NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% 
NP-40, and 1% Complete Mini protease inhibitor (Roche, 
Mannheim, Germany)]. Protein concentration of the samples 
was determined with Pierce™ BCA Protein Assay Kit (Thermo 
Fisher Scientific, Inc., Waltham, MA, USA). Fifteen microgram 
of denatured total cellular protein was applied to each lane 
of a 15% polyacrylamide gel for electrophoresis at 80 mV. 
After overnight transfer to PVDF membranes at 4°C, we 
blocked the membrane with PBS containing 5% skim milk for 
1 h, then incubated the blots with primary antibodies against 
mPiezol (Proteintech, Manchester, UK, #15939-1-AP, 1:100), P- 
MYL2 (1:500, M YL-Serl9 mouse mAb, #3675 Cell Signaling 
Technology, Danvers, Ma, USA), or MYL2 (1:500, MYL2 rabbit 
Ab, #3672 Cell Signaling Technology, Danvers, Ma, USA), and
FIGURE 1 | Blebbistatin scoring system. Scores ranging from 1 to 3 were given for individual pancreatic stellate cells (PSCs) based on three criteria (membrane 
concavities, stress fibers, and dendritic-like processes), which are characteristic morphological alterations observed in blebbistatin-treated PSCs. The representative 
images show aSMA immunocytochemistry of PSCs. The membrane concavities are highlighted with orange arrows.
for housekeeping control GAPDH (1:2,000, GAPDH mouse 
mAb, #ab125247, Abcam, Cambridge, UK) overnight at 40C. 
After washing three times with PBS, we applied HRP-conjugated 
goat-anti rabbit (1:10,000, Goat Anti-Rabbit IgG H&L, #ab6721, 
Abcam, Cambridge, UK) in case of Piezo1 and P-MYL2; and 
goat anti mouse secondary antibody (1:10,000, Goat Anti-Mouse 
IgG H&L, #ab6708, Abcam, Cambridge, UK) in case of MYL2. 
Chemiluminescence was detected using a commercial detection 
system (Chemidoc MP, Bio-Rad, Hercules, CA, USA), and band 
intensities were evaluated with ImageJ.
Calcium Influx Measurement
We applied the Mn2+ quench technique to monitor calcium 
influx into the cells (Merritt et al., 1989; Fels et al., 2016; Nielsen 
et al., 2017). Mn2+ largely mimics Ca2+ as it enters cells via 
similar pathways. In contrast to Ca2+ ions, Mn2+ ions quench the 
fluorescence emission of the calcium sensitive dye Fura-2. These 
experiments are performed at the Ca2+ insensitive, isosbestic 
excitation wavelength of Fura-2. The Mn2+-induced drop of the 
Fura-2 fluorescence is largely proportional to the transmembrane 
influx of Ca2+.
After staining the cells with the Ca2+-sensing dye Fura-2- 
AM (#F1221, Thermo Fisher Scientific, Inc., Waltham, MA,
USA; 6 ^M ) for 20 min at 370C in HEPES buffered Ringer’s 
solution, cells were visualized using a ionic imaging setup 
consisting of a fluorescence microscope, a high-speed shutter 
and a polychromator (Visitron Systems, Puchheim, Germany). 
The proper isosbestic excitation wavelength, at which the 
emission is Ca2 + independent, was determined using the Ca2 + 
ionophore ionomycin (not shown). Thereafter, measurements 
were conducted at an excitation wavelength of 357 nm and 
fluorescence emission was recorded at 510 nm. Images were 
acquired in 10 s intervals. The experimental protocol started with 
an initial 3 min incubation in Ringer’s solution. This was followed 
by another 3 min incubation in a Ca2 + -containing, Mn2 + 
supplemented Ringer’s solution for the experiments depicted in 
Figures 2C , 5A . For all other measurements we used a Ca2 +- 
free, Mn2 + supplemented Ringer’s solution (Mn2 + Ringer’s). The 
Mn2 + concentration in Mn2 + Ringer’s was 400 ^M  in case of 
PSCs and 1 mM in case of HEK293 cells. Also, in HEK293 cells, 
GFP caused negligible interference with the Fura-2 signals (not 
shown).
Data analysis was performed by measuring fluorescence 
intensities over the whole cell area and correcting it for 
background fluorescence. The extracted fluorescence intensities 
F were normalized to the initial fluorescence intensities F0
FIG U R E 2 | Piezo1 is functionally expressed in PCSs. (A) Representative Western blots of Piezo1 compared to  GAPDH in PSCs, w ild-type HEK293 cells (HEKWT) and 
HEK293 cells transfected with control plasmid (HEKGFP+) or Piezo1 (HEKPiezo1+) (N =  3). (B) Piezo1 immunocytochemistry o f non-permeabilized PSCs shows 
homogeneous channel distribution in the cell membrane. (C) Representative Mn2+-induced Fura-2 quench traces of PSCs in the presence of 20 ^M  Yoda1 or 
equivalent amount of the solvent, 0.075% DMSO (Ctrl). The scatter plots on the right show the respective values of Mn2+ quench slopes, the Mn2+ entry rate. The 
black lines indicate mean ±  SEM. (n =  72, N  =  3 for each condition). (D) Representative GFP image of Piezo1-transfected HEK293 cells. Only GFP+ cells were 
evaluated in the Mn2+ quench experiments. The bar chart on the right shows the evaluation of GFP signal intensities after control plasmid (HEKGFP+) and Piezo1 
(HEKPiezo1+) transfection compared to  untransfected HEK293 cells with intensities <100. (E) HEK293 cell derived Mn2+ quench traces in the presence of the solvent 
0.025% DMSO or 5 ^M  Yoda1 in case of HEKGFP+ (n =  82; n =  50, respectively, N  =  3) or HEKPiezo1 + cells (n =  106; n =  60, respectively, N  =  3). The scatter plots 
indicate Mn2+ entry rates of individual cells for each condition. The black lines indicate mean ±  SEM. *p <  0.05.
determined under control conditions in the presence of Ringer’s 
solution (F/Fo). For each cell, slopes of linear regression 
(AF/Fo/min) were calculated before and after Mn2+ application 
during intervals of 30 s. Subsequently, the slope after Mn2+ 
application was subtracted by the slope in the presence of 
Ringer’s solution to correct for potential photobleaching. Lastly, 
for easier interpretation, the inverse value of the Mn2+ quench 
was determined which directly correlates with Ca2+ influx.
Determination of the Intracellular pH
We assessed the intracellular pH (pH;) of HEK293 cells using the 
fluorescent pH indicator BCECF-AM. Prior to the experiment, 
HCO^-buffered cell culture medium was exchanged for the 
HEPES-buffered Ringer’s solution for 15 min to equilibrate pH; 
at 37° C. BCECF staining was performed using 1 |xM BCECF-AM 
for 3 min in Ringer’s solution (pH 7.4) at 37° C. Afterwards, cells 
were washed and continuously superfused with Ringer’s solution 
for 3 min, followed by 3 min superfusion of acidified Ringer’s
solution (pH 6.6) or Ringer’s solution supplemented with 30 mM 
sodium propionate (Sigma-Aldrich, Merck KGaA, Darmstadt, 
Germany). To maintain osmolarity the latter replaced 30 mM 
NaCl. Lastly, for calibration purposes, cells were permeabilized 
for protons using 1 [xM nigericin (Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany) and superfused with a modified Ringer’s 
solution (KCl 125 mM, MgCl2 1 mM, CaCl2 1 mM, and HEPES 
20 mM) titrated to pH 7.5 and pH 6.5. Data were acquired with 
the same ionic imaging setup used for Ca2+ influx measurements 
measuring with dual excitation wavelengths of 440 and 490 nm 
and emission wavelength of 510 nm.
During data analysis, fluorescence intensities were 
measured over the whole cell area and corrected for 
background fluorescence. Subsequently, the 440 nmex/490 
nmex fluorescence intensity ratios were calculated. As BCECF 
fluorescence ratio follows a linear trend between pH 6.5 
and pH 7.5, two-point calibration was performed using 
linear regression.
Cell Migration and Spheroid Traction 
Experiments
Migration of PSCs was monitored using time-lapse video 
microscopy as described previously (Schwab et al., 2005; Fels 
et al., 2016). PSCs in cell culture medium were seeded in 
pre-coated 12.5 cm2 dishes, Here, the coating matrix mimics 
the desmoplastic stroma and contained the following: 40 ^g/ml 
laminin (Sigma-Aldrich, Merck KGaA, Darmstadt, Germany), 
40 ^g/m l fibronectin (Sigma-Aldrich, Merck KGaA, Darmstadt, 
Germany), 800 ^g/m l collagen I (Corning, New York, NY, USA), 
12 ^g/m l collagen III (Corning, New York, NY, USA), and
5.4 ^g/m l collagen IV (BD Biosciences, Heidelberg, Germany). 
Cell migration was recorded in temperature-controlled chambers 
(370C) with CMOS cameras for 12 h at 5 min intervals using 
the MicroCamLab 3.1 software (Bresser, Rhede, Germany). 
Quantitative analysis of single cell migration was based on 
the segmentation of PSC contours using the Amira software 
suite (Thermo Fisher Scientific, Inc., Waltham, MA, USA). 
From the segmented cell contours, cell velocity (^m /m in) and 
translocation were calculated as described before (Dieterich et al.,
2008). Migration velocity was defined as the displacement of the 
cell centroid as a function of time. Mean translocation represents 
the net distance covered during the entire experiment.
For spheroid formation, 5,000 PSCs were inserted into a 
hanging drop of 40 ^L containing 0.31% methylcellulose (Sigma- 
Aldrich, Merck KGaA, Darmstadt, Germany) in cell culture 
medium. Spheroids formed spontaneously within 48 h. They 
were transferred into a modified matrix suitable for spheroid 
embedding containing 75 ^g/m l laminin, 75 ^g/m l fibronectin, 
4.3 mg/ml collagen I, 27 ^g/m l collagen III, and 12 ^g/ml 
collagen IV. The matrix also contained 1 x  1,010 microbeads 
per ml (FluoSpheres 1 ^m , Invitrogen, Carlsbad, CA, USA) to 
monitor matrix traction. Eighty microliter of matrix containing 
a spheroid was allowed to polymerize in 12.5 cm2 tissue culture 
dishes for 2h  at 370C in 5% CO2, and subsequently 3mL 
cell culture medium was added to the dishes supplemented 
with 50 ng/ml platelet-derived growth factor (PDGF). The 
experiments started after an equilibration period of another 2 h 
at 370C in a 5% CO2 /air atmosphere.
The fate ofPSC spheroids in the three-dimensional matrix was 
monitored using time-lapse video microscopy for a total of 48 h, 
similarly to the single cell migration assay described above. As a 
readout of spheroid invasion, the equatorial cross-sectional area 
of a given spheroid after 24 h was divided by the initial spheroid 
area at t =  0 h. The number of cells detached from the spheroid 
after 24 h was counted. Spheroids apply a remarkable amount of 
traction toward the matrix, as visible in Video 1. The traction 
of the matrix was evaluated by quantifying the movement of 
10 beads within a maximal radius of 500 ^m  neighboring the 
spheroid during a 12 h period. The mean velocity of the beads 
(^m /h) is a surrogate of the traction of the spheroid toward the 
surrounding matrix.
Spheroid Histology and Confocal 
Reflectance Imaging
PSC spheroids were incubated for 24 h at pH 7.4 and 
pH 6.6 in the presence of 20 ^M  Yoda1 or vehicle (0.1%
DMSO), respectively. Afterwards, the collagen matrix containing 
spheroids was scraped off the dishes using a scalpel. Spheroids 
in the collagen matrix were fixed in 4% paraformaldehyde, 15% 
saturated picric acid in 100 mM phosphate buffer overnight at 
40C, dehydrated via ascending ethanol series, and embedded 
in paraffin. For histology, thin sections (5 -7  ^m ) were cut 
with a rotary microtome (Leica RM 2135), rehydrated, and a 
routine hematoxylin and eosin stain (HE) was performed. The 
hematoxylin stains cell nuclei in a blue color, whereas eosin stains 
the ECM as well as the cytoplasm pink.
To evaluate the consistence of PSC spheroids, first, total cross­
sectional area of spheroids was measured in multiple sections of 
each spheroid. Afterwards, by thresholding according to Li (Li 
and Tam, 1998), the acellular area within each spheroid could be 
measured in ImageJ. Spheroid fragmentation was calculated by 
dividing the acellular spheroid area by total spheroid area.
Assessment of Cellular Viability
M TT assays were performed with matrix-embedded PSC 
spheroids cultured at pH 7.4 and pH 6.6 with 20 ^M  Yoda1 
or vehicle (0.1% DMSO), respectively, for 24h. First, spheroids 
were transferred to a 96-well plate, medium was exchanged 
for one containing 0.5 mg/ml M TT reagent (Sigma-Aldrich, 
Merck KGaA, Darmstadt, Germany). Spheroids were incubated 
at 370C in 5% CO2 for 2h. Then medium was discarded 
and 100 ^L  DMSO were added in order to dissolve formazan 
crystals. Absorbance was measured at 546 nm and corrected 
for absorbance at 650 nm using a multi-well spectrophotometer 
(Beckman Coulter, Brea, CA, USA). M TT reduction was 
normalized to absorbance of spheroids cultured at pH 7.4 
with vehicle.
Annexin V staining was performed with trypsin-digested 
PSC spheroids according to manufacturer’s instructions. Briefly, 
PSC spheroids were extracted from the collagen gels manually, 
washed with PBS and then inserted into tubes containing 
0.25% Trypsin-EDTA solution (Sigma-Aldrich, Merck KGaA, 
Darmstadt, Germany) and shaken at 250 rpm at 370C for 10 min. 
After centrifugation at 200 g for 5 min, cells were resuspended in 
Annexin V binding buffer (Mybiosource, San Diego, CA, USA) 
and stained with Annexin V conjugated with Alexa 555 (A35108, 
Invitrogen, Carlsbad, CA, USA, 1:20) at RT for 15 min. Lastly, 
cells were washed with Annexin V binding buffer and visualized 
using a fluorescence microscope at 10 x  magnification in the 
red fluorescence channel and DIC (Zeiss Axio Observer, Zeiss, 
Oberkochen, Germany). Annexin V positivity was evaluated by 
manual thresholding in ImageJ for 3 visual fields per spheroid. 
Annexin V positive cells were counted and summed for all visual 
fields and divided by the total number of cells counted in the 
respective DIC images.
Statistics
Data are presented as mean values ±  S.E.M and following test 
for normality unpaired Student’s t-tests or one-way ANOVA 
were performed with Tukey’s post-hoc test where applicable 
using Graphpad Prism 7. Statistical significance was assumed 
when p  <  0.05.
RESULTS 
Piezol Channels Are Expressed in 
Pancreatic Stellate Cells
We performed Western blot to investigate Piezol expression 
in whole-cell lysates of cell populations investigated in our 
study: namely in untransfected HEK293 cells, in HEK293 cells 
transiently transfected with control plasmid or Piezol and in 
PSCs (Figure 2A). We found that Piezol is abundantly expressed 
in PSCs, whereas overall Piezol was scarcely expressed in 
both untransfected and transiently transfected E1EK293 cells. To 
visualize membrane expression of Piezol in PSCs, we labeled 
the channel using immunocytochemistry (Figure 2B ). Piezol is 
expressed homogeneously in the cell membrane at a density 
of 0.52 ±  0.08 channels/[xm2 (n =  300 regions of 30 cells, 
N =  3 experiments). Moreover, to assess functionality of the 
channels, we measured Piezol-mediated Ca2+ influx using the 
Mn2+ quench technique in the presence or absence of the 
Piezol agonist, Yodal. ffere, we found that 20 [xM Yodal almost 
doubles Ca2+ influx into PSCs, from 0.29 ±  0.02 to 0.52 ±  0.03 
AF/Fo/min (p  <  0.0001, N =  3 experiments with n =  72 PSCs) 
(Figure 2C ).
To validate the specificity of the Yodal-induced Mn2+ quench 
assay, we compared Ca2+ influx into untransfected E1EK293 
cells with that into E1EK293 cells transfected with a control 
plasmid or with Piezol (Figure 2E). As overall Piezol expression 
in the transiently transfected E1EK293 cell population is low, 
we only measured Mn2+ quench in transfected GFP+ E1EK293 
cells (Figure 2D ). GFP intensities of GFP+ control (1,724 ±  
79, n =  523) and Piezol transfection (2,266 ±  61, n =  
816) were proportionately increased compared to wild-type 
E1EK293 autofluorescence with intensities <100  (Figure 2D ). 
Untransfected and control transfected E1EK293 cells exhibit the 
same (p =  0.97) Yodal-induced Mn2+ quench rate: 0.27 ±  0.02 
AF/Fo/min (n =  50, N =  3) and 0.28 ±  0.02 AF/Fo/min (n 
=  82, N =  3), respectively (Figure 2E). In contrast, Piezol- 
transfection leads to a 2-fold higher Mn2+ quench rate in 
F1EK293 cells (0.55 ±  0.02 AF/Fo/min, n =  106, N =  3). 
Interestingly and in line with the Western blot results shown in 
Figure 2A, we needed a considerably higher Mn2+ concentration 
for F1EK293 cells than for PSCs to elicit comparable quench 
rates. Piezol-mediated Ca2+ influx is distinctly amplified using 
5 [xM Yodal (0.81 ±  0.03 AF/Fo/min, n =  60, N  =  3) 
compared to solvent (0.025% DMSO) superfusion (Figure 2E). 
Collectively, these results provide evidence that PSCs express 
Piezol channels and that their function can be assessed with the 
Mn2+ quench technique.
Piezol Channels Facilitate Pancreatic 
Stellate Cell Migration and Cell-ECM 
Interaction
Aiming for a readout of the physiological functions of Piezol 
in PSCs, we investigated whether cellular migration is altered 
by the Piezol activator Yodal. Indeed, 5 [xM Yodal stimulate 
the migration of PSCs seeded on a matrix resembling the 
desmoplastic matrix found in the PDAC stroma (Figure 3A).
Velocity and translocation rise from 0.25 ±  0.01 [xm/min and
20.4 ±  2.2 [xm (n =  83, N  =  3) under control conditions (0.075% 
DMSO) to 0.29 ±  0.01 [xm/min (p  =  0.0002) and 41.2 ±  4.3 [xm 
(p =  0.0089, n =  52, N =  3), respectively. The fact that the 
increase of translocation is more pronounced than that of the 
velocity indicates a Yodal-mediated increase in directionality 
(Figure 3B ). Further increasing the concentration of Yodal to 
15 [xM lessens the stimulatory effect on PSC migration (velocity 
0.27 ±  0.01 [xm/min, p =  0.04; translocation 32.5 ±  3.6 [xm, p 
=  0.62; n =  47, N =  3 experiments). In the presence of 50 [xM 
Yodal, PSCs are no longer accelerated (velocity 0.22 ±  0.01 and 
translocation 17.0 ±  1.4 [xm; n =  36, N  =  3) when compared to 
equivalent vehicle-treated PSCs (0.25 % DMSO; velocity 0.25 ±  
0.02 ixm/min, p =  0.09; translocation 18.6 ±  1.9 [xm,p =  0.48; n 
=  45, N  =  3; Figure 3B).
We next tested whether the Piezol activator Yodal also 
affects the migratory behavior of PSCs in a more physiological 
three-dimensional environment (Figure 3C). To this end we 
monitored the emigration of PSCs from a spheroid placed in 
a 3D desmoplastic collagen matrix. The normalized equatorial 
cross sectional area of PSC spheroids after 24 h increases similarly 
under control conditions (0.1% DMSO; by 3.5 ±  0.2-fold, n =  51 
spheroids; N  =  8) and in the presence of 20 [xM Yodal (by 3.0 
±  0.2-fold, n =  54 spheroids, N  =  8; p =  0.06). However, 20 |xM 
Yodal lead to the detachment of more cells from the spheroid 
(11.0 ±  1.3 cells, n =  45 spheroids; N  =  3) compared to control 
cells (6.5 ±  0.7 cells, n =  40 spheroids; N  =  3) (Figure 3C).
When monitoring PSC emigration from spheroids with live­
cell imaging, it was conspicuous that the surrounding matrix was 
pulled toward the spheroids. We quantified this phenomenon 
by tracking the movement of microbeads incorporated into 
the matrix (Figure 3D). As judged from the bead movement, 
spheroids pull on the matrix more vigorously in the presence of 
20 ixM Yodal (11.0 ±  0.4 [xm/h, n =  105 beads, A  =  3) compared 
to DMSO-treated spheroids (9.5 ±  0.4 [xm/h, n =  90 beads, N =  
3) (Video 1).
Both Intra- and Extracellular Acidification 
Impair Piezol Activity
In order to assess how extracellular and/or intracellular 
acidification affect Piezol function, Piezol-transfected HEK293 
cells were treated with pH 6.6 Ringer’s solution (n =  64, N 
=  3) and/or with 30 mM sodium propionate (n =  68, N =  
3), respectively (Figure 4A). Our pH; measurements indicate 
that 30 mM sodium propionate acidify HEK293 cells from pH; 
7.24 to pH; 6.77 (ApH; = -0 .4 7 ± 0 .0 1 ) within 1 min. pH; then 
reaches a steady state. In contrast, pH; acidification occurs much 
more slowly upon treatment with pH 6.6 Ringer’s solution, 
as pH; only drops by 0.1 ±  0.002/min. Thus, when assessing 
Piezol function by means of the Mn2+ quench technique at 
t =  1 min after the start of the acidification stimulus, we can 
clearly distinguish between the effect of an intracellular or 
extracellular acidification.
Acidification of pHe decreases Ca2+ influx into Piezo 1- 
transfected HEK293 cells (Figure 4B ). The Mn2+ quench rate 
falls from 0.55 ±  0.02 under control conditions (pHe7.4) to
FIGURE 3 | Yoda1-elicited responses in PSCs. (A) Trajectories of individual PSCs migrating on a 2D substrate in the absence or presence of 5 ^M  Yoda1. Trajectories 
are normalized to common starting points. The radii o f the orange circles show the mean translocation in both cases. (B) Mean velocity and translocation, respectively 
were calculated from the trajectories for a 6-h time span. Five micrometer and 15 ^M  Yoda1 treatments were compared to  0.075% DMSO (Ctrl), whereas 50 ^M  Yoda 
was compared to 0.25% DMSO (Ctrl high DMSO). (C) Phase contrast images of spheroids at time points 0 and 24 h show matrix invasion of the vehicle-treated (Ctrl) 
and 20 ^M  Yoda1-treated spheroids. The left plot shows spheroid area after 24 h normalized to the initial area at 0 h (Ctrl: n =  54, N  =  8; Yoda1 n =  51, N  =  8). The 
right plot indicates the number of cells detached from the spheroids (Ctrl: n =  45, N  =  8; Yoda1 n =  39, N  =  8). (D) Phase contrast image of 50 ng/ml PDGF-treated 
PSC spheroid boundary shows microbead traction toward the spheroid (pink lines, see also V ideo  1). Black lines on the scatter plot show mean ±  SEM. *p <  0.05.
0.42 ±  0.01 AF/Fo/min (n =  196, N  =  5; p  <  0.0001). The 
acidification of pH; by sodium propionate elicits a similar effect: 
0.45 ±  0.02 AF/Fo/min (n =  81, N  =  3; p  <  0.0001). These 
effects are additive in Piezol-transfected F1EK293 cells, so that 
the most pronounced inhibition of Ca2+ influx occurs upon dual 
acidification of the intra- and extracellular space by co-applying 
pFl 6.6 Ringer’s solution with 30 mM sodium propionate: 0.31 ±  
0.01 AF/Fo/min, n =  77, N  =  3; p  <  0.0001). This combined 
acidification diminishes the Mn2+ quench to a rate that is only 
20% higher than that of control plasmid-transfected F1EK293 
cells (Figure 4D ).
When Piezol-transfected E1EK293 cells are treated with 5 [xM 
Yodal, pHe acidification (0.66 ±  0.02 AF/Fo/min, n =  151, N  
=  4) as well as pH; acidification (0.5 ±  0.02 AF/Fo/min, n =  
129, N  =  4) still impair Ca2+ influx (Figure 4C ). Interestingly, 
in case of Yodal stimulation, intracellular acidification is 
more effective in inhibiting Ca2+ influx than extracellular 
acidification (p  <  0.0001), and there appears to be no 
additional effect of dual acidification (0.48 ±  0.04 AF/Fo/min, 
n =  34, N  =  2).
Piezol Function in PSCs Is Affected by the 
Cytoskeleton
As it is not known whether Piezol is functionally coupled 
to cytoskeletal tethers in PSCs, we aimed to investigate this 
by disrupting the actomyosin architecture using the myosin­
inhibitor blebbistatin. Upon pre-incubating PSCs with 5 [xM 
blebbistatin for only 15 min, 5 [xM of the Piezol activator 
Yodal leads to an increase of only 28% in Mn2+ quench 
(0.37 ±  0.02 AF/Fo/min, n =  175, N  =  3) (Figure 5A). 
This effect is not due to decreased membrane recruitment of 
the channel. Immunofluorescence staining of Piezol in the 
plasma membrane showed that the channel density after 5 [xM 
blebbistatin treatment (0.47 ±  0.01 channels/ixm) does not differ 
from that of untreated PSCs (p  =  0.91, Figure 5B). Blebbistatin 
also causes substantial morphological changes in PSCs, that we 
evaluated by the criteria shown in Figure 1. Compared to control 
incubation with 0.1% DMSO (membrane concavities: 1.3 ±  0.1; 
stress fibers: 2.7 ±  0.1; dendrite-like protrusions: 1.3 ±  0.1; n 
=  30, from N  =  3), PSCs treated with blebbistatin have more 
membrane concavities (2.7 ±  0.1) and denrite-like protrusions
FIGURE 4 | pH-dependent modulation of Piezo1 function. (A) Evaluation of intracellular acidification after superfusion of HEK293Piezo1+ cells with pH 6.6 Ringer’s 
solution (n =  68) or 30 mM propionate (PA; n =  64). Error bars represent SEM. (B,C) Representative Mn2+ quench traces upon superfusion of HEK293Piezo1 + cells 
with solvent (B) or 5 ^M  Yodal (C) with pH 7.4 or pH 6.6 Ringer’s solution, sodium propionate (PA) or pH 6.6 Ringer’s solution +  propionate (PA). The bar graphs on 
the right show the statistical evaluation for each condition, where 4 indicates acidification of the pHe or pHi. Column charts show mean ±  SEM. *p <  0.05 (D) The 
scatter plot shows Mn2+ entry rates after acidification of the intracellular and/or extracellular space in control-transfected or Piezol-transfected HEK293 cells without 
or with the co-superfusion with 5 ^M  Y odal. The number of evaluated cells is indicated above each group. The dashed line indicates the mean Mn2+ entry rate of all 
control transfected HEK293 cells for better comparability. The intracellular (circle) and extracellular (rectangle) pH environment is color-coded below the groups, with 
blue meaning physiological pH (pHi =  7.25, pHe =  7.4), whereas red means acidic pH (pHi =  6.7, pHe =  6.6). Black lines show mean ±  SEM.
(2.5 ±  0.1), but less stress fibers (1.5 ±  0.1; n =  30, N  =  3) 
(Figure 5C).
To elucidate whether Piezol modulates cellular contractility, 
we measured the phosphorylation status of the regulatory 
myosin light chain MYL9, which is known to have a regulatory 
role in smooth muscle cells (Figure 6A ). We performed 
immunocytochemistry experiments and normalized the staining 
of P-MYL9 to that of the non-muscle myosin NMIIA. 
The treatment with 5 fiM Yodal increased the ratio of P- 
MYL9/NMIIA from 0.90 ±  0.03 (vehicle-treated cells) to 1.31 
±  0.04 (n =  90, N  =  3 for both conditions; p  <  0.0001). For 
comparison, we also measured the phosphorylation status of 
MYL2, another regulatory myosin light chain that exerts its main 
function in cardiac muscle. The Western blot analysis comparing 
the amount of P-MYL2 to MYL2 in PSC cell lysates shows that 
the phosphorylation of MYL2 is not significantly different in 
Yodal-treated cells (1.4 ±  0.4, n =  5, N  =  5 control lysates vs.
3.2 ±  1.2, n =  4, N  =  4 lysates from Yodal-treated PSCs; N  =  5 
each; p  =  0.17) (Figure 6B ).
Acidic pH Disrupts PSC Spheroid Integrity
To get a better understanding of how PSC physiology is affected 
in the acidic tumor core, we inspected how changes in intra- 
and extracellular pH affect Piezol-elicited responses of PSCs. Our 
results show that Mn2+ entry rate in case of pHe acidification 
alone (0.23 ±  0.02 AF/Fo/min, n =  57, N  =  5) remains analogous 
to the control pH 7.4 Ringer’s perfusion (0.24 ±  0.02 AF/Fo/min, 
n =  48, N  =  5; p  =  0.99) (Figure 7A). On the contrary, 
intracellular acidification decreases Mn2+ entry by 40% (0.14 ±  
0.01 AF/Fo/min, n =  45, N =  5;p =  0.003) similarly to combined 
intra- and extracellular acidification (0.16 ±  0.01 AF/Fo/min, 
n =  46, N  =  5; p  =  0.03). Thus, Ca2+ influx and thereby 
Piezol function appears to be predominantly inhibited by an 
intracellular acidification of PSCs.
FIGURE 5 | Blebbistatin disrupts the cytoskeleton and impairs Piezo1 function 
in PSCs. (A) Representative Mn2+ quench traces of control and 20 ^M  Yoda1 
treated PSCs after pretreatment with 5 ^M  blebbistatin (+Blebbi) for 15 min. 
For comparison, a trace of Yoda-1 induced Mn2+ quench without blebbistatin 
pretreatment is shown in gray. The scatter plots show the Mn2+ entry rate (n =  
133 and n =  175, respectively, N  =  3). *p <  0.05. (B) Piezo1 
immunofluorescence after pretreatment with 5 ^M  blebbistatin. Scatter plot 
depicts Piezo1 channel densities (n =  300 regions of 30 cells, N  =  3 
experiments). (C) Representative immunofluorescence against aSMA (green). 
Images show PSCs treated with 0.1% DMSO (Ctrl) or blebbistatin (Blebbi). The 
Blebbistatin score graph depicts the quantification of the cytoskeletal and 
morphological alterations, detailed in F igure  1. Column charts show mean ±  
SEM (n =  30 cells, N  =  3).
As PSCs require Ca2+ to exert ECM traction, we expected that 
inhibited Ca2+ influx in acidic conditions would impair bead
traction in PSC spheroids (Figure 7B ). Interestingly, it turned 
out bead displacement toward PSC spheroids at pHe6.6 (9.5 ±  
0.4 ^m /h, n =  57, N  =  5) is comparable to the displacement 
at pHe7.4 (11.0 ±  0.4 ^m /h, n =  108, N  =  5). Even more 
intriguingly, in the presence of 20 ^M  Yodal at pHe6.6, bead 
displacement is decreased by 40% (5.8 ±  0.3 ^m /h, n =  37, 
N  =  5). To obtain knowledge regarding the mechanism of 
these phenomena, we investigated the composition of spheroids 
at different conditions by hematoxylin and eosin staining 
(Figure 7D ). Spheroids treated with 20 ^M  Yodal at pHe6.6 are 
largely fragmented (19.3 ±  1.5 % spheroid cross sectional area, n 
=  52 sections, N  =  3 spheroids) compared to pHe6.6 alone (6.1 ±  
0.5 % area, n =  35, N  =  3, p  <  0.0001) (Figure 7C ). In contrast, at 
pHe7.4 there is no difference between vehicle (5.1 ±  0.4 % area, 
n =  58, N  =  3) and 20 ^M  Yoda1 treatment (4.5 ±  0.4% area, 
n =  42, N  =  3, p  =  0.99). Lastly, we investigated the cellular 
viability in order to find out whether spheroid fragmentation is 
due to impaired cell metabolism and viability. M TT reduction 
normalized to control spheroids cultured at pHe7.4 (1.00 ±  0.07, 
n =  n =  6, N  =  3) is almost halved at pHe6.6 in the presence of 
20 ^M  Yoda1 (0.52 ±  0.05, n =  6, N  =  3, p  =  0.03) (Figure 7E ). 
For comparison, M TT reduction in the presence of 20 ^M  Yoda1 
at pHe7.4 (1.19 ±  0.07, n =  6, N  =  3, p  =  0.56) and pHe6.6
cultured spheroids with vehicle treatment (0.82 ±  0.12, n =  6,
N  =  3, p  =  0.6) is not different. However, loss of M TT reduction 
can also be attributed to decreased proliferation and decreased 
cell metabolism and is not a specific readout for cell viability 
in general. Therefore, we also performed Annexin V staining to 
detect apoptosis (Figure 7F ). Here, cells derived from spheroids 
that were treated with Yoda1 and pH 6.6 have approximately 
twice as many Annexin V positive cells (31.0% ±  4.4, n =  6,
N  =  3) than under control conditions (16.3% ±  2.3, n =  6,
N  =  3, p  =  0.0046).
DISCUSSION
Research from recent years has shown that activated 
myofibroblast-like cells such as pancreatic stellate cells, could 
serve as potential therapeutic targets in fibrotic conditions. 
PDAC is characterized by a massive fibrosis produced by PSCs 
(Robinson et al., 2016) which causes a markedly increased tissue 
pressure and an acidosis inside the desmoplastic tumor tissue. 
Our study demonstrates that Piezo1 is a prominent transduction 
channel involved in adapting the behavior ofPSCs to the ambient 
microenvironmental conditions. Our study focused in particular 
on the impact of the intra- and extracellular pH for Piezo1 and 
PSC function.
According to the “force through lipid” model the intrinsically 
mechanosensitive Piezo1 recognizes changes of tension of the 
neighboring phospholipid bilayer (Teng et al., 2015). In contrast, 
the “force through tether” model postulates the necessity of 
associated proteins e.g., laminin or collagens to translate the force 
applied to the cell membrane (Lewis and Grandl, 2015; Gaub and 
Muller, 2017). Our findings support the “force through tether” 
model, as disruption of the cytoskeleton through blebbistatin 
inhibited Yoda1-induced activation of Piezo1 (Figure 5A).
FIGURE 6 | Yoda-1 modifies myosin light chain phosphorylation (P-MYL9) in PSCs. (A) Immunocytochemistry images of PSCs treated with vehicle (0.2% DMSO; Ctrl) 
or 5 ^M  Yoda1 for 1 h, indicating P-MYL9 (red) and NMIIA (green) of different cells. Scatter plot indicates the total cellular fluorescence intensity o f P-MYL9 normalized 
to  NMIIA fluorescence (n =  90, N  =  3). (B) Representative Western blots of P-MYL2 and MYL-2, compared to  GAPDH, respectively, w ithout or with 5 ^M  Yoda1 
treatment. Scatter plot shows the results for individual PSC lysates (Ctrl: n =  5, N  =  5; Yoda1 n =  4, N  =  4). *p <  0.05.
Upon blebbistatin-mediated inhibition of the myosin ATPase, 
morphological changes in the cytoskeleton of PSCs are also 
striking. Similar morphological changes were observed in hepatic 
stellate cells, who also showed decreased cell contraction in the 
presence of blebbistatin (Liu et al., 2010). Moreover, blebbistatin- 
treated PSCs are less sensitive to Yoda1 which then no longer 
induces Ca2+ influx into the cells. A reason for that could have 
been that the overall Piezo1 density decreases upon blebbistatin 
treatment. However, our immunocytochemistry data declines 
this possibility. Thus, our results are consistent with the notion 
that in PSCs, Piezo1 exhibits its downstream effects through its 
direct or indirect interaction with the cytoskeleton.
Employing the Piezo1 activator Yoda1, we showed a 
dose-dependent change in the motility of PSCs plated on a 
two-dimensional matrix, with enhanced cell migration at lower 
concentrations and inhibition at high concentrations (Figure 3) . 
In contrast, a recent study focused on transformed fibroblasts 
(Chubinskiy-Nadezhdin et al., 2019) found that similar 
concentrations of Yoda1 inhibit collective cell migration in 
wound healing in a dose-dependent manner. Those experiments 
investigated directed collective cell migration toward the 
mechano-chemical gradient in wound healing assay. In our 
2D setting we investigated the spontaneous undirected cell 
migration. Thus, the discrepancies may indicate that Piezo1 
has a differential role in the distinct forms of cell migration. 
Furthermore, we did not see a difference in the overall matrix 
invasion of the 3D spheroid, which is characterized by a 
collective and directed cell migration from the spheroid core. 
However, the number of detached cells increased. In another 
3D system investigating lymphatic valve formation, Piezo1 also 
plays an eminent role in the protrusion of valve leaflets, which 
is associated with collective cell migration (Nonomura et al., 
2018). These findings reinforce our hypothesis that Piezo1 acts 
differently in different cell migration settings and may direct cells 
to detach from cell aggregates.
The effects seen by using Yoda1 in cell migration studies can 
be credited to downstream effects of Piezo1-induced Ca2 + influx 
such as those on the contractile apparatus of PSCs. Ca2 + influx 
leads to phosphorylation of myosin light chains such as MYL9 
and activation of the myosin II ATPase. This in turn causes 
retraction of the trailing edge of cells and mediates the polarity 
of the leading front edge, which are essential for proper cell 
migration (Vicente-Manzanares et al., 2009). TRPV4, another 
mechanosensitive ion channel has also been shown to be involved 
in the retraction of the trailing part of migrating HEK293 cells 
(Mrkonjic et al., 2015). Also, cell migration is supported by the 
concomitant activation of Ca2 + activated ion channels such as 
KC a 3.1 which trigger a localized volume loss at the rear part of 
migrating cells (Schwab et al., 2012).
We showed that Piezo1 activation leads to a boosted 
phosphorylation state of the regulatory myosin light chain P- 
MYL9, thus further strengthening the cell cortex (Figure 6 ). Even 
though MYL phosphorylation is impacted by Piezo1, MYL and 
ion channel function are not interchangeable. First, elevation 
of [Ca2 + ] i  through ion channels has many cytoskeleton- 
independent consequences as reviewed by Gryshchenko et al. 
(Gryshchenko et al., 2016). Also, interfering with myosins can 
lead to secondary signaling alterations. This is indicated by 
the fact that Myo9b- / -  dendritic cells have not only impaired 
migratory capacity but also an altered dendritic cell-T cell 
interaction (Xu et al., 2014).
We did not observe any changes in total cellular MYL2 
phosphorylation in Western blot, which is in line with our work 
on endothelial cells (Prystopiuk et al., 2018). This phenomenon 
argues for localized phosphorylation of myosin light chains in the 
cell cortical area. A beautiful example of such a localized signaling 
complex has been described in the recent work of Ellefsen 
et al. where they have shown that traction forces generated 
by myosin II evoke Piezo1-dependent localized Ca2 + flickers 
(Ellefsen et al., 2019).
FIGURE 7 | Yoda1 impairs PSC viability in spheroids in acidic conditions. (A) Representative Mn2+ quench traces of PSCs upon acidification with 30 mM sodium 
propionate (PA) in pH 6.6 or pH 7.4 Ringer’s solution. Scatter plots show statistical evaluation in each condition (n =  48, n =  57, n =  45, n =  46, respectively, N  =  5). 
(B) Microbead traction toward the spheroid in the presence of vehicle (0.1% DMSO, Ctrl) or 20 ^M  Yoda1 in pH 6.6 or pH 7.4 buffered medium supplemented with 
50 ng/ml PDGF (n =  48, n =  57, n =  45, n =  46, respectively, N  =  5). (C) Total area of dissociated acellular space within a spheroid section compared to whole 
cross-sectional spheroid area (n =  58, n =  42, n =  35, n =  52 sections, respectively, of spheroids from N  =  3 mice). (D) Representative spheroid sections stained 
with hematoxylin and eosin. (E,F) Scatter plots indicate viability of PSC spheroids in conditions detailed above using MTT reduction assay and Annexin V staining, 
respectively (n =  6, N  =  3). Data points were normalized to  pH 7.4 buffered medium supplemented with 50 ng/ml PDGF and vehicle (0.1% DMSO). *p <  0.05.
Another Ca2+ signaling mediator that may be affected after 
Piezo1-induced Ca2+ influx is bradykinin, which is implicated to 
have key physiological functions in PSCs through the bradykinin 
receptor 2 (Won et al., 2011; Gryshchenko et al., 2016). This 
is further supported by the fact that bradykinin in return 
potentiates Piezo2 currents (Borbiro and Rohacs, 2017). These 
findings imply that after initial PSC activation by bradykinin, 
Piezo channel function may be potentiated in PSCs and cause an 
enhanced Ca2+ influx.
Tumor tissue is not only characterized by an increased 
matrix elasticity, but also by a marked interstitial acidosis. Our 
experiments showed in a large sample of cells that Piezo1 is 
modified through extracellular and intracellular acidosis in a 
partly additive manner (Figures 4B,C ). Our observation, that 
an intracellular acidification with propionate leads to a stronger 
inhibition of Mn2+ quench, is very well in line with the thorough 
patch-clamp based study of Bae et al., where protonation of 
Piezo1 was shown to stabilize the channel in an inactivated
state (Bae et al., 2015). Another possibility is that the short 
chain fatty acid propionate directly interacts with the channel 
and/or modifies the biophysical properties of the cell membrane. 
As fatty acids have been described to fine-tune the function 
of Piezo1 (Romero et al., 2019), this may indeed contribute 
to the effects seen by our propionate treatment. On the other 
hand, the inhibitory effect of a propionate-induced intracellular 
acidification might have been underestimated. Exposing cells to 
30 mM propionate causes a substantial cell swelling which could 
increase membrane tension and thereby constitute a trigger for 
Piezo1 activation.
In prolonged extracellular acidosis, the pH i  of stromal cells 
becomes acidic as well. Under these conditions Piezo1 is likely 
to not fully function, as demonstrated by our experiments with 
HEK293 cells (Figures 4B,C ) and PSCs (Figure 7A ) . This indeed 
seems to have an important protective function for the cells. 
When acid-primed PSCs are treated with the Piezo1 activator 
Yoda1, there is less traction applied to the matrix indicated
by the decreased bead displacement (Figure 7B ). Also, M TT 
reduction becomes decreased (Figure 7D ). Both findings point 
to a severe loss of spheroid integrity. This loss can be accredited 
to Ca2+ overload and a subsequent induction of cell death 
which is also supported by the fragmentation of the spheroid 
(Figure 7C ). The decreased viability of Yoda-1 treated acid- 
stressed spheroids is confirmed by increased Annexin V positivity 
of cells derived from the spheroid (Figure 7E ). Besides apoptosis, 
a supplementary explanation for the loss of spheroid integrity 
could be that due to the acidic environment PSCs lose attachment 
from neighboring cells in a similar manner as we observed 
previously in melanoma cells (Hofschroer et al., 2017). Along 
these lines, the fragmentation of the spheroids can be explained 
by prolonged cell contraction and acidosis-induced loss of cell- 
to-cell contact.
In conclusion, our study shows that Piezo1 in PSCs is in close 
cooperation with the cytoskeleton and is sensitive to changes 
in extra- and intracellular pH. Although the desmoplastic tissue 
of PDAC exerts a massive mechanical stress onto the cells, the 
marked tissue acidosis in the tumor core renders Piezo1 less 
responsive, thus less active in PSCs and cells do not undergo 
cell death. Because of this protective effect, PSCs may survive 
to migrate into the well-perfused invasive border of the tumor, 
where Piezo1 is fully responding to mechanical cues due to the 
lack of protonation-caused inhibition.
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Chronic pancreatitis, a known risk factor for the development of pancreatic ductal 
adenocarcinoma (PDA), is a serious, widespread medical condition characterized 
by inflammation, fibrosis, and acinar to ductal metaplasia (ADM). ADM is a cell 
type transdifferentiation event where pancreatic acinar cells become ductal-like under 
conditions of injury or oncogenic mutation. Here, we show that chronic pancreatitis and 
ADM in genetically wild type mice results in the formation of a significant population 
of chemosensory tuft cells. Transcriptomic analyses of pancreatitis tuft cells identify 
expression of inflammatory mediators, consistent with a role for tuft cells in injury 
progression and/or resolution. Though similar to tuft cell populations in other organs 
and disease systems, we identified a number of key differences that suggest context- 
specific tuft cell functions. We evaluated seven different mouse strains for tuft cell 
formation in response to chronic injury and identified significant heterogeneity reflecting 
varying proclivity for epithelial plasticity between strains. These results have interesting 
implications in the role of epithelial plasticity and heterogeneity in pancreatitis and 
highlight the importance of mouse strain selection when modeling human disease.
K eyw ords: tu f t  ce lls , D clk1, p a n cre a titis , m e tap las ia , m ouse  m ode ls
INTRODUCTION
Pancreatitis, the third leading cause of gastrointestinal-related hospitalizations, is a serious medical 
condition characterized by inflammation of the exocrine pancreas. Major risk factors include 
gallstones and alcohol abuse; however, pancreatitis can also result from use of certain medications, 
autoimmune diseases, infection, trauma, metabolic disorders, surgery, or mutations in genes 
associated with digestive enzymes (such as Prssl) (Whitcomb, 2013) . Pancreatitis presents in either 
an acute or chronic form. Acute pancreatitis is a painful, short-term condition with sudden onset 
that typically resolves within a few days following treatment, but can be fatal in severe cases 
associated with multi-organ failure (Murtaugh and Keefe, 2015; Yang and Forsmark, 2017). By 
contrast, chronic pancreatitis is largely asymptomatic, occurs gradually, and is typically diagnosed
only after the presentation of complications. In its chronic form, 
pancreatitis is characterized by persistent inflammation, fibrosis, 
and acinar cell metaplasia and results in permanent pancreatic 
damage (Murtaugh and Keefe, 2015). Repeated episodes of acute 
pancreatitis can progress to chronic pancreatitis. While both 
forms carry a risk of mortality, they can also lead to other serious 
conditions. For example, chronic pancreatitis is a known risk 
factor for pancreatic ductal adenocarcinoma (PDA), currently 
the third-most common cause of cancer-related death in the 
United States (Pinho et al., 2014; Siegel et al., 2019) .
The exocrine compartment of a healthy pancreas is comprised 
largely of acinar cells, which produce and secrete digestive 
enzymes and ductal cells, which transport these enzymes to the 
duodenum. Under conditions of chronic injury or oncogenic 
mutation, differentiated acinar cells undergo metaplasia, or a 
morphological remodeling, to form ductal-like cells expressing 
developmental factors, thought to represent a facultative 
progenitor population (Storz, 2017) . This acinar to ductal 
metaplasia (ADM) is a reversible process thought to play a role in 
tissue healing and regeneration after injury (Storz, 2017). In the 
presence of persistent oncogenic KrasG12D expression, however, 
metaplastic cells are no longer able to re-differentiate to acinar 
cells, and instead progress to pancreatic intraepithelial neoplasias 
(PanINs) and PDA (Storz, 2017) .
We previously showed that KrasG 12D-induced ADM is 
characterized by substantial cellular heterogeneity, including a 
significant population of tuft cells (Delgiorno et al., 2014) . Tuft 
cells are solitary chemosensory cells found in the hollow organs 
of the respiratory and digestive tracts and can be identified by 
their large microvilli and deep actin rootlets in the supranuclear 
cytoplasm (Sato, 2007) . Tuft cell formation has been identified 
in response to tissue injury and tumorigenesis in a number 
of organs including the colon, lung, and stomach (Filippenko, 
1981; Gerbe et al., 2011; Saqui-Salces et al., 2011). Tuft cells are 
associated with human pancreatitis, but have not previously been 
identified in genetically wild-type mouse models of pancreatic 
injury (Delgiorno et al., 2014) .
Despite the discovery of this striking cell type in 1956, little 
functional data existed until recently (Jarvi and Keyrilainen, 1956; 
Rhodin and Dalhamn, 1956) . Several groups have independently 
shown that intestinal tuft cells sense and repel parasite infection 
through the expression of succinate receptor 1 and secretion 
of cytokine IL-25 (Gerbe et al., 2011; Howitt et al., 2016; von 
Moltke et al., 2016; Lei et al., 2018; Nadjsombati et al., 2018; 
Schneider et al., 2018) . Further, thymic tuft cells have been shown 
to play a role in the development and polarization of thymic 
invariant natural killer T cells (Bornstein et al., 2018; Miller 
et al., 2018). While these data demonstrate a role for tuft cells in 
mediating inflammation, their role in tissue injury represents a 
substantial knowledge gap.
In contrast to the intestines and thymus, the murine pancreas 
is normally devoid of tuft cells. Rather, pancreatic tuft cells 
emerge in response to expression of tumor-initiating mutations 
(Bailey et al., 2014; Delgiorno et al., 2014) . Despite this 
unexpected discovery, we previously lacked the genetic tools 
and mouse models to properly study tuft cell function in the 
pancreas. This led tuft cell function to be predicted largely on
the basis of transcriptomic and protein expression studies done 
in the intestines. For example, in intestines, high expression 
of the tubulin kinase Dclk1 is largely restricted to tuft cells 
(Gerbe et al., 2011) . In the pancreas, however, Westphalen et al. 
(2016) have shown by lineage tracing with BAC transgenic Dclk1- 
CreERT mice that Dclk1 labeling is not tuft cell-restricted as it 
also labels acinar and ductal cells. This is consistent with acinar 
cell plasticity and the reliance of the pancreas on metaplasia 
to heal. Intermediate cell types that exhibit acinar and ductal 
characteristics are generated during metaplasia and preclude the 
use of a single marker for tuft cell identification.
Here, we demonstrate that tuft cell formation occurs 
during ADM in response to chronic injury in multiple 
strains of genetically wild type mice. We characterize this 
pancreatitis tuft cell population using a combination of histology, 
fluorescence and electron microscopy, and molecular strategies. 
Transcriptomic characterization of pancreatitis tuft cells reveals 
both similarities and differences to those found in other 
organs and disease systems. Our data demonstrate that tuft cell 
formation is a normal part of pancreatic injury and suggest a 
role in recovery. Interestingly, we found tuft cell formation and 
loss of acinar identity to be strain-specific. We have found that 
a proportion of human pancreatitis cases are characterized by 
tuft cell formation (Delgiorno et al., 2014) . Therefore, these data 
highlight the importance of using the appropriate mouse strain 
and conditions to more accurately model the human condition.
MATERIALS AND METHODS 
Animal Strains
Mice were housed in accordance with NIH guidelines in 
Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC)-accredited facilities at the Salk Institute 
for Biological Studies. The Institutional Animal Care and 
Use Committee at the Salk Institute approved all animal 
studies. C57BL/6J mice were either purchased from The Jackson 
Laboratory or bred in-house. Eight-weeks-old DBA/2, Swiss 
Webster, BALB/c, and FVB mice were purchased from Charles 
River Laboratories. CD-1 mice were either purchased from 
Charles River Laboratories or bred in-house. Eight-weeks- 
old 129S6 mice were purchased from Taconic Biosciences. 
Ptf1aCreERTM/+  and R osaYFP strains have been previously 
described and were purchased from The Jackson Laboratory (Pan 
et al., 2013). FLARE25 (Il25F25/F25) mice (C57Bl/6J strain) were 
generously provided by the Locksley (University of California at 
San Francisco, CA, United States) and von Moltke (University of 
Washington, WA, United States) laboratories and were bred to 
the CD-1 mouse strain (von Moltke et al., 2016) . F1 mice were 
used for experiments.
Pancreatitis Induction
Pancreatitis was induced by intraperitoneal (IP) injection of 
caerulein (Bachem). One cycle includes twice daily treatment, 
5 days a week at 125 ^g/kg with 2 days recovery. Mice 
in Supplementary Figure S3 were treated with 62.5 ^g/kg, 
125 ^g/kg, or 250 ^g/kg caerulein.
Lineage Tracing
Lineage tracing was conducted using the Ptf1aCreERTM/+; 
R osaYFP mouse model, as previously described (Pan et al., 2013; 
Delgiorno et al., 2014). Mice were bred into the CD-1 mouse 
strain; F4 mice were used. In this model, tamoxifen treatment 
induces Cre activity, which then initiates expression of yellow 
fluorescent protein (YFP) specifically in P tfla  +  acinar cells. 
Acinar cells were labeled in Ptf1aCreERTM/+ ; R osaYFP mice with 
five daily doses of 5 mg tamoxifen (Sigma, 5 days/week for 
2 weeks) delivered in corn oil (Sigma) by oral gavage. Pancreatitis 
was then induced with four cycles of 250 ^g/kg caerulein.
Histological Staining and Quantification
Tissues were fixed overnight in zinc-containing neutral-buffered 
formalin (Fisher Scientific), embedded in paraffin, cut in 5 
sections, mounted, and stained. Sections were deparaffinized in 
xylene, rehydrated in a series of ethanol, and then washed in 
PBST and PBS. Endogenous peroxidase activity was blocked 
with a 1:50 solution of 30% H2 O 2 : PBS followed by microwave 
antigen retrieval in 100 mM sodium citrate, pH 6.0. Sections 
were blocked with 1% bovine serum albumin (BSA) and 5% 
goat or rabbit serum in 10 mM Tris (pH 7.4), 100 mM MgCl2 , 
and 0.5% Tween-20 for 1 h at room temperature, followed 
by an avidin/biotin blocking kit (Thermo Fisher Scientific) per 
the manufacturer's instructions. Primary antibodies were diluted 
in blocking solution and incubated overnight. Information on 
primary antibodies is provided in Supplementary Table S1. 
Slides were then washed, incubated in streptavidin-conjugated 
secondary antibodies (for rabbit or mouse antibodies, Abcam, for 
rat or goat antibodies, Vector) and developed with DAB substrate 
(Vector). Hematoxylin and eosin (H&E) staining was done to 
assess tissue morphology. All slides were scanned and imaged 
on an Olympus VS-120 Virtual Slide Scanning microscope. For 
quantification of histology, ten 20 x  fields per scanned slide 
were scored in a blinded fashion using the ImageJ/FIJI plugin 
immunohistochemistry (IHC) image analysis toolbox (Shu et al.,
2013) . A statistical color detection model was trained based 
on multiple regions of interest (ROIs) manually and selected 
from desired color pixel regions from sample images for each 
strain using the IHC Toolbox plugin. Each image was color 
deconvolved using its corresponding trained model within the 
plugin and a new RGB image containing only the isolated color 
was automatically generated. The hematoxylin counter stain was 
deconvolved in a similar manner. Using ImageJ/FIJI, the desired 
color-isolated image and the counter stain-isolated image was 
binarized and staining area of the two was measured by counting 
the number of pixels of foreground (Schindelin et al., 2012). The 
percentage of signal was determined by dividing the stain area by 
the sum of the stain area and the counter stain.
Fluorescence Microscopy
Immunofluorescence on paraffin-embedded tissues followed the 
IHC protocol until the blocking step. Instead, tissues were 
blocked with 5% normal donkey serum and 1% BSA in 10 mM 
PBS for 1 h at room temperature. Tissue sections were stained 
with primary antibodies in 10 mM PBS supplemented with 1%
BSA and 0.1% Triton X-100 overnight (Supplementary Table 
S1) . Sections were then washed 3 x  15 min in PBS with 1% Triton 
X-100, incubated in Alexa Fluor secondary antibodies and/or 
phalloidin (Invitrogen), washed again for 3 x  5 min, rinsed with 
distilled water, and mounted with Prolong Gold containing Dapi 
(Invitrogen). Immunofluorescence on OCT-embedded sections 
was conducted as previously described (Delgiorno et al., 2014). 
Tissues were imaged on a Zeiss 710 confocal microscope, a 
Zeiss 880 Airyscan Super-Resolution microscope or an Olympus 
VS-120 Virtual Slide Scanning microscope.
Multiplex Immunofluorescence
Co-expression of amylase and pan-cytokeratin (antibodies, 
Supplementary Table S1) was determined using a Perkin 
Elmer Opal 4-color Manual IHC Kit (NEL810001KT) per the 
manufacturer's instructions.
Transmission Electron Microscopy
Tissues were fixed in a solution of 2% paraformaldehyde, 2.5% 
glutaraldehyde, and 2 mM CaCl2 in 0.15 M sodium cacodylate 
buffer (pH 7.4) for 2 h at room temperature. They were then post­
fixed in 1% osmium tetroxide for 40 min and 1.5% potassium 
ferricyanide in sodium cacodylate buffer for 1 h at 4°C in the 
dark. Tissues were stained en block in 1% aqueous uranyl acetate 
(4°C in the dark), dehydrated in a series of graded ethanol, and 
embedded in Eponate12 resin (Ted Pella). Ultra-thin sections 
(70 nm) were obtained using a diamond knife (Diatome) in an 
ultramicrotome (Leica EM UC7) and placed on copper grids 
(300 mesh). Sections were imaged on a Zeiss Libra 120 TEM 
operated at 120 kV.
All images (IHC, IF, and EM) were digitally enhanced to edit 
the color, brightness, and contrast levels using Zen (Carl Zeiss) 
and/or Photoshop (Adobe) software.
Tuft Cell Preparation and Cell Sorting
Pancreatitis tuft cells were isolated from wild-type CD-1 mice 
treated with four cycles of 250 ^g/kg caerulein (allowed to 
recover for 0 -2  days). The pancreas was quickly dissected, 
minced in 5 ml of DMEM with FBS and allowed to incubate 
for 2 min. Supernatant and fat were removed and pancreatic 
tissue was then incubated in 10 ml DMEM supplemented with 
1 mg/ml collagenase I (Sigma), 1 mg/ml soybean trypsin inhibitor 
(Gibco), 1 mg/ml hyaluronidase (Sigma), and 250 ^ l  of DNAse 
I, shaking gently at 37°C for a maximum of 30 min. Digestion 
was monitored and tissue was further digested mechanically 
by pipetting. Digested tissue was passed through a 100 
filter, washed with fluorescence activated cell sorting (FACS) 
buffer (PBS, 1 mM EDTA, 0.5% BSA), and incubated with 
ACK lysing buffer (Gibco) to remove red blood cells before 
staining for FACS.
Single cell suspensions were incubated on ice with mouse 
Fc receptor block (BD Biosciences, 1:200) followed by antigen- 
specific antibodies in FACS buffer. DAPI (molecular probes, 
1:1000) and Annexin V (Biolegend, Pacific Blue conjugate at 
1:200) were used to exclude dead and dying cells. Cells were 
labeled with Cd45 (Alexa Fluor 488), EpCAM (Alexa Fluor 647), 
and Siglec F (PE) (Biolegend, 1:200) antibodies. Fluorescence
minus one (FMO) staining controls were included for gating 
populations of interest. Cells were FACS purified at the Salk 
Institute’s Flow Cytometry core facility on a BD Biosciences 
Influx cell sorter (100-pm  size nozzle, 1 x  PBS sheath buffer 
with sheath pressure set to 20 PSI). Cells were sorted in 1-drop 
Single Cell sort mode for counting accuracy; these were deposited 
directly into lysis buffer composed of DNase/RNase-free water, 
(%) Triton X-100, and Ribolock (Thermo Fisher Scientific) in 
a 96 well plate.
RNA-seq Library Generation, 
High-Throughput Sequencing, and 
Analysis
Low input bulk RNA sequencing (RNA-seq) on pancreatitis 
tuft cells was performed using the Smart-Seq2 protocol as 
previously described (Picelli et al., 2014). In brief, five biological 
replicates, each with 100 tuft cells from an individual mouse, 
were sorted directly into 2 pl of Smart-Seq2 lysis buffer. Full- 
length cDNA was generated and size distribution was checked 
with Agilent TapeStation 4200 to ensure RNA quality. cDNA 
were then amplified with 18-22 PCR cycles, tagmentated, 
and amplified again with 10 PCR cycles using a Nextera 
XT kit (Illumina FC-131-1096). The sequencing library was 
purified with AMPure XP beads. 50 bp single-end sequencing 
was performed with Illumina HiSeq 2500. Sequencing reads 
were quality checked with FastQC and mapped to the mouse 
genome (mm9) using Hisat2 (Kim et al., 2015) . Transcript 
assembly and quantification were performed by Stringtie and 
Ballgown (Pertea et al., 2016) . Gene expression distribution 
between samples was checked to ensure similar transcriptome 
quality. Genes that have RPKM variance across samples <1 
were first removed to exclude non-expressed genes. The RPKM 
values were then Log2 transformed and quantile normalized 
with the R package preprocessCore. Differential expression 
analysis between tuft and non-tuft epithelial cells was performed 
with empirical Bayes shrinkage and moderated t-test using 
the Limma package and p-values were converted into false 
discovery rates (FDR) using the Benjamini-Hochberg procedure 
(Ritchie et al., 2015) . Heat map plotting and clustering (with 
Euclidean distance and complete linkage) was performed 
with heatmap.2 in R. The differential expression score was 
calculated as: —Log1o (FDR) x  Log2 (fold change), which 
factors in both statistical confidence and the effect size. 
Gene ontology network analyses of differentially expressed 
genes were performed with ClueGO plug-in of Cytoscape 
(Bindea et al., 2009) .
RT-qPCR
RT-qPCR was performed using Power SYBR Green PCR 
Master Mix (Applied Biosystems) on the ABI 7900 detection 
system (Applied Biosystems). Relative expression values were 
determined using the standard curve method. RT-qPCR was 
performed on bulk tuft cells and non-tuft epithelial cells from 
CD-1 mice with pancreatitis (100 cells per group) after the 
amplification step of the SmartSeq2 protocol (Picelli et al., 2014).
Results were normalized to the housekeeping gene Rplp0. Primer 
sequences can be found in Supplementary Table S2.
RESULTS 
Chronic Pancreatic Injury Induces Tuft 
Cell Formation
Tuft cell formation is characteristic of a portion of human 
pancreatitis cases and has also been shown in multiple mouse 
models of tissue injury in several gastrointestinal organs (Saqui- 
Salces et al., 2011; Delgiorno et al., 2014) . We and others have 
shown that tuft cells form in the pancreas in response to genetic 
modifications, such as oncogenic KrasG12D or TGFa, Sox17, or 
IL-1ß overexpression (Bailey et al., 2014; Delgiorno et al., 2014; 
Westphalen et al., 2016) . Importantly, studies of the generality of 
tuft cell formation in genetically wild type mice have yet to be 
reported. Therefore, we conducted a multiparameter analysis of 
caerulein-induced mouse pancreatitis.
Caerulein is a cholecystokinin ortholog that induces 
endoplasmic reticulum (ER) stress in pancreatic acinar cells, 
resulting in cell death, inflammation, and edema (Sah et al.,
2014) . Previously, we evaluated tuft cell formation in response 
to caerulein using mixed background mice and 2 weeks 
(two cycles) of treatment and were unable to detect a robust 
response (Delgiorno et al., 2014). To more thoroughly evaluate 
the potential for tuft cell genesis, we varied treatment dose and 
timing in outbred CD-1 mice. We found that prolonged caerulein 
treatment resulted in acinar cell loss and an increase in ADM, 
stromal deposition, and mucin expression (Supplementary 
Figure S1) . By IHC, we identified robust up-regulation of 
Dclk1 +  cells with tuft cell morphology after four cycles of 
caerulein treatment (Figures 1A -C ). Interestingly, this response 
was enhanced with increasing caerulein dosage and length 
of time of treatment (data not shown). We confirmed tuft 
cell identity using co-immunofluorescence for additional tuft 
cell markers and F-actin marker phalloidin, which labels the 
deep actin rootlets and striking microvilli characteristic of 
this cell type (Figures 1D -G ; Delgiorno et al., 2014). This 
analysis revealed that cells with high Dclk1 expression are 
tuft cells (100% +, 130/130 cells, 3 mice) (Figure 1D) . We 
further confirmed tuft cell genesis with markers phospho- 
EGFR, a receptor tyrosine kinase (100% +, 128/128 cells, 3 
mice), transient receptor potential cation channel, subfamily 
M, member 5 (Trpm5) a chemosensory cell marker (100% +, 
110/110 cells, 3 mice), and Cox1, a prostaglandin synthase 
(95% +, 218/230, 3 mice) (Figures 1E-G ; Bezencon et al., 
2008; Gerbe et al., 2011; Delgiorno et al., 2014) . Pancreatitis- 
induced tuft cells (C ox1+) express tuft cell master regulator 
Pou2f3 (97% +, 189/195 cells, 4 mice), and consistent with 
K rasG12D-induced tuft cells, are not proliferative, (0% K i67+, 
150/150 cells, 3 mice) (Figures 1H,I; Delgiorno et al., 2014; 
Gerbe et al., 2016) . Taken together, these data reveal tuft cell 
genesis in response to chronic, long-term injury in the outbred 
CD-1 mouse strain.
Next, we used transmission electron microscopy (TEM) to 
explore the ultrastructure of pancreatitis-induced tuft cells. We
FIGURE 1 | Chronic injury induces tuft cell formation in the pancreata of wild type mice. (A) Schematic of caerulein treatment for pancreatitis induction in wild type 
mice. (B) Immunohistochemistry (IHC) demonstrating an increase in Dclk1 expression (brown) in the injured pancreas over time and quantified in (C) (n = 3 mice per 
condition). Scale bar, 50 ^m. (D) Co-immunofluorescence (Co-IF) for tuft cell marker phalloidin (red, labels the microvilli and actin rootlets of tuft cells) and Dclk1, (E) 
phospho-EGFR, (F) Trpm5, or (G) Cox1 (green). (H) Co-IF for tuft cell marker Cox1 (red) and Pou2f3 or (I) Ki67 (green). Red arrows, Ki67 + nuclei, white arrow, Ki67- 
tuft cell. Scale bars, 5 ^m. (J) Electron microscopy confirming tuft cell formation in pancreatitis, and (K) demonstrating the presence of vesicles at the tips of the 
microvilli (arrows). Scale bars, 5 ^m and 500 nm, respectively.
induced pancreatic injury and tuft cell formation with four 
cycles of caerulein. We then confirmed tuft cell formation 
by the presence of cells with characteristic microvilli, actin 
rootlets, and abundant intracellular vesicles and mitochondria 
(Figure 1J) . Closer examination revealed membrane-bound 
electron lucent vesicles, which appear to be budding from 
the tips of the microvilli, consistent with injury-induced tuft 
cells being a secretory cell type (Figure 1K) . Collectively, 
these data identify de novo , spontaneous tuft cell formation in 
chemically induced pancreatic injury. The data further suggest a 
potential secretory role for pancreatic tuft cells in inflammation.
To further evaluate this role, we conducted RNA sequencing 
(RNA-seq).
Transcriptomic Analysis of Pancreatitis 
Tuft Cells
To provide a comprehensive, agnostic, molecular assessment of 
the potential role(s) for tuft cells in pancreatic injury, we used 
RNA-seq and bioinformatic analyses. To accomplish this, we 
induced pancreatitis with caerulein, collected tuft cells by FACS, 
and then conducted RNA-seq. Siglec f  is a cell surface lectin
that is typically used to detect eosinophils, but expression is 
also evident in intestinal tuft cells (Gerbe et al., 2016). Using 
co-immunofluorescence with phalloidin, we found that Siglec f 
also labels pancreatitis-induced tuft cells in wild type CD-1 mice 
(98.6% +, 276/280 cells, n =  3 mice) (Figure 2A) .
As tuft cells are rare in pancreatitis, we employed a 
small cell number sequencing approach. We used FACS to 
isolate 100 Cd45-neg; EpCA M +; Siglec f +  tuft cells and an 
equivalent number of Cd45-neg; EpCAM+; Siglec f-neg non-tuft 
epithelial cells from five mice with pancreatitis (Supplementary 
Figure S2A). Tuft cells constituted approximately 0.80% of 
the epithelium (range 0.2-1.7% ). We then isolated bulk RNA, 
prepared cDNA, and amplified it using SmartSeq2 methodology 
(Picelli et al., 2014) . RNA-seq identified 1010 genes as 
differentially expressed between tuft cells and non-tuft epithelial 
cells in pancreatitis (Figure 2B ; FDR <  0.05 and average fold 
change > 4 ). Tuft cell isolation and enrichment was confirmed 
in the Siglec f +  population by high expression of tuft cell 
markers such as Dclk1, Pou2f3, and Trpm5 (Figure 2C ), and 
low-to-no expression of acinar cell markers, such as amylase 
genes, or islet cell markers, such as chromogranin A and 
somatostatin (Supplementary Figures S2B,C) . Similar to tuft 
cells characterized in other organs, pancreatitis-associated tuft 
cells express a number of genes associated with bacterial or 
viral infection (Supplementary Figure S3) . In contrast to 
intestinal tuft cells, Sucnr1 was not expressed (Nadjsombati 
et al., 2018) . Interestingly, network analysis of genes differentially 
up-regulated in tuft cells identified a number of immune cell 
signaling pathways, consistent with a role in inflammation 
(Figure 2D and Supplementary Figure S3) . These data are 
consistent with a sentinel cell role for pancreatitis tuft cells in 
innate immunity.
Pancreatitis Tuft Cells Express Cytokine 
IL-25
Interleukin 25 (IL-25, also called IL-17E) is a member of the IL-17 
cytokine superfamily that has been demonstrated to both induce 
and enhance the helper T cell 2 (Th2) immune response while 
inhibiting Th1 and Th17-driven immunity. Expression has been 
shown in many different cell types, tissues, and systems, among 
which are tuft cells (Bezencon et al., 2008; von Moltke et al., 2016). 
Within the small intestine, tuft cell-derived IL-25 is required for 
the “weep and sweep” response that rids the host of helminth 
infection (Gerbe et al., 2016; Howitt et al., 2016; von Moltke et al.,
2016) . Given the established role for this cytokine as a tuft cell 
effector, we used several orthogonal methods to determine if IL- 
25 is expressed in pancreatitis tuft cells. By RNA-seq, we found 
Il25  expression to be significantly higher in tuft cells than non-tuft 
epithelial cells (Figure 3A ), which was confirmed by RT-qPCR 
(Figure 3B ) . To further confirm IL-25 expression, we induced 
chronic injury in IL-25 reporter mice (Flare25, flox and reporter 
of Il25 ;Il25F25/F25). By co-immunofluorescence with phalloidin, 
we found that 100% of tuft cells analyzed (101/101 cells, n =  5 
mice) were positive for red fluorescent protein (RFP) and IL-25 
expression (Figure 3C) . These data suggest a potential role for 
tuft cell-derived IL-25 in pancreatitis.
Pancreatitis Tuft Cells Result From 
Acinar to Ductal Metaplasia
Previously, we used lineage tracing to show that the majority 
of KrasG 12D-induced pancreatic tuft cells result from acinar-to- 
ductal metaplasia (ADM, 68.7%) (Delgiorno et al., 2014) . To 
determine if pancreatitis tuft cells transdifferentiate from the 
acinar cell epithelium in response to injury, we conducted lineage 
tracing usingPtf1aCreERTM/+ ;R osaYFP mice crossed into the CD- 
1 background. In this model, tamoxifen treatment induces Cre 
activity and expression of YFP, specifically in P tf1 a+  adult acinar 
cells (Pan et al., 2013). Adult mice were given tamoxifen followed 
by four cycles of caerulein treatment to induce pancreatitis 
and tuft cell formation (Figure 4A) . To identify tuft cells, we 
conducted co-immunofluorescence with phalloidin and observed 
YFP expression in 97.6% of tuft cells analyzed (203/208 cells, n =  2 
mice), signifying that injury-induced pancreatitis tuft cells can 
arise from acinar cells (Figure 4B ) . The other 2.4% of tuft cells 
may not have expressed YFP due to incomplete recombination, 
reporter methylation, or additional cell(s) of origin (ductal cells, 
etc.). Interestingly, although significantly lower than in non-tuft 
epithelial cells, a number of acinar cell genes were detected in 
our Siglec f +  tuft cell population by RNA-seq (Supplementary 
Figure S2B), perhaps reflecting their acinar cell of origin.
Tuft Cell Formation Is Mouse 
Strain-Dependent
To determine the function of tuft cells in pancreatitis, we sought 
to employ a number of genetically engineered mouse models 
(GEMMs) that would allow us to eliminate tuft cell formation 
and/or secreted effectors. For the purpose of standardization, 
however, most GEMMs are typically backcrossed into the inbred 
C57Bl/6J mouse strain. To first confirm that C57Bl/6J can 
generate tuft cells in response to chronic injury, we induced 
pancreatitis with 1-5  cycles of caerulein treatment. Surprisingly, 
we found that, although C57Bl/6J mice develop pancreatitis and 
suffer significant loss of pancreas tissue in response to caerulein, 
similar to CD-1 (Figures 5A,B) , we were unable to detect D clk1+ 
cells with tall columnar, tuft cell morphology (Figures 5B,C ) . To 
determine if this strain exhibits reduced sensitivity to caerulein 
treatment or has a sex-specific response, we varied the dose of 
caerulein (four cycles of either 62.5 ^g/kg or 250 ^g/kg) and 
induced injury in both genders (Supplementary Figure S4) . We 
found that increasing caerulein dosage leads to the formation 
of a few cells with tuft cell morphology, but to a lesser extent 
than identified in CD-1 mice (Supplementary Figure S4C) . 
To determine if injury-induced tuft cell formation is unique 
to CD-1 mice, we evaluated pancreatitis in an additional five 
mouse strains. In total, we examined seven strains of mice: 
C57Bl/6J, BALB/c, FVB, CD-1, Swiss Webster, DBA/2, and 
129S6. A minimum of three mice from each strain were treated 
with four cycles of caerulein and examined histologically. All 
treated mice experienced a decrease in pancreas weight to body 
weight ratio compared to control mice (of the same strain), 
and tissue injury and inflammation could be identified by H&E 
analysis in all strains (Figures 5D,E and Supplementary Figure 
S5) . Interestingly, we found a significant increase in Dclk1
FIGURE 2 | Transcriptomic analysis of pancreatitis-induced tuft cells in wild type CD1 mice. (A) Co-immunofluorescence for phalloidin (red, labels the microvilli and 
actin rootlets of tuft cells) and Siglec f (green) in the injured pancreas. Scale bar, 5 pm. (B) Heat map with hierarchical clustering showing differentially expressed 
genes in EpCAM+; Siglec f+ tuft cells as compared to EpCAM+; Siglec f-neg non-tuft epithelial cells. (C) Confirmation of Siglec f expression and tuft cell markers in 
sorted EpCAM+; Siglec f+ cells. n = 5 mice. (D) Gene ontology network analysis of genes differentially up-regulated in tuft cells, as compared to non-tuft epithelial 
cells, identifies immune cell signaling pathways (labeled in red). *p < 0.05; ***p < 0.005; #p < 0.001.
FIGURE 3 | Pancreatitis-induced tuft cells in wild type CD1 mice express cytokine IL-25. (A) RNA-seq demonstrating significantly higher expression of II25 in tuft 
cells (EpCAM+; Siglec f+ cells) as compared to non-tuft epithelial cells (EpCAM+; Siglec f-neg cells). (B) RT-qPCR confirms significantly higher 1125 expression in tuft 
cells. (C) Co-immunofluorescence for red fluorescent protein (RFP, red) and phalloidin (green) in II25F25/F25 mice with pancreatitis. Scale bar, 5 pm. *p < 0.05;
****p < 0.001.
FIGURE 4 | Lineage tracing of pancreatitis tuft cells in wild type mice reveals acinar cell origin. (A) Schematic of tamoxifen and caerulein treatment for lineage tracing 
in Ptf1aCreERTM/+; RosaYFP mice. (B) Co-immunofluorescence for tuft cell marker phalloidin (red, labels the microvilli and actin rootlets of tuft cells) and YFP, green, 
in caerulein-treated pancreata. Scale bar, 5 ^m.
expression, identified by IHC, in nearly all strains (Figure 5F) . 
However, expression levels varied and cellular morphology was 
often inconsistent with that of tuft cells, demonstrating that 
Dclk1 is not tuft cell specific (Figures 5E,F) . Consistent with 
this, we identified Dclk1 staining in the normal ducts of the 
pancreas within all strains, which lack tuft cells. Importantly, 
and consistent with prior reports, these ducts lack tuft cells 
(Supplementary Figure S5; May et al., 2010; Delgiorno et al., 
2014; Westphalen et al., 2016) . Further, our histological and 
RNA-seq analyses are consistent in showing that while Dclk1 
expression is significantly higher in tuft cells, it is not specific to 
them (Figure 2C ).
Due to the lack of specificity of Dclk1 in identifying tuft cells, 
we evaluated expression of additional tuft cell markers Pou2f3 
and Trpm5 (Figures 6A,B) . Pou2f3 expression is absent from the 
normal pancreas, but has been reported to occur in response to 
activation of K rasG12D (Supplementary Figure S6; Zhang et al.,
2018) . Consistent with the literature, Trpm5 can be detected in 
the islets of the normal pancreas; however, expression is absent 
in the exocrine portion of the tissue (Supplementary Figure S6; 
Colsoul et al., 2010) . In response to four cycles of caerulein, 
we observed a significant increase in Pou2f3 expression in 4 of 
the 7 strains analyzed. The Pou2f3+ strains also presented with 
Trpm5 expression consistent with tuft cell formation. While 97% 
of pancreatitis tuft cells are Pou2f3 positive (189/195 cells, n = 4 
mice), only 81% of Pou2f3 positive cells (118/145 cells, n = 4 mice) 
were determined to be tuft cells by co-expression of marker Cox1 
(conducted in the CD-1 strain). Consistent with this analysis, 
79% of Pou2f3+ cells (239/302 cells, n = 4 mice) were positive 
for acetylated a-tubulin (which labels the dense tubulin network 
found in tuft cells). To confirm tuft cell formation, we conducted
co-immunofluorescence for markers Dclk1, Cox1, and acetylated 
a-tubulin on treated and control pancreata from all seven strains. 
By this analysis we confirmed that the CD-1, Swiss Webster, 
DBA/2, and 129S6 strains do, in fact, form tuft cells in response 
to chronic injury (Figure 6C ) . These data demonstrate that 
mouse strains differ significantly in their susceptibility to tuft cell 
formation in response to injury.
The Epithelial and Stromal Composition 
of Pancreatitis Varies by Mouse Strain
Our lineage tracing analyses, conducted in CD-1 mice, 
demonstrate that nearly all pancreatitis tuft cells result from 
ADM (Figure 4 ) . These results led us to hypothesize that the 
proclivity for acinar cells to undergo this cell state reprograming 
varies between mouse strains. As an initial test of this hypothesis 
we compared the relative area occupied by acinar and ductal cells 
in caerulein-treated pancreata from all seven strains. Amylase is 
a digestive enzyme produced by acinar cells, while cytokeratin is 
a structural protein characteristic of ductal cells. Consistent with 
this hypothesis, we found significantly less amylase expression 
in mouse strains that form tuft cells in response to injury 
(48.7 ±  3.8%; CD1, Swiss Webster, DBA/2, 129S6; n = 5 for 
CD1, n =  3 for all other strains) vs. those strains that do not 
(62.1 ±  5.6%; C57BL/6J, BALB/c, FVB; n = 3 each) (Figures 7A,B 
and Supplementary Figure S7) . Cytokeratin expression, 
however, was not significantly different between the two groups 
(47.88 ±  9.9% for tuft cell positive stains vs. 48.1 ±  3.4% for tuft 
cell negative strains) (Figures 7A,B and Supplementary Figure 
S7) . Interestingly, we found that T C +  strains are characterized by 
significantly more stromal deposition (collagen, 28.49 ±  10.52%;
FIGURE 5 | Tuft cell formation in response to pancreatitis in wild type mice is strain-dependent. (A) Pancreas: Body weight ratio (PW/BW) changes in C57BL/6J (B6) 
and CD1 mice in response to four cycles of caerulein treatment. (B) H&E and IHC for tuft cell marker Dclk1 in caerulein-treated C57BL/6J and CD1 mice showing 
expression consistent with tuft cell morphology (black arrows) as well as non-tuft cells (red arrows), quantified in (C). (D) Pancreas: Body weight ratio (PW/BW) 
changes in an additional five mouse strains in response to four cycles of caerulein treatment. (E) H&E and IHC for tuft cell marker Dclk1 in the same caerulein-treated 
mouse strains. Cells with tuft cell morphology (black arrows), non-tuft cells (red arrows). Dclk1 IHC quantified in (F). Bal, BALB/c; SW, Swiss Webster; Dba, DBA/2; 
129, 129S6. Scale bar, 50 ^m. *p < 0.05, **p < 0.01; ***p < 0.005; ****p < 0.001.
n = 4 for CD1, n = 3 for all other strains) than T C -  strains 
(8.39 ±  5.74%; n = 3 for all strains) (Figures 7A,B and 
Supplementary Figure S7) . When we evaluated co-expression 
of amylase and cytokeratin, we were surprised to find cells with
acinar cell morphology that co-expressed both markers in the 
caerulein-treated pancreata from all seven strains, regardless of 
tuft cell status (Figure 8 ). Collectively, these data indicate that 
acinar cells up-regulate cytokeratin expression in response to
FIGURE 6 | Tuft cell marker expression in response to pancreatitis in wild type mice is strain-dependent. (A) IHC for tuft cell markers Pou2f3 and Trpm5 in all strains. 
Scale bar, 50 ^m. (B) Quantification of Pou2f3 IHC in all seven strains of mice. (C) Co-immunofluorescence for tuft cell markers Cox1 (pink), acetylated a-tubulin 
(white), and Dclk1 (green). Scale bar, 5 ^m. Bal, BALB/c; SW, Swiss Webster; Dba, DBA/2; 129, 129S6. *p < 0.05; ****p < 0.001.
FIGURE 7 | Epithelial and stromal marker expression in caerulein-induced pancreatitis varies by mouse strain. (A) IHC for acinar cell marker amylase or ductal cell 
marker cytokeratin (both brown), or collagen staining (Trichrome, blue) in the pancreata of mice treated with four cycles of caerulein, quantified in (B). Scale bar 
50 ^m. TC-, measurements from mouse strains lacking tuft cells (C57BL/6J, BALB/c, and FVB); TC+, measurements from mouse strains that form tuft cells in 
response to caerulein (CD1, Swiss Webster, DBA/2, 129S6). ****p < 0.01; ns, not significant.
injury, but do not necessarily undergo metaplasia (ADM). While 
this is suggestive of varying proclivity for ADM between strains, 
lineage tracing in each strain will be required to evaluate this 
hypothesis more thoroughly.
DISCUSSION
Our data show that tuft cell formation occurs in genetically wild 
type mice as part of the epithelial response to chronic pancreatic
injury, and that this process is highly strain dependent. While 
tubulin kinase Dclk1 is a fairly specific tuft cell marker in the 
intestines, our data clearly show that non-tuft cells express Dclk1 
under conditions of pancreatic injury, consistent with previous 
studies (Westphalen et al., 2016). Consequently, multiple markers 
must be used to confirm tuft cell formation, and additional 
analysis by electron microscopy provides the gold standard for 
unambiguous identification.
Our studies reveal that nearly all pancreatitis tuft cells 
arise from acinar cells, identifying a new layer of epithelial
Amylase/Cytokeratin 
No treatment 4 cycles
FIGURE 8 | Co-expression of acinar and ductal markers in the normal or 
injured pancreata of wild type mice. Immunofluorescence for acinar cell 
marker amylase (red) or ductal cell marker cytokeratin (green) in the pancreata 
of untreated or treated (four cycles of caerulein) mice from all seven strains. 
Cells co-positive for amylase and cytokeratin appear yellow. Scale bar, 50 ^m.
cell plasticity in pancreatic injury. One implication of this 
discovery is that tuft cells play a role in pancreatitis progression 
and/or recovery from injury. Previous studies have shown that 
in response to injury and regeneration, existing acinar cell 
populations mainly drive the genesis of new exocrine tissue 
rather than ADM-derived ductal cells (Desai et al., 2007;
Strobel et al., 2007) . This begs the question of the function of 
these morphologically distinct and highly specialized cells in 
pancreatitis. Consistent with a function in recovery, we found 
that, while two cycles of caerulein treatment is insufficient to 
induce tuft cell formation, pancreatic tuft cells will form in these 
mice during the recovery phase (data not shown).
We also show that pancreatitis tuft cells express cytokine IL- 
25. In the gut, it has been shown that tuft cell-derived IL-25 is 
required to mount a Th2 immune response to parasite infection. 
Tuft cell-derived IL-25 stimulates group 2 innate lymphoid 
cells (ILC2s) to produce IL-5, -9, and -13, promoting type 2 
inflammation (Ting and von Moltke, 2019). IL-13 is sufficient 
to skew the lineage of undifferentiated intestinal epithelial cells 
toward tuft and mucin-producing goblet cells. Goblet cells then 
secrete large amounts of mucus, which aids in clearance of 
the infection (Gerbe et al., 2016; Howitt et al., 2016; von 
Moltke et al., 2016) . While the pancreas is devoid of goblet 
cells, pancreatitis is characterized by the formation of mucin- 
producing cells, which may play a role in neutralizing injury 
and promoting epithelial recovery. Further, IL-25 itself has been 
shown to suppress tumorigenesis in a number of cancer models, 
including PDA, consistent with a protective role for tuft cells 
in pancreas disease (Benatar et al., 2010) . While, IL-25 is an 
attractive candidate to study tuft cell function in pancreatitis, 
our RNA-seq analysis identified a number of other potential 
candidates, which also play a role in mediating inflammation and 
deserve further investigation (Supplementary File S1) .
Interestingly, we found significant differences between mouse 
strains in their ability to form tuft cells in response to the 
same stimuli. All seven strains analyzed experience pancreatitis 
in response to chronic caerulein treatment, as evidenced 
by a significant decrease in the pancreas to body weight 
ratio and inflammation identified histologically, but epithelial 
heterogeneity was substantially different. It is well reported in the 
literature that different mouse strains, and even different mouse 
sub-strains, react to caerulein-induced injury with disparate 
immune infiltrates and varying severity of disease (Wang et al., 
2010; Ulmasov et al., 2013) . The root of these differences 
lies in the intrinsic genetic and epigenetic variations between 
strains. This poses interesting implications for susceptibility to 
pancreatitis in patients. This report, to the best of our knowledge, 
is the first to demonstrate strain-dependent tuft cell formation 
and susceptibility to ADM. As tuft cells likely play an important 
role in pancreatitis, genetic susceptibility to tuft cell formation 
may represent a critical factor in pancreatitis formation, severity, 
and progression in patients.
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The interest in pancreatic stellate cells (PSCs) has been steadily growing over the past 
two decades due mainly to the central role these cells have in the desmoplastic reaction 
associated with diseases of the pancreas, such as pancreatitis or pancreatic cancer. In 
recent years, the scientific community has devoted substantial efforts to understanding 
the signaling pathways that govern PSC activation and interactions with neoplastic cells. 
This mini review aims to summarize some very recent findings on signaling in PSCs and 
highlight their impact to the field.
K eyw ords: ca lc iu m , H ippo, p a n cre a tic  cancer, p an c re a tic  s te lla te  ce lls , pancreas, PDAC, s ign a lin g , W nt
INTRODUCTION
Since their discovery, pancreatic stellate cells (PSCs) have often been overlooked in favor of other 
cellular components of the pancreas -  pancreatic acinar cells (PACs), ductal cells, and pancreatic 
islets -  that all are present in evident abundance in the tissue architecture and perform obvious 
exocrine or endocrine functions. Only relatively recently have PSCs gained substantial attention 
from the scientific community, and this was once it became clear that these cells play important 
roles in pancreatic pathophysiology. PSCs occupy periacinar space and form a dynamic network 
in between pancreatic acini. In health, PSCs predominantly occur in a quiescent phenotype and 
are a minority among cellular components of the pancreas, comprising merely 4-7%  of all cells 
in the organ (Apte et al., 1998) . One characteristic propensity of quiescent PSCs is the presence 
of retinoid droplets in the cytosol (Apte et al., 1998). Upon activation triggered by tissue injury, 
PSCs undergo a series of morphological alterations, which include the loss of retinoid droplets, 
increased prominence of the ER network, and elongation of the cellular processes; they also start 
expressing alpha smooth muscle actin (a-SMA) as well as collagen types I and III, laminin, and 
fibronectin (Apte et al., 1998; Bachem et al., 1998) . As a result, activated PSCs increase in numbers, 
and their products -  extracellular matrix (ECM) components -  may become a significant part of 
the organ. If unbalanced, this mechanism underlies the development of pancreatic fibrosis. This 
mini review aims to summarize the most recent studies on signaling in PSCs relevant in physiology 
and pathophysiology of the pancreas.
SIGNALING AND PSC ACTIVATION
Physiologically, the transition of quiescent PSCs into a proliferative, fibrogenic phenotype is 
an autonomous repair reaction to tissue injury. Since the damage to enzyme-storing PACs is
particularly threatening to the integrity of the tissue, there 
is an obvious need for an efficient and well-balanced system 
orchestrating regeneration and containment of the injury with 
PSC activation at its center. This mechanism is expected 
to have cross-talks between numerous signaling pathways 
(Figure 1), given that PSC activation may be triggered by 
various stimuli, such as inflammatory mediators (Mews et al.,
2002), alcohol metabolites (Apte et al., 2000), and growth 
factors, including transforming growth factors TGF-a and TGF- 
ß, platelet-derived growth factor (PDGF) (Apte et al., 1999), 
or connective tissue growth factor (CTGF) (Gao and Brigstock, 
2005) . These activating factors are secreted not only by infiltrating 
immune cells but might also be coming from other sources 
e.g., acinar cells (PACs) (Masamune and Shimosegawa, 2009). 
Other pathophysiologically relevant factors associated with PSC 
activation include hyperglycemia (Nomiyama et al., 2007), 
hypoxia (Masamune et al., 2008), and oxidative stress (Casini 
et al., 2000) . It is widely accepted that signaling pathways, such 
as the MAPK/ERK (Jaster et al., 2002; Yoshida et al., 2004), PI3K 
(McCarroll et al., 2004), Smad (Ohnishi et al., 2004), Jak/STAT 
(Komar et al., 2017), PKC (Nomiyama et al., 2007), and Hedgehog 
(Li et al., 2014), play a crucial role in PSC physiology and have 
been subjects of previous reviews (Masamune and Shimosegawa, 
2009) . However, recent evidence has indicated that the Hippo 
and W nt pathways as well as authophagy and calcium signaling 
might be equally important players in PSCs. These new findings 
are briefly described below.
Hippo Signaling Pathway
The Hippo signaling pathway is one of the main restrictors of cell 
proliferation that tend to promote apoptosis; it can be triggered 
by numerous microenvironmental cues, such as cell-cell contact,
mechanotransduction, and cellular stress (Meng et al., 2016). 
During tissue repair, which normally requires cell proliferation, 
the Hippo pathway is often downregulated by phosphorylation 
of its main effectors: yes-associated protein 1 (YAP1) and 
transcriptional co-activator with PDZ-binding motif (TAZ) 
(Furth et al., 2018). This results in the switched off expression of 
YAP1/TAZ target genes, particularly CTGF, responsible for PSC 
activation. Liu J. et al. (2019) have recently demonstrated that 
acinar-specific deletion of central kinases in Hippo signaling -  
large tumor suppressor 1 and 2 (LATS1/2) -  contributed to 
inflammation and severe fibrosis in vivo, even without the 
initiation of acinar cell rupture; whereas removal of CTGF with a 
neutralizing antibody attenuated this effect. The authors have also 
shown that in the mouse model of caerulein-induced pancreatitis 
there was an upregulation of secreted phosphoprotein 1 (SPP1) 
(Liu J. et al., 2019), a previously reported target of YAP1/TAZ 
involved in fibroinflammatory responses in other organs (Pardo 
et al., 2005) . Interestingly, YAP1 and TAZ activity can be 
further modulated by the W nt/ß-catenin pathway. For instance, 
Wnt signaling can activate YAP1/TAZ by preventing their 
degradation by the ß-catenin destruction complex (Hansen 
et al., 2015) . Since the Wnt/ß-catenin pathway plays a role 
in embryonic development as well as in homeostasis of the 
developed tissues, W nt signaling becomes particularly important 
in the pathogenesis of proliferative diseases, including cancer.
Wnt Signaling Pathway
The main factors associated with the W nt signaling pathway 
were found both in the endocrine and exocrine pancreas; this 
includes ß-catenin, Wnt2, Wnt5a, and W nt inhibitors e.g., the 
secreted frizzled-related protein (SFRP) family (Heller et al.,
2003). The distribution of these factors is dependent on the
FIGURE 1 | Schematic illustration shows that PSC activation is controlled by different signaling pathways.
condition of the tissue -  that is it changes upon tissue damage 
and in fibrosis. An analysis of human samples revealed that in 
the non-fibrotic pancreatic tissue, ß-catenin is mainly located 
at the cell membrane of PACs, inhibitory SFRP4 is present 
in these cells, and Wnt2 is expressed at a low level (Blauer 
et al., 2019) . In moderate fibrosis, the expression of W nt2 in 
PACs increases, and ß-catenin can now be found in the acinar 
nuclei indicating transcriptional activation; whereas in advanced 
fibrosis, ß-catenin mostly localizes to PSCs (Blauer et al.,
2019) . Interestingly, this distribution pattern can be modeled 
in vitro. PSCs express ß-catenin in monocultures, but when co­
cultured with PACs, the levels of SFRP4 increase compared to 
monoculture, and thus PSCs do not exhibit nuclear distribution 
of ß-catenin (Blauer et al., 2019) . The above indicates that, in 
terms of W nt signaling, a monoculture of PSCs reflects advanced 
stages of fibrosis, whereas a co-culture of PACs-PSCs has the 
expression pattern seen in moderate fibrosis. In another study, 
reversion of activated PSCs to quiescence was associated with 
upregulation of retinoic acid receptor ß (RARß), an increase in 
SFRP4 expression, and a reduction in nuclear ß-catenin content 
in these cells (Carapuca et al., 2016) . However, other reports 
suggest that both Wnt2 and SFRP4 might be elevated upon PSC 
activation (Hu et al., 2014) . It is likely that PSCs could utilize 
multiple mechanisms regulating SFRP4, and thus its role in the 
interplay between PSCs and PACs, as well as in the process of 
PSC phenotype transition, is yet to be fully elucidated.
Autophagy
Autophagy is traditionally viewed either as a means for nutrient 
seeking under stress or as a physiological process for a cell 
quality check and removal of dysfunctional cellular components 
(Glick et al., 2010; Bootman et al., 2018) . While it is normally 
pro-survival, disruption of autophagy has been associated with 
non-apoptotic cell death via the interaction of its main effector 
Beclin-1 with anti-apoptotic Bcl-2 protein (Pattingre et al., 
2005) . Just like other autophagy-related proteins (Atg), including 
Atg1 or Atg5, Beclin-1 acts as an initiator of autophagosome 
formation (Shibutani et al., 2015) . The relationship between 
PSC activation, pancreatic fibrosis, and autophagy has recently 
been well documented in the literature; autophagy has been 
suggested to be a source of energy and molecular material for 
PSC phenotype transition and ECM deposition (Endo et al., 
2017) . In highly fibrotic pancreatic solid tumors, cancer cells 
can stimulate autophagy of PSCs. This leads to the release of 
non-essential amino acids (NEAA), mainly alanine, from PSCs; 
NEAA are then used by cancer cells as an alternative (to glucose) 
energy source (Sousa et al., 2016). However, mouse models 
revealed that deregulation of Atg5 in the pancreas results in a 
similar phenotype to that seen in human chronic pancreatitis, 
indicating that the development of this disease appears to involve 
defects in autophagy (Diakopoulos et al., 2015) . Mammalian 
target of rapamycin (mTOR) is a very well-known suppressor 
of autophagy that inhibits this process by regulating the activity 
of the initiator complex Atg1/ULK1 (Mizushima, 2010) . In turn, 
mTOR can be upregulated by sphingosine-1-phosphate (S1P) or 
its analog, the immunomodulator fingolimod (FTY720), both of 
which inhibit autophagy (Thangada et al., 2014) . FTY720 has
been shown to suppress PSC activation and autophagy via the 
mTOR pathway; it can also increase the Bax/Bcl-2 ratio with a 
simultaneous decrease in the mitochondrial membrane potential 
(Cui et al., 2019) . The mTOR pathway also links autophagy with 
intracellular calcium signals (Bootman et al., 2018).
Calcium Signaling
Calcium signaling is one of the most universal pathways, 
regulating virtually every cellular process from excitability and 
motility to apoptosis (Clapham, 2007) . Sophisticated machinery 
consisting of pumps, ion channels, and active transporters 
controls Ca2+  homeostasis; while spatiotemporal changes in 
Ca2+ concentration encode signals that exert cell responses. In 
the pancreas, Ca2+  signals play a particularly important role 
in regulating secretion of digestive enzymes by PACs, which 
has been a relatively frequent subject of research in the past 
decades (Petersen and Tepikin, 2008) . In contrast, Ca2+  signaling 
in PSCs has so far been investigated only by a handful of 
studies. Nevertheless, recent reports indicate that Ca2+ signals 
are also important in the regulation of PSC physiology, showing 
a clear cross-talk with other pathways, such as NO signaling 
(Jakubowska et al., 2016) . We already know that PSCs express 
bradykinin receptor type 2 (BDKRB2) (Ferdek et al., 2016), and 
pharmacological studies revealed that these cells produce Ca2+ 
responses even to very low doses of bradykinin (Won et al., 
2011; Gryshchenko et al., 2016a) . Since bradykinin is a well- 
known pro-inflammatory mediator, BDKRB2 signaling may well 
play a role in activation of PSCs in diseases of the pancreas 
(Gryshchenko et al., 2016b). PSCs also express a number of Ca2+ 
channels, particularly those from the family of transient receptor 
potential (TRP). For example, TRPC6 has been associated 
with autocrine stimulation of PSCs in hypoxic conditions 
(Nielsen et al., 2017); whereas another TRP member, TRPC1, 
was proposed to contribute to pressure-induced activation of 
these cells (Fels et al., 2016). Deregulated Ca2+  signals directly 
underlie the pathophysiology of acute pancreatitis, and thus it is 
somewhat surprising that so little is known about the effects that 
common inducers of pancreatic pathology, such as bile acids and 
ethanol metabolites, have on Ca2+  signaling in PSCs. Given that 
ethanol induces the expression of TRPV4 in these cells (Zhang 
et al., 2013), whereas sodium cholate and taurocholate generate 
noxious and sustained Ca2+  signals (Ferdek et al., 2016), the 
contribution of PSCs in the development of acute pancreatitis 
might still be underrated by the current dogma.
PSCs IN DISEASES OF THE PANCREAS
Despite being a minority in the normal pancreas, the role 
of activated PSCs becomes apparent in pathophysiological 
conditions. It is well established that persistent activation of 
PSCs is the main contributor to fibrosis in pancreatic diseases, 
with pancreatic cancer and pancreatitis being the most prevalent. 
In health, PSCs regulate ECM turnover not only by producing 
its components but also by secreting key enzymes engaged in 
EMC remodeling -  matrix metalloproteinases (MMP) as well as 
their inhibitors -  tissue inhibitors of metalloproteinases (TIMPs)
(Phillips et al., 2003). PSCs have been shown to activate in 
response to cytokines upregulated in acute pancreatitis (Mews 
et al., 2002) . Upon activation, the fate of PSCs largely depends 
on the external stimuli and can follow different scenarios. If the 
injury is transient, activated PSCs revert to quiescence or become 
senescent (McCarroll et al., 2003) . However, a subpopulation of 
PSCs may expand excessively when activating factors accumulate 
or occur in a persistent manner e.g., in chronic pancreatitis 
(Haber et al., 1999; Masamune et al., 2009). Activated PSCs 
secrete increased amounts of MMP-2 (Phillips et al., 2003), 
and this enzyme breaks down normal basement membrane, 
which then may hasten its replacement by fibril-forming collagen 
(Friedman, 2000).
Pancreatic cancer -  mainly pancreatic ductal adenocarcinoma 
(PDAC) -  remains one of the most serious problems of our 
modern society. According to the Global Cancer Statistics 2018 
(GLOBOCAN 2018), PDAC has been ranked the 11th most 
frequent cancer worldwide and the 7th most deadly cancer, 
accounting for 4.5% of all cancer-related deaths (Bray et al., 2018). 
The hallmark of pancreatic tumorigenesis is a desmoplastic 
reaction that leads to the formation of fibrotic stroma. The 
stroma not only provides a hypoxic microenvironment for the 
neoplastic cells, but it also constitutes a physical barrier that limits 
the efficacy of drug delivery to the tumor. Despite significant 
advances in the treatment regimens and surgical procedures, the 
collagen-rich fibrotic microenvironment of pancreatic cancer is 
the main reason why chemotherapeutics are largely ineffective 
and the clinical outcome remains very poor (Dangi-Garimella 
et al., 2011; Shields et al., 2012) . It is becoming increasingly clear 
that a successful therapy should not only be focused on cancer 
cells but also target the tumor-associated fibrotic stroma.
Pancreatic stellate cells are the main cellular contributors to 
the desmoplastic reaction in PDAC. They become progressively 
activated in the process of tumorigenesis and deposit collagen 
fibers that embed and protect cancer cells. This collagen-rich 
microenvironment becomes an integral part of the developing 
tumor, and the interactions between the stroma and cancer cells 
are essential practically at every stage of tumorigenesis from its 
initiation, through progression, and to metastasis. As an example, 
PSCs have been shown to increase the viability and proliferative 
capacity of cancer cells as well as reduce gemcitabine-induced 
apoptosis of these cells. This was attenuated by pharmacological 
blockade of TGF-ß receptor I (TGF-ßRI, ALK5) (Liu S.L. 
et al., 2019) . The inhibition of stroma-cancer cell interactions is 
currently attracting a lot of interest as a promising strategy that 
may sensitize PDAC to therapy and increase the 5-year survival 
rate of patients suffering from this disease (Cannon et al., 2018).
SIGNALING IN PSC-CANCER CELL 
INTERACTIONS
In light of the above, a number of recent studies have been 
devoted to investigating signaling pathways in tumor-stroma 
interactions. Yet again, the Hippo pathway stands out as an 
important player in pancreatic tumorigenesis. YAP1 is expressed 
by cancer cells as well as is present in the nuclei of PDAC-derived
PSCs, correlating with their activated phenotype. Xiao et al. 
(2019) have recently demonstrated in vitro that depletion of YAP1 
in PSCs (via silencing its expression) results in a shift of PSC 
phenotype toward quiescence, evidenced by a downregulation of 
markers such as a-SM A and collagen I as well as a decrease in PSC 
contractility and proliferation. While secreted protein acidic and 
cysteine rich (SPARC) has previously been associated with the 
poor outcomes of pancreatic cancer patients (Erkan et al., 2008; 
Whatcott et al., 2015), very recently SPARC has been identified 
as a downstream target of YAP1 that mediates its effects on 
cancer cell proliferation via paracrine signaling (Xiao et al., 2019). 
Since YAP1 expression shows a strong correlation with the degree 
of tissue fibrosis in patient samples, YAP1 was suggested as a 
feasible target in PDAC therapy that, in principle, could inactivate 
PSCs and limit the development of the tumor-associated stroma 
(Xiao et al., 2019) .
Another recently revealed paracrine factor involved in 
stroma-cancer cell interactions is leukemia inhibitory factor 
(LIF) (Ohlund et al., 2017; Bressy et al., 2018; Shi et al., 2019) . This 
cytokine is secreted by activated PSCs in PDAC lesions and acts 
on the neighboring cancer cells via its receptor LIFR, activating 
the STAT3 pathway, driving tumor progression and increasing 
chemoresistance (Shi et al., 2019) . Since its circulating and tissue 
levels increase in PDAC patients, LIF was postulated to be both a 
novel biomarker and a feasible therapeutic target.
Stroma-cellular interaction may also occur via cell surface 
receptors such as integrins (Schnittert et al., 2018) . Integrin a- 
11 (ITGA11), a collagen type I-binding receptor, is an interesting 
example: essentially absent in the healthy pancreas, it becomes 
expressed within the stromal fraction of PDAC tissues. It has been 
found that approximately 80% of a-SMA-positive cells are also 
ITGA11-positive, and knockdown of ITGA11 in PSCs results in 
attenuation of differentiation, migration, and secretion of ECM 
components by these cells (Schnittert et al., 2019) . Another cell 
surface protein, integrin a-5 (ITGA5), was also shown to be 
present in as many as 72% of a-SMA-positive cells in human 
PDAC tissues, and its high expression was associated with poor 
prognosis (Kuninty et al., 2019). ITGA5 was demonstrated to 
play a role in TGF-ß-mediated activation of PSCs via Smad2 and 
FAK pathways; and its knockdown inhibited both PSC-induced 
cancer cell proliferation in vitro and tumor growth in vivo 
(Kuninty et al., 2019) . The authors went even one step further and 
developed a novel ITGA5-antagonizing peptidomimetic (AV3) 
that could inhibit PSC activation and enhance the cytotoxic 
effects of gemcitabine in spheroid co-cultures of cancer cell lines 
with PSCs (Kuninty et al., 2019) .
Bcl2-associated athanogene 3 (BAG3) is expressed by multiple 
cancer types, including PDAC, and correlates with poor 
prognosis. Recent studies show that this marker is also present 
in activated PSCs and may promote, via IL -6 , T G F - ß2, and 
insulin-like growth factor-binding protein 2 (IGFBP2) signaling, 
autocrine-driven maintenance of the activated phenotype in these 
cells (Yuan et al., 2019) . Vice versa, BAG3-positive PSCs also 
increase migration and invasion capacity of nearby cancer cells 
via soluble factors such as I L - 8, monocyte chemoattractant 
protein-1 (MCP-1), T G F - ß2, and IGFBP2 (Yuan et al., 2019). 
A recent report shows that plasminogen activator inhibitor-1
(PAI-1), a common regulator of blood coagulation, cell apoptosis, 
and migration, is secreted by pancreatic cancer cells and 
activates PSCs LRP-1/ERK/c-JUN signaling (Wang et al., 2019). 
Interestingly, knockdown of PAI-1 in cancer cells abolished 
activation in co-cultured PSCs, indicating that PAI-1 might 
be one of the key players in PSC -  cancer cell interaction 
(Fanget al., 2012).
While cancer-associated PSCs secrete hepatocyte growth 
factor (HGF), its receptor c-M ET is present on pancreatic cancer 
cells. Simultaneous inhibition of HGF and c-M ET combined with 
gemcitabine is more effective in reduction of tumor volume in 
an orthotopic model of pancreatic cancer than chemotherapy 
alone, indicating a critical role of the HGF/c-M ET pathway in 
PSC-cancer cell interactions (Pothula et al., 2017) . What is more, 
inhibition of HGF, c-MET, and urokinase-type plasminogen 
activator (uPA) has been shown to decrease the angiogenic 
properties of endothelial cells, suggesting the role of PSCs and 
the HGF/c-MET pathway in neoangionesis (Patel et al., 2014). 
The authors envision that a novel antiangiogenic approach that 
targets the HGF/c-MET and uPA pathways could be used against 
pancreatic cancer (Patel et al., 2014).
MECHANOSENSING AND ECM 
STIFFNESS
The human pancreas is an organ that weights only approximately 
100 g (Innes and Carey, 1994), but it produces daily as much as 
1 L (or 1 kg) of pancreatic juice, comprising water, bicarbonate, 
and a variety of digestive enzymes (Pallagi et al., 2015). This 
substantial difference between the juice mass and the mass of 
the tissue is associated with mechanical stress in the organ 
exerted by the fluid pressure on pancreatic duct walls and 
pancreatic acini. PSCs have recently been attributed to sensing 
the mechanical properties of pancreatic microenvironment 
(Cortes et al., 2019b). PSCs control mechanostasis (mechanical 
homeostasis of the organ in response to various types of forces) 
not only in the normal tissue but also under pathophysiological 
conditions like that present in the development of fibrosis 
(Ferdek and Jakubowska, 2017). Deposition of collagen fibers 
by activated PSCs, as well as the presence of cross-linking in 
these fibers, affects the mechanical properties of the pancreatic 
microenvironment, making it dense and rigid (Cortes et al., 
2019a,b). In light of the recent findings, activated PSCs might be 
able to sense fiber topology, adhesiveness of their surroundings, 
and viscoelasticity of the stroma (Papalazarou et al., 2018). 
Stress, strain, and forces that stretch the fibrillary proteins are 
also mechanosensed by myofibroblast-like cells (Chen et al.,
2017). Importantly, the increased matrix stiffness may further 
promote activation of PSCs, supporting a positive feedback 
loop that perpetuates formation of the dense fibrotic tumor 
stroma (Bachem et al., 2005). Therefore, modulation of the 
mechanical properties of the desmoplastic pancreatic tissue, 
in order to decrease its density and overcome problems with 
drug delivery, may become one of key strategies in successful 
therapy of pancreatic cancer (Papalazarou et al., 2018). Only 
very recently has tamoxifen, a drug used successfully against
breast cancer cells, been demonstrated to inhibit differentiation 
of quiescent PSCs into myofibroblasts via the G protein­
coupled estrogen receptor (GPER)- and hypoxia-inducible 
factor-1 alpha (HIF-1a)-mediated mechanism and suppress 
matrix remodeling (Cortes et al., 2019a,b). Another plausible 
anti-fibrotic and mechanomodulatory strategy against pancreatic 
diseases could be targeting YAP and TAZ signal transduction 
of the Hippo pathway: YAP/TAZ, via their interaction with the 
cell cytoskeleton, promote cell “sternness,” tissue regeneration, 
and remodeling of the stroma; whereas YAP can modulate 
fibroinflammatory responses (Martinez et al., 2019) .
What is more, activated PSCs express hyaluronan synthase 
2 (HAS2) as well as hyaluronidase 1 (HYAL1) and have been 
identified as an important source of stromal hyaluronic acid 
(HA) (Junliang et al., 2019). In turn, HA has been attributed to 
high interstitial fluid pressure and vascular collapse in PDAC 
desmoplastic reaction (Provenzano et al., 2012). Enzymatic 
degradation of HA has been shown to reduce the interstitial 
pressure, restore the microvasculature and enhance the efficacy 
of chemotherapy (Kultti et al., 2012; Provenzano et al., 2012; 
Jacobetz et al., 2013). Of note is that HA binds to CD44, 
commonly expressed by many types of cancer cells, and this 
interaction promotes tumor-driving signaling and transport 
activities (Slomiany et al., 2009; Toole, 2009). Since CD44 has 
also been found on the surface of PDAC cells (Zhao et al., 2016), 
the full spectrum of HA roles in pancreatic cancer might be even 
more complex; but this notion requires further investigation.
REVERSION TO QUIESCENCE
Since activation of PSCs can often become part of the 
pathophysiological process, a number of attempts have been 
made to either block the phenotype transition in these cells 
or force already activated PSCs back to quiescence. Treatment 
with retinol and retinoic acid (both ATRA and 9-RA) was used 
to inhibit cell proliferation, expression of activation markers 
and the MAPK signaling pathway in these cells; and retinol 
even blocked ethanol-induced activation of PSCs (McCarroll 
et al., 2006) . Further, ligands of PPARy, a nuclear receptor
FIGURE 2 | Bar chart shows the number of new scientific papers published 
each year between 2008 and 2019 with the phrase "pancreatic stellate cells” 
in the text (based on online search via PubMed.gov). Trend line (dotted): 
y = 3.8179x; R2 =0.914.
regulating lipid storage and glucose metabolism, inhibited PSC 
proliferation and decreased expression of a-SM A and MCP-1, 
suggesting a potential role of PPARy in the development of 
pancreatic fibrosis and inflammation (Masamune et al., 2002). 
More recently, it was shown that vitamin D receptor (VDR) 
is present in the stroma of human pancreatic tumors, and 
its ligand, calcipotriol, reduces markers of inflammation and 
fibrosis in mouse models of pancreatitis and pancreatic cancer 
(Sherman et al., 2014) . A different group demonstrated that while 
vitamin D2, vitamin D3 and calcipotriol inhibit activation of 
PSCs in vitro, they fail to reverse the phenotype transition after 
the cells have already been activated (Wallbaum et al., 2018).
CONCLUDING REMARKS
For the last two decades, there has been a steady (linear) increase 
in the number of papers on PSCs published every year (Figure 2 ). 
This new field continues to expand, and increasingly more 
efforts are directed toward uncovering the signaling pathways 
that control PSC physiology. Since PSC activation underlies the 
pathogenesis of pancreatic disorders, the signals that induce
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Paneth cells are residents of the intestinal epithelium. Abnormal appearance of Paneth 
cells has been widely documented in non-intestinal tissues within the digestive tract and 
even observed in non-gastrointestinal organs. Although metaplastic Paneth cells are 
part of the overarching pathology of intestinal metaplasia (IM), only a fraction of intestinal 
metaplastic lesions contain Paneth cells. We survey literature documenting metaplastic 
Paneth cells to gain insights into mechanism underlying their etiologic development as 
well as their potential relevance to human health. A synthesized view from this study 
suggests that the emergence of metaplastic Paneth cells at extra-intestinal mucosal 
sites likely represents a protective, anti-bacterial, and inflammatory response evoked by 
an altered microbial activity.
K eyw ords: P aneth  ce lls , Paneth ce ll m e tap las ia , m ic rob iom e , in tes tin a l m e tap las ia , g a s tr it is , B a rre tt’s  esophagus
INTRODUCTION
Paneth cells are a group of mature intestinal epithelial cells present in humans and other mammals. 
They are primarily localized at the base of the crypts of Lieberkühn in the small intestine. These 
cells were first described by Schwalbe (1872) and later fully characterized by Josef Paneth (1888). 
Normal Paneth cells differentiate from intestinal stem cells and live for about 60 days (Ireland 
et al., 2005) . Paneth cells can be found in human cecum and ascending colon but are extremely 
rare in human distal colon and are absent in rodent colonic epithelium (Tanaka et al., 2001). 
Conventional histological examination identifies Paneth cells as large columnar epithelial cells 
with characteristic eosinophilic secretory granules densely packed in the cytoplasm. In addition to 
secretion of growth factors (e.g., W nt and EGF ligands) (Clevers and Bevins, 2013) to maintain the 
intestinal stem cell niche (Clevers and Bevins, 2013), Paneth cells secrete numerous antimicrobial 
peptides (e.g., a-defensins, lysozyme, Reg3A, etc.) (Bevins and Salzman, 2011) to regulate mucosal 
immune response.
Loss or reduction of Paneth cells are found in ileal Crohn’s disease (Wehkamp et al., 2005; 
Perminow et al., 2010; Adolph et al., 2013), intestinal ischemia (Grootjans et al., 2011), necrotizing 
enterocolitis (McElroy et al., 2013), pathogenic bacterial infection (Zhang et al., 2012; Conway 
et al., 2013; White et al., 2017), and graft vs. host disease (Fishbein et al., 2008; Levine et al., 
2013; Kroemer et al., 2016). In contrast, abnormal appearance of Paneth cells in other parts of
the gastrointestinal and extra-gastrointestinal region is referred 
to as Paneth cell metaplasia (PCM). Abundant appearance of 
Paneth cells in the human distal colons have been extensively 
documented in literatures published on ulcerative colitis (Tanaka 
et al., 2001; Bedini et al., 2014; Simmonds et al., 2014), Crohn’s 
disease (Tanaka et al., 2001; Simmonds et al., 2014), and 
colonic tubular adenoma (Symonds, 1974; Wada et al., 2005; 
Shi, 2007; Wehkamp and Stange, 2010; Wang et al., 2011a; 
Mahon et al., 2016) . Although these Paneth cell alterations are 
frequently associated with chronic inflammation, the molecular 
mechanism and significance of Paneth cell-related pathologies 
are poorly understood.
Intestinal metaplasia (IM) represents a gastrointestinal 
pathological condition and is defined as an abnormal presence 
of intestinal epithelial cells in non-intestinal tissues. Although 
not all IM contain Paneth cells, metaplastic Paneth cells have 
been widely reported in diseased upper alimentary tissues 
such as Barrett’s esophagus (BE) (Chen et al., 2015), chronic 
gastritis (Montero and Loizaga, 1971; Lewin et al., 1976; Rubio 
et al., 1987; Deveci and Deveci, 2004; Shen et al., 2005), 
and Brunner’s gland (Coutinho et al., 1996) . Surprisingly, 
rare metaplastic Paneth cells were even observed in other 
gastrointestinal and non-gastrointestinal tissues (Symonds, 1974; 
Tanaka et al., 2001; Mitsuhashi et al., 2005; Puiman et al., 2011; 
Gassler, 2017) . In addition to briefly summarizing the well- 
studied PCM in the left colon, which represents a hallmark 
change in idiopathic inflammatory bowel disease (IBD), this 
review will analyze literature on metaplastic Paneth cells in 
upper gastrointestinal or non-gastrointestinal tissues, an area 
of research that has received little attention. We noted a 
potential correlation between bacterial activity and the etiologic 
development of metaplastic Paneth cells within these extra­
intestinal mucosal niche.
Metaplastic Paneth Cells in Colon and Its 
Disease Relevance
Paneth cells are normally present in proximal (right and 
transverse) colons in human but are extremely rare in the 
distal (left) colon. Detection of Paneth cells in the left colon 
were referred to as PCM, and documented in many IBD 
studies (Lewin, 1969; Bansal et al., 1984; Ajioka et al., 2005; 
Simmonds et al., 2014). In addition, PCM in other colonic 
inflammation conditions such as diverticulitis (Sandow and 
Whitehead, 1979) and radiation colitis (Watanabe, 1978) had 
also been reported. However, the histogenesis of colonic PCM 
is not fully understood. Metaplastic Paneth cells in IBD colon 
were usually found in crypt regions and morphologically identical 
to normal Paneth cells that reside in the small intestines 
(Cunliffe et al., 2001). Immuno-histochemical studies indicated 
that colonic metaplastic Paneth cells expressed antimicrobial 
peptides: lysozyme (Klockars et al., 1977), sPLA2 (Haapamaki 
et al., 1997), and a-defensins (Cunliffe et al., 2001). Normal 
colonic mucosa does not express human alpha defensin 5 (HD5; 
antimicrobial protein produced by Paneth cells). However, HD5 
was detected in colonic crypts ofIBD  patients’ samples, consistent 
with the occurrence of PCM (Cunliffe et al., 2001) .
By reporting significantly higher PCM incidences in the distal 
colon of IBD patients compared to non-IBD and control patients, 
Tanaka et al. (2001) proposed an association of colonic Paneth 
cells with IBD. Regression analysis suggested that repair and 
regeneration might be the most potent stimuli causing PCM 
(Tanaka et al., 2001) . Moreover, Paneth cells can sense commensal 
microbiota (Vaishnava et al., 2008) and shape the microbiome 
(Salzman et al., 2010) to maintain the intestinal homeostasis. 
Therefore, the presence of PCM could be an adaptive response 
to protect the damaged colonic epithelium against bacterial 
invasion. Additionally, Wehkamp et al. (2007) suggested that the 
antibacterial peptides produced by Paneth cells might counteract 
bacterial attack as an “on-demand” mechanism.
The detection of Paneth cells in colorectal adenomas was 
reported as early as 1967 (Gibbs, 1967) and the reported 
frequencies of such detection varied from 0.2 to 39% in different 
studies (Bansal et al., 1984; Wada et al., 1994, 2005; Joo 
et al., 2009; Pai et al., 2013; Mahon et al., 2016) . Furthermore, 
Paneth cells not only produce antimicrobial components but also 
constitute an important epithelial niche for small intestinal stem 
cells by producing epithelial growth factor (EGF), transforming 
growth factor (TGF-a), Wnt3, and Notch ligands (Sato et al., 
2011) . The IBD patients have an increased risk to develop 
inflammation-associated colon cancer. Additionally, during 
repair and regeneration of damaged epithelium in IBD patients, 
there might be an increased chance of mutation accumulation 
(cyclic hit model, described in later paragraphs), and the 
metaplastic Paneth cells may contribute to accelerated epithelial 
tumorigenesis by providing stem cell growth factor to tumor cells 
(Chen and Huang, 2014) .
Metaplastic Paneth Cells in Gastric 
Mucosa and Its Disease Relevance
Intestinal metaplasia in human stomach was first reported by 
Morson (1955) and later recognized as a precursor for gastric 
cancer in various studies (Morson, 1955; Ming et al., 1967; 
Matsukura et al., 1979; Segura and Montero, 1983; Shimada 
et al., 1987) . Kawachi et al. (1976) used Tes Tape method to 
characterize IM by disaccharidase visualization and classified 
the lesions into two types. In type I IM, also known as the 
complete IM, goblet cells, Paneth cells, as well as enterocyte 
enzymes, including sucrase, maltase, trehalase and alkaline 
phosphatase were present. In type II, the incomplete form 
of IM, trehalase, alkaline phosphatase, and Paneth cells were 
absent. Thus, complete metaplasia partially resembles small 
intestinal epithelium containing Paneth cells whereas incomplete 
metaplasia resembles colonic epithelium lacking Paneth cells. In 
their study, out of 96 samples of IM, 57% showed type I IM 
with the presence of Paneth cells, while 43% were type II lacking 
Paneth cells (Kawachi et al., 1976) .
By using various staining procedures (Table 1), Albedi et al. 
(1984) reported that immature Paneth cells were present in less 
differentiated IM. Other authors also confirmed the presence 
of PCM by immunostaining for PSTI (Pancreatic secretory 
trypsin inhibitor) (Kazal et al., 1948; Bohe et al., 1986, 1987), 
lysozyme (Heitz and Wegmann, 1980), and human defensin 5
TABLE 1 | Methods used for identification of metaplastic Paneth cells.
O rgan M e thod  o f id e n tific a tio n R eferences
Esophagus Conventional H&E staining Chen et al., 2015
H&E, light microscopy and electron microscopy Schreiber et al., 1978
H&E, periodic acid-Schiff/Alcian blue Takubo et al., 1995
H&E, Lendrum's Phyloxine-tartrazine stain Thompson et al., 1983
Stomach Periodic acid-Schiff/Alcian blue at pH 2.5 Abraham et al., 2003
H&E, Masson’s Trichome, Lendrum’s Phyloxine-tartrazine, Periodic acid-Schiff/Alcian blue at pH 2.5 
and colloidal iron pH 1.9 staining
Albedi e ta l., 1984
H&E, Periodic acid-Schiff/Alcian blue at pH 2.5, immunostaining for lysozyme Deveci and Deveci, 2004
Immunostaining for lysozyme Gassler et al., 2002
Conventional H&E staining Inada et al., 1997
H&E, Periodic acid-Schiff/Alcian blue at pH 2.5 and Electron microscopy Matsubara, 1977
Immunoelectron microscopy for lysozyme Ohtani and Sasano, 1988
Immunostaining for HD5 and HD6 Ostaff et al., 2015
Conventional H&E staining Rubio et al., 1987
Lysozyme immunostaining Rubio, 2012
Gallbladder Conventional H&E staining Albores-Saavedra et al., 1986
Conventional H&E staining Bae et al., 2002
Electron microscopy, H&E, Periodic acid-Schiff Laitio and Nevalainen, 1975
Conventional H&E staining Sakaki et al., 2000
Ovary Conventional H&E staining Alrajban et al., 2018
Conventional H&E staining Niemiec et al., 1989
Prostate Conventional H&E staining, immunostaining for lysozyme Frydman et al., 1992
Conventional H&E staining Adlakhaand Bostwick, 1994
(Shen et al., 2005). Additionally, Paneth-like cells were reported 
in gastric adenomas and carcinomas (Heitz and Wegmann, 1980; 
Ito et al., 1986; Caruso et al., 1989; Rubio, 1989) . Although some 
of these tumors exhibited aggressiveness (Ohtani and Sasano, 
1988), the prognostic value of these Paneth-like cells for gastric 
carcinoma remain unclear.
Inada et al. (1997) further classified gastric IM on the basis 
of differentiation status into two major classes (i) gastric and 
intestinal (GI) mixed type; and (ii) solely intestinal (I) type. Six 
subclasses were further established for the mixed GI type. In this 
study, they observed the presence and absence of Paneth cells in 
IM at almost the same incidence rate i.e., 15 and 17%, respectively 
in fundic mucosa. The incidences of intestinal subtypes with 
Paneth cells were 17% in fundic and 19% in pyloric mucosa, 
respectively. The incidences of G I(Su-Pa+) subtypes which are 
characterized as showing presence of Paneth cells (Pa) and 
absence of surface mucous cells (Su) were 11% in fundic and 14% 
in pyloric mucosa (Inada et al., 1997) . Within these metaplastic 
lesions, the presence of Paneth cells near the proliferative zone 
and the large intracellular granules suggested that these cells were 
neither chief cells nor pyloric gland cells (Inada et al., 1997) .
Matsubara performed morphological characterizations of 
Paneth cells and reported that Paneth cells in normal small 
intestinal epithelia contained more phagolysosomes in lower 
cytoplasm compared to Paneth cells found in IM (Matsubara, 
1977) . This represented one of the earliest attempts to distinguish 
intestinal resident cells vs. metaplastic Paneth cells. Gassler 
et al. (2002) later reported that the expression of calnexin was 
inversely related to secretory lysozyme in Paneth cells of normal
intestinal mucosa but became directly correlated to lysozyme in 
metaplastic Paneth cells in gastric mucosa. They further identified 
the expression of proliferative marker Ki67 in metaplastic Paneth 
cells but not in Paneth cells of normal small intestines. These 
studies suggested that metaplastic Paneth cells may behave 
differently from normal Paneth cells (Gassler et al., 2002). 
However, detailed information at the molecular level is currently 
absent to distinguish normal from metaplastic Paneth cells.
Most human gastric cancers arise after long-term H elicobacter 
pylori infection via progression of metaplastic changes, first 
named by Correa (Correa, 1992; Correa and Shiao, 1994; 
Uemura et al., 2001) with the first metaplastic change that 
increases risk for progression to cancer being atrophic gastritis, 
involving loss of acid secreting parietal cells with concomitant 
pseudopyloric metaplasia (aka SPEM, discussed below) of the 
remaining cells. Some authors believe IM is a requisite step 
after atrophy (Correa’s hypothesis), whereas others like David 
Graham (Graham et al., 2019) have suggested IM is more 
of a reparative lesion, not directly related to carcinogenesis, 
and atrophy is the more diagnostic risk factor (El-Zimaity 
et al., 2002) . In gastric atrophy, caused by long-term H. pylori 
colonization, mature chief cells that are present at the base of 
glands are replaced by (metaplastic) cell types that co-express 
both the chief cell marker and markers of normal mucus- 
secreting cells residing in the gland neck, such as Trefoil Factor 
2, TFF2 (spasmolytic polypeptide). This type of metaplasia was 
also known as spasmolytic polypeptide-expressing metaplasia 
(SPEM) or pseudopyloric metaplasia due to the lack of mature 
chief and parietal cells, resembling antrum or pyloric epithelium
(Goldenring et al., 2011; Saenz and Mills, 2018) . During SPEM, 
the differentiated cells change their fate to a regenerative state 
by first shutting down the mTORC1 signaling followed by 
expression of progenitor markers to reactivate mTORC1. This 
process was named as paligenosis (Jin and Mills, 2018; Willet 
et al., 2018) . In mouse models, SPEM emerged in chronically 
inflamed stomach and clearly proceeded to give rise to gastric 
cancer (Fox et al., 1996) . Inflammation due to infection or other 
insults increases paligenotic events. This continuous process 
of paligenosis increases the risk of accumulation of mutations 
leading to emergence of a neoplastic or dysplastic clone. This 
phenomenon was called “cyclical hit model” (Burclaff and Mills, 
2018; Saenz and Mills, 2018; Jin and Mills, 2019) . Although there 
is no study that has explicitly studied how Paneth cells originated 
during the process of metaplasia, a recent study by Leushacke 
et al. (2017) showed L G R 5+ subpopulation of chief cells co­
expressed intestinal stem cell and W nt markers in advanced 
intestinal type tumors in the corpus. Therefore, metaplastic 
Paneth cells could be part of the program of IM, the origin 
of which may relate to infection and inflammation but remain 
poorly understood.
Although the relevance of metaplastic Paneth cells during 
gastric mucosal pathogenesis are not clear, the characteristic 
production of antimicrobial peptides by Paneth cells suggested 
that the metaplasia might be an adaptive response to bacterial 
infection. Paneth cells secrete defensins and lysozyme shown 
to reduce the colonization of H. pylori in the stomach (Tanabe 
et al., 2008) . Interestingly, mucosal areas with IM or with pseudo- 
pyloric metaplasia showed a lack of H. pylori, suggesting presence 
of Paneth cells in the metaplastic mucosa may be an adaptation 
against bacterial infection (Rubio, 2015) . Gastric atrophy is 
characterized by the loss of chief and parietal cells and during 
infection this atrophy progresses from antrum to corpus (Kimura 
et al., 1996; Shichijo et al., 2015) . As H. pylori infection is 
associated with IM and a higher risk of cancer, attempts were 
made to reduce the infection (Fukase et al., 2008; Ogura et al., 
2008; Sakitani et al., 2011; Shichijo et al., 2016) . Some studies 
reported that IM did not seem alleviated even after eradication of 
H. pylori infection, suggesting the potentially irreversible nature 
of IM (Wang et al., 2011b; Kodama et al., 2012; Mera et al., 2018). 
However, other studies showed that eradication of H. pylori 
somewhat reduced the IM (Correa et al., 2000; Zullo et al., 
2000; Kong et al., 2014). In addition, Paneth cell antimicrobial 
peptides, especially human defensin 5 and 6, were recently found 
upregulated in gastric mucosa of heavy alcohol users (Ostaff et al., 
2015) . Thus, IM in gastric mucosa might also be caused by non- 
bacterial factors such as excessive alcohol use, retrograde bile 
reflux, aspirin, and anti-inflammatory drugs (Webb et al., 1996; 
Bresalier, 1998) . However, these changes may also indirectly alter 
the gastric colonization of H. pylori or other bacterial species. 
More studies are required to elucidate these causal relationships.
Metaplastic Paneth Cells in Esophageal 
Mucosa and Disease Relevance
The presence of Paneth cells in BE was first described by 
Schreiber et al. (1978), when metaplastic Paneth cells similar
to intestinal resident Paneth cells were detected in BE biopsy 
samples from 4 patients. BE is characterized by a single layer of 
columnar epithelium replacing the native multi-layered stratified 
squamous epithelium of distal esophagus. BE is considered as a 
form of protective adaption from chronic insults, secondary to 
gastroesophageal reflux disease (Burgess et al., 1971; Naef et al., 
1975; Ozzello et al., 1977), and the precursor to most esophageal 
adenocarcinomas. This esophageal disorder is pathologically 
manifested by the presence of multiple intestinal epithelial cell 
lineages including Paneth cells and enteroendocrine cells along 
with gastric cells (Boulton et al., 2003) .
Later, Thompson et al. (1983) exhibited the presence of 
Paneth cells in 50% of the esophagogastrectomy samples of 
Barrett’s metaplasia and specimens with adenocarcinoma at 
the gastroesophageal junction. No difference in sex ratio or 
age range was observed among the samples associated with 
or without metaplasia. Compared to earlier studies using 
biopsy samples, sampling error was minimized in this study 
using esophagogastrectomy. Moreover, various experimental 
approaches including scanning electron microscopy, specimen 
radiography, and dissecting microscopy along with regular 
histochemical techniques were used in this study in comparison 
to earlier studies that mainly relied on histologic analysis.
In the last decade, immunostaining for various antimicrobial 
peptides was used to identify Paneth cells. Shen et al. (2005) 
reported human defensin 5 immunostaining as a tool for 
identification of IM in BE as well as in gastric IM. Under normal 
conditions, human defensin 5 is present in intestinal Paneth 
cells, and is generally confined to the small intestinal epithelium. 
However, the expression of defensin 5 was also observed in 
IM. The frequency of human defensin 5 staining was higher in 
gastric IM compared to BE. This difference was attributed to 
higher H. pyloric infection in stomach compared to esophagus 
(Shen et al., 2005) .
Rubio also reported the presence of PCM in BE by 
detecting expression of lysozyme and other Paneth cell-specific 
antimicrobial proteins (Rubio, 2012) . In a recent study, Chen 
et al. (2015) conducted a large study on 757 esophageal 
biopsy specimens, and reported that 31% of this cohort with 
IM contained metaplastic Paneth cells. These results were in 
accordance with previous reports showing a similar frequency of 
PCM in BE (Schreiber et al., 1978; Thompson et al., 1983; Takubo 
et al., 1995). Moreover, the highest incidence of PCM in BE was 
observed in indefinite dysplasia and low grade dysplasia samples. 
Additionally, in their follow-up study, they showed PCM was 
associated with reduced disease regression and suggested it as a 
potential marker for identification of severe disease (Chen et al.,
2015) . Moreover, presence of metaplastic Paneth cell products 
such as antimicrobial peptides may accelerate the cascade of BE 
by altering the expression of E-cadherin, thereby reducing the 
cell-cell interaction (Nomura et al., 2013) .
Similar to gastric IM, BE was also viewed as an adaptation 
following chronic inflammation or injury to the esophageal 
epithelium. Bile acid was reported as one ofthe major contributor 
to the development of BE in animal models (Clark et al., 
1994; Quante et al., 2012). Patients with gastroesophageal reflux 
disease often received proton pump inhibitors, which could cause
reduced gastric acid secretion leading to bacterial overgrowth in 
BE. Additionally, it was reported that BE biopsies were highly 
associated with presence of bacteria compared to esophageal 
biopsies without BE (Osias et al., 2004) . Two different types 
of microbiome were observed in esophageal biopsies: type 
I was dominated by genus Streptococcus and present with 
phenotypically normal esophagus; and type II contained Gram­
negative anaerobes that were correlated with BE (Yang et al.,
2009) . Other studies also reported the presence of residential 
bacterial population in gastroesophageal reflux disease and BE. 
One study showed the presence of Bacteroidetes, Firmicutes, 
Proteobacteria, and Actinobacteria (Pei et al., 2005), while the 
other reported 46 bacterial species including high levels of 
Cam pylobacter consisus and Cam pylobacter rectus (Macfarlane 
et al., 2007) . Liu et al. (2013) also observed Firmicutes, 
Proteobacteria, Bacteroides, Fusobacterium, and Actinobacter in 
6 cases of BE. These studies suggested a potential rational toward 
a self defense mechanism against pathogenic bacteria. Therefore, 
presence of metaplastic Paneth-like cells in these lesions may 
represent an adaptive antibacterial response by the infected 
mucosa. However, besides an antibacterial role, defensins were 
also proposed to reduce E-cadherin in esophageal epithelium to 
possibly accelerate the BE pathogenesis (Nomura et al., 2013).
Appearance of Paneth Cells in Other 
Gastrointestinal and 
Non-gastrointestinal Organs
Intestinal metaplasia has also been observed in several other 
gastrointestinal tissues. Although IM in gallbladder is very 
rare, complete IM was reported in gallbladder as early as 
1967 (Jarvi and Lauren, 1967) . Laitio and Nevalainen (1975) 
studied 100 gallbladders following cholecystectomies to 
remove gallstones. One specimen showed the presence of 
Paneth cells. Electron microscopy of this sample showed 
Paneth cells in columnar shape with apical cytoplasm 
occupied by secretory granules and well-developed Golgi 
apparatus. Later, Albores-Saavedra et al. (1986) reported 
that 3 out of 49 gallbladder samples showed the presence 
of Paneth cells. The presence of similar morphology in the 
IM in gallbladder to those in the stomach suggested that 
gastric and gallbladder epithelia have the same potential 
to differentiate into similar cell lineages. Although the IM 
of gallbladder containing Paneth cells was suspected to be 
associated with carcinoma development, the presence of higher 
immunoreactivity of lysozyme in non-dysplastic mucosa than 
in carcinoma did not support the hypothesis. Furthermore, the 
frequency of observing Paneth cells was found to be lowest in 
gallbladder cancer tissues compared to non-neoplastic mucosa, 
suggesting an inverse correlation of PCM to gallbladder cancer 
(Yamamoto et al., 1989). This observation was consistent 
with a recent comprehensive case-control study of 1,900 
colorectal adenomas showing metaplastic Paneth cells in distal 
colorectal adenomas were inversely associated with synchronous 
advanced adenoma and carcinoma (Mahon et al., 2016) . Sakaki 
et al. (2000) observed a case of gallbladder adenocarcinoma 
with extensive PCM.
Moreover, PCM was also observed in intestinal type 
cholangiocarcinoma associated with hepatolithiasis in large 
hepatic bile duct (Bae et al., 2002) . Abnormal cholesterol and bile 
acid metabolism and secretion are common pathophysiological 
defects in gallbladder-related diseases. The presence of 
metaplastic Paneth cells in these diseases could be attributed to 
the presence of bacterial community. Bile-acid metabolism was 
reported to be regulated by the gut microbiome, thus the role 
of microbiota in disease cannot be overruled (Abeysuriya et al., 
2008; Wang et al., 2009; Sayin et al., 2013) . Similarly, the presence 
of microbiota in lithogenic bile could also promote inflammation 
and gall stones (White et al., 2006; Capoor et al., 2008; Sekirov 
et al., 2010) and microbiota association with gallstones was well 
reported (Kaufman et al., 1989; Lee et al., 1999; Maurer et al., 
2005; Saltykova et al., 2016) . Additionally, various microbes 
have also been isolated from bile in patients with cholesterol 
stones (Stewart et al., 1987; Cull and Beck, 1988; Darko and 
Archampong, 1994). Although, no study has established a direct 
correlation of PCM and the presence of bacteria in gallbladder 
related diseases, existing studies showed the presence of bacterial 
communities in lithogenic bile (Abeysuriya et al., 2008) and 
metaplastic Paneth cells in gallbladder with gallstones (Laitio and 
Nevalainen, 1975) . Therefore, the presence of Paneth cells could 
be a protective mechanism against the pathogenic bacteria in 
lithogenic bile.
Alrajban et al. (2018) reported the first PCM in Krukenberg 
tumors, which represents 1-2%  of ovarian tumors and are 
characterized by the presence of metastatic adenocarcinoma 
cells. A poorly differentiated carcinoma was observed to contain 
a mixture of signet ring malignant cells with eosinophilic 
cytoplasm characteristic of PCM. PCM was also observed in the 
lining of urethral diverticulum (Niemiec et al., 1989), a condition 
in which a variable sized pouch is formed. The E. coli was 
the most common organism among other enteric gram-negative 
bacteria isolated from urethral diverticulum patients (Ljungqvist 
et al., 2007; Greiman et al., 2019) . Since urethral diverticulum 
is connected to the urethra and filled during urination, the 
metaplastic change in urethral lining could be due to exposure 
to irritants like bacterial colonization and retained urine. Thus, 
the metaplastic Paneth cells could again be an anti-bacterial 
response in this scenario. The reported presence of Paneth cells 
in neovaginitis (van der Sluis et al., 2016) might suggest a similar 
adaptive response to combat bacterial presence.
Intestinal metaplasia has been described in both benign 
and malignant prostate glands following estrogen therapy 
(Bainborough, 1952; Maung et al., 1988) . Paneth cell-like 
metaplasia of prostate gland was first reported by Frydman 
et al. (1992). Adlakha and Bostwick later reported that these 
Paneth cell-like changes resembled intestinal Paneth cells by light 
microscopy. However, they lacked lysozyme immunoreactivity, 
and retained many prostate markers. Since these Paneth-like 
cells were positive for neuroendocrine markers, they were called 
“neuroendocrine cells with large eosinophilic granules” (Adlakha 
and Bostwick, 1994) . PCM was also found in epididymis 
disorders (Nevalainen et al., 2001; Nistal et al., 2007) . Together, 
these Paneth-like cells may represent transformed normal or 
neoplastic prostate cells.
The association of infection and inflammation had been 
investigated in many prostate cancer studies. In a recent study, 
Shrestha et al. (2018) showed that urine samples of patients 
with biopsy-proven prostate cancer had increased bacterial 
clusters frequently associated with other urogenital infections 
such as prostatitis and bacterial vaginosis (Massari et al., 2019). 
Additionally, a recent study testing prostatic fluid from prostate 
cancer and non-prostate cancer patients showed the presence of 
microbes in both samples, but revealed a difference in microbial 
species (Ma et al., 2019) . Similarly, the presence of microbiota 
within tumoral, peritumoral and non-tumoral prostate tissue 
has also been reported (Cavarretta et al., 2017) . Thus, whether 
emergence of Paneth like cells in prostate pathology represented 
another form of protective mechanism against bacteria may 
require future investigation.
CLOSING REMARKS
The mucosa of the gastrointestinal tract is continuously 
challenged by various micro-environmental factors ranging 
from pathogenic and opportunistic bacteria, and their products, 
to harsh secretions with digestive properties. In turn, human 
body has developed defense mechanisms like peristalsis, 
continuous revival of lining epithelium, and production 
of antimicrobial peptides, such as those secreted by the
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